<SEC-DOCUMENT>0001193125-23-053968.txt : 20230228
<SEC-HEADER>0001193125-23-053968.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228163102
ACCESSION NUMBER:		0001193125-23-053968
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230228
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COMMUNITY HEALTH SYSTEMS INC
		CENTRAL INDEX KEY:			0001108109
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				133893191
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15925
		FILM NUMBER:		23686017

	BUSINESS ADDRESS:	
		STREET 1:		4000 MERIDIAN BOULEVARD
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-465-7000

	MAIL ADDRESS:	
		STREET 1:		4000 MERIDIAN BOULEVARD
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMMUNITY HEALTH SYSTEMS INC/
		DATE OF NAME CHANGE:	20000229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d449097d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cyh="http://www.chs.net/20230228" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-02-28_to_2023-02-28">COMMUNITY HEALTH SYSTEMS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-02-28_to_2023-02-28">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-02-28_to_2023-02-28">0001108109</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cyh-20230228.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-02-28_to_2023-02-28"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001108109</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-28</xbrli:startDate> <xbrli:endDate>2023-02-28</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-02-28_to_2023-02-28">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): February&#160;28, 2023 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt:datemonthdayyearen">February 28, 2023</ix:nonNumeric>)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">COMMUNITY HEALTH SYSTEMS, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-02-28_to_2023-02-28">001-15925</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-02-28_to_2023-02-28">13-3893191</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-02-28_to_2023-02-28">4000 Meridian Boulevard</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-02-28_to_2023-02-28">Franklin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-02-28_to_2023-02-28">37067</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-02-28_to_2023-02-28">(615)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-02-28_to_2023-02-28">465-7000</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-02-28_to_2023-02-28">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-02-28_to_2023-02-28">CYH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-02-28_to_2023-02-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;28, 2023, CHS/Community Health Systems, Inc. (&#8220;CHS&#8221;), a wholly-owned subsidiary of Community Health Systems, Inc. (the &#8220;Company&#8221;), entered into an Asset Purchase Agreement (&#8220;Purchase Agreement&#8221;) with Novant Health, Inc., a North Carolina <span style="white-space:nowrap">non-profit</span> corporation (&#8220;Purchaser&#8221;). Pursuant to the Purchase Agreement, and subject to the terms and conditions set forth therein, Purchaser has agreed to acquire substantially all of the assets, and assume certain liabilities, from CHS related to, (i)&#160;Lake Norman Regional Medical Center in Mooresville, North Carolina and (ii)&#160;Davis Regional Medical Center in Statesville, North Carolina (the transactions contemplated by the Purchase Agreement, the &#8220;Transaction&#8221;). The total purchase price payable by Purchaser to CHS at the closing of the Transaction is $320&#160;million in cash, subject to adjustment based on closing net working capital and the amount of any capitalized leases assumed by Purchaser. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement contains various representations, warranties and covenants made by the parties. The Purchase Agreement also provides for indemnification by the parties with respect to breaches of representations, warranties and covenants by such parties, as well as with respect to certain other indemnifiable matters specified in the Purchase Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The closing of the Transaction is subject to the satisfaction or waiver of certain closing conditions set forth in the Purchase Agreement, which includes the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. Consummation of the Transaction is currently expected to occur in the second half of 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement may be terminated by either party under certain circumstances set forth in the Purchase Agreement, including if the Transaction is not consummated on or before December&#160;31, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement provides that, at closing, the parties, and/or their respective affiliates, will enter into certain ancillary agreements, including transition services agreements under which CHS and/or an affiliate thereof will provide certain information technology and operational transition<span style="font-weight:bold"> </span>services to Purchaser for a period of 12<span style="font-weight:bold"> </span>months following the closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Transaction and the terms and conditions of the Purchase Agreement is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, which is attached hereto as <span style="text-decoration:underline">Exhibit 2.1</span> and incorporated herein by reference. The representations, warranties, and covenants contained in the Purchase Agreement were made solely for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to the Purchase Agreement, may have been qualified in the Purchase Agreement by confidential disclosure schedules (which disclosure schedules may contain information that modifies, qualifies and creates exceptions to the representations, warranties and covenants set forth in the Purchase Agreement), may be subject to limitations and contractual risk allocation mechanisms agreed upon by the parties to the Purchase Agreement, and may be subject to standards of materiality that differ from what an investor may view as material, and thus should not be relied upon as necessarily reflecting the actual state of facts or conditions. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;28, 2023, the Company issued a press release announcing CHS&#8217;s and Purchaser&#8217;s entry into the Purchase Agreement. A copy of this press release is attached hereto as <span style="text-decoration:underline">Exhibit 99.1</span> and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Forward-Looking Statements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;contains</span> forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, Section&#160;21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. These forward-looking statements are based on the Company&#8217;s current beliefs, understandings and expectations. These forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond the Company&#8217;s control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied include: (i)&#160;the parties to the Purchase Agreement may be unable to complete the Transaction in a timely manner or at all, because, among other reasons, </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions to the closing of the Transaction set forth in the Purchase Agreement may not be satisfied or waived; (ii)&#160;uncertainty as to the timing of completion of the Transaction; (iii)&#160;the occurrence of any event, change or other circumstances that could give rise to the termination of the Purchase Agreement; (iv)&#160;risks related to disruption of management&#8217;s attention from the Company&#8217;s ongoing business operations; (v)&#160;the outcome of any legal proceedings to the extent initiated against the parties to the Purchase Agreement or others related to the Transaction; (vi)&#160;post-closing risks related to the transition services agreement and ancillary agreements to be entered into at closing as noted above; and (vii)&#160;the ability of the Company to execute on its strategy and achieve its goals and other expectations after any completion of the Transaction, as well as the risks set forth in our Annual Report on <span style="white-space:nowrap">Form&#160;10-K&#160;for</span> the year ended December&#160;31, 2022, filed with the Securities and Exchange Commission on February&#160;17, 2023, and the Company&#8217;s other filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">ITEM&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:95%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d449097dex21.htm">Asset Purchase Agreement, dated as of February&#160;28, 2023, by and between CHS/Community Health Systems, Inc. and Novant Health, Inc.<span style="font-weight:bold">*</span> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d449097dex991.htm">Community Health Systems, Inc. Press Release, dated February&#160;28, 2023 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> The Company agrees to furnish, on a supplemental basis, a copy of such omitted schedules and exhibits to the Securities and Exchange Commission upon request. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: February&#160;28, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">COMMUNITY HEALTH SYSTEMS, INC.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">(Registrant)</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#160;&#160;/s/ Tim L. Hingtgen</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Tim L. Hingtgen</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">(principal executive officer)</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d449097dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET
PURCHASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BY AND BETWEEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHS/COMMUNITY HEALTH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOVANT HEALTH,
INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">February&nbsp;28, 2023 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PURCHASE OF ASSETS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assumed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of the Acquired Company Ownership Interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Working Capital, Estimates and Audits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Patients</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prorations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions of Seller at Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions of Buyer at Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REPRESENTATIONS AND WARRANTIES OF SELLER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existence and Capacity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Powers; Consents; Absence of Conflicts With Other Agreements, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Binding Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absence of Certain Changes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medicare Participation/Accreditation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title to Other Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation or Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Relations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third-Party Payor Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Staff Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condition of Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Experimental Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.26</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates of Need</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.27</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Representations with Respect to the Hospitals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.28</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Partial Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">REPRESENTATIONS AND WARRANTIES OF BUYER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existence and Capacity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Powers; Consents; Absence of Conflicts With Other Agreements, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Binding Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Availability of Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COVENANTS OF SELLER PRIOR TO CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Negative Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Financial Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">No-Shop</FONT> Clause</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Efforts to Close</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estoppels and Contract Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee List</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COVENANTS OF BUYER PRIOR TO CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Commitment and Surveys</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Efforts to Close</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CONDITIONS PRECEDENT TO OBLIGATIONS OF BUYER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representations/Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Policy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions/Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Material Adverse Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insolvency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting/Recordation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Deliveries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representations/Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Actions/Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insolvency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Deliveries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SELLER&#146;S COVENANT NOT TO COMPETE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ADDITIONAL AGREEMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Allocation of Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Prior to Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Closing Access to Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preservation and Access to Records After the Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax and Medicare Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reproduction of Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cooperation on Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Misdirected Payments, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indigent Care Policies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Use of Controlled Substance Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Staff Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transition Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Billing and Collection Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">License Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Records Including as to Recovery and Audit Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuation of Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Quality Reporting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Telephone Access</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guaranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medicare Transition Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Seller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limitations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice and Control of Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Claim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mitigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exclusive Remedy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Schedules and Exhibits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Assurances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consented Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consents, Approvals and Discretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Choice of Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit/Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Brokerage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of Transaction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(continued) </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public Announcements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gender and Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Divisions and Headings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Survival</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Inferences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limited Third Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement/Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk of Loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.26</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBITS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B><I>Description</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I>Exhibit</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limited Power of Attorney</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">C</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">SCHEDULES</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B><I>Description</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I>Schedule</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)(i)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)(ii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provider Numbers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(j)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Working Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absence of Certain Changes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medicare Participation/Accreditation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property &#150; Violations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Zoning</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenants and Rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rent Roll</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eminent Domain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(e)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of First Refusal (Real Property)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10(f)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation or Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Relations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third-Party Payor Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Medical Staff Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condition of Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance Program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates of Need</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Representations with Respect to the Hospitals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Partial Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">vi </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">GLOSSARY OF CERTAIN DEFINED TERMS </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B><I>Defined Term</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><B><I>Section</I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Firm</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment and Assumption Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance Sheet Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.4(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Business Associate Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(j)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recital B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Indemnified Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CERCLA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.12(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recital D</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FTC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Government Entity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospitals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recital C</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immaterial Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnifying Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Services Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(j)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Justice Department</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">License Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2(m)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Working Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permitted Encumbrances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RCRA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Introduction</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Cost Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">vii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Entities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recital&nbsp;A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Indemnified Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State Health Agency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surveys</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Commitment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title Policy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WARN Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.16(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">viii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS ASSET PURCHASE AGREEMENT</B> (the &#147;Agreement&#148;) is made and entered into as of February&nbsp;28, 2023, by and between
<B>CHS/COMMUNITY HEALTH SYSTEMS, INC.</B>, a Delaware corporation (&#147;Seller&#148;), and <B>NOVANT HEALTH, INC.</B>, a North Carolina <FONT STYLE="white-space:nowrap">non-profit</FONT> corporation which is exempt from federal income tax as an
organization described in Section&nbsp;501(c)(3) of the Code (&#147;Buyer&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A</B>.&nbsp;&nbsp;&nbsp;&nbsp;Seller owns or controls, directly or indirectly, the organizations listed on
<U>Exhibit</U><U></U><U>&nbsp;A</U> attached hereto (each a &#147;Seller Entity&#148; and together the &#147;Seller Entities&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>B</B>.&nbsp;&nbsp;&nbsp;&nbsp;Buyer owns or controls, directly or indirectly, the organizations listed on
<U>Exhibit</U><U></U><U>&nbsp;B</U> attached hereto (each a &#147;Buyer Entity&#148; and together the &#147;Buyer Entities&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>C</B>.&nbsp;&nbsp;&nbsp;&nbsp;The Seller Entities directly or indirectly own and operate Lake Norman Regional Medical Center in
Mooresville, North Carolina, and Davis Regional Medical Center in Statesville, North Carolina (each, a &#147;Hospital&#148; and collectively, the &#147;Hospitals&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>D</B>.&nbsp;&nbsp;&nbsp;&nbsp;Seller desires to cause the Seller Entities to sell to the Buyer Entities and Buyer desires to cause the
Buyer Entities to purchase substantially all of the assets of the Seller Entities which are directly or indirectly related to, necessary for, or used in connection with, the operation of the Hospitals, together with certain related businesses,
including but not limited to medical office buildings, outpatient care facilities, physician practices and ancillary services (collectively with the Hospitals, the &#147;Facilities&#148;), on the terms and conditions set forth in this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>E.</B>&nbsp;&nbsp;&nbsp;&nbsp;A Seller Entity owns all of the issued and outstanding membership interests (the &#147;Acquired Company
Ownership Interests&#148;) in Piedmont Surgical Center of Excellence, LLC, a Delaware limited liability company (the &#147;Acquired Company&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>F.</B>&nbsp;&nbsp;&nbsp;&nbsp;Such Seller Entity desires to sell to a Buyer Entity and the Buyer desires that a Buyer Entity purchase from
the applicable Seller Entity the Acquired Company Ownership Interests, on the terms and conditions set forth in this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW,
THEREFORE</B>, for and in consideration of the premises and the mutual agreements, covenants, representations, and warranties hereinafter set forth and other good and valuable consideration, the receipt and adequacy of which are forever acknowledged
and confessed, the parties hereto agree as follows: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PURCHASE OF ASSETS. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Assets</I></B>. Subject to the terms and conditions of this Agreement, as of the Closing (as
defined in <U>Section</U><U></U><U>&nbsp;2.1</U> hereof), Seller agrees to cause the Seller Entities to sell, convey, transfer, assign and deliver to the Buyer Entities, and Buyer agrees to cause the Buyer Entities to purchase, all of the assets
owned or used by the Seller Entities in connection with the operation of the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Facilities, other than the Excluded Assets (hereinafter defined)(collectively, the &#147;Assets&#148;), which Assets shall include, without limitation, the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;fee simple title to the real property described in <U>Schedule 1.1(a)(i)</U> hereto, together with
all improvements, any construction in progress, any other buildings and fixtures thereon, and all rights, privileges and easements appurtenant thereto (collectively, the &#147;Owned Real Property&#148;), and leasehold title to the real property that
is leased, <FONT STYLE="white-space:nowrap">sub-leased</FONT> or otherwise licensed by the Seller Entities pursuant to the leases, subleases or licenses described in <U>Schedule</U><U></U><U>&nbsp;1.1(a)(ii)</U> (collectively, the &#147;Leased Real
Property&#148;) (the Owned Real Property and the Leased Real Property are collectively referred to herein as the &#147;Real Property&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all tangible personal property, including, without limitation, all major, minor or other equipment,
vehicles, furniture and furnishings of the Seller Entities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all supplies and inventory used or
held for use in respect of the Facilities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;assumable deposits and prepaid expenses that have
continuing value to the Buyer Entities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all claims of the Seller Entities against third parties
to the extent such claims relate to the condition of the Assets and, to the extent assignable, all warranties (express or implied) and rights and claims assertable by (but not against) the Seller Entities related to the Assets; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;to the extent legally transferable, all right, title and interest in the financial, patient, medical
staff and personnel records relating to the Facilities (including, without limitation, all equipment records, medical administrative libraries, medical records, documents, catalogs, books, records, files, operating policies and procedures, manuals
and current personnel records); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all rights and interests in the contracts, commitments, leases,
licenses and agreements listed in <U>Schedule 1.1(g)</U> hereto and all Immaterial Contracts (hereinafter defined) (the contracts being assigned are referred to herein as the &#147;Contracts&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all licenses and permits, to the extent legally assignable, held by the Seller Entities relating to
the ownership, development, and operation of the Facilities (including, without limitation, any pending or granted governmental approvals); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;the trade names, trademarks, service marks (or variations thereof), domain names and copyrights
listed in <U>Schedule 3.24</U>, all goodwill associated therewith, and all applications or registration associated therewith; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;to the extent legally transferable, all provider numbers listed in
<U>Schedule</U><U></U><U>&nbsp;1.1(j)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all goodwill associated with the Facilities and the
Assets; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;petty cash; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;the telephone numbers used in connection with the business or operation of the Facilities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all computer hardware and data processing equipment
located at the Facilities to the extent assignable or transferable, and all rights in warranties of any manufacturer or vendor with respect thereto; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;whether or not reflected in the financial statements, wherever located and whether or not similar to
the items specifically set forth, all other businesses and ventures owned by the Seller Entities in connection with the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(p)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all property and rights of the foregoing types arising or acquired by the Seller Entities between the
date hereof and the Closing Date; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(q)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all other property of every kind, character or description
owned, leased or licensed by the Seller Entities and used or held for use in the business of the Facilities or the Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Excluded Assets</I></B>. Those assets of the Seller Entities described below, together with any
assets described in <U>Schedule 1.2</U> hereto, shall be retained by the Seller Entities (collectively, the &#147;Excluded Assets&#148;) and shall not be conveyed to the Buyer Entities: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;cash, cash equivalents and marketable securities (except petty cash); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;board-designated, restricted and trustee-held or escrowed funds (such as funded depreciation, debt
service reserves, working capital trust assets, and assets and investments restricted as to use) and accrued earnings thereon; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all amounts payable to the Seller Entities in respect of third-party payors pursuant to retrospective
settlements (including, without limitation, pursuant to Medicare, Medicaid and CHAMPUS/TRICARE cost reports filed or to be filed by the Seller Entities for periods prior to the Effective Time, retrospective payment of claims that are the subject of
Centers for Medicare and Medicaid Services (&#147;CMS&#148;) Recovery Audit Contractor appeals, and all payments for periods prior to the Effective Time related to all Medicaid programs including but not limited to Uncompensated Care (UC),
Disproportionate Share (DSH), Delivery System Reform Incentive Payment (DSRIP), Uniform Hospitals Rate Increase Program (UHRIP), Hospitals Quality-Based Payment Program for Potentially Preventable Readmissions (PPR) and Potentially Preventable
Complications (PPC), and Uncompensated Trauma Care), and all appeals and appeal rights of the Seller Entities relating to such settlements, including cost report settlements, for periods prior to the Effective Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all Seller Entity records relating to (i)&nbsp;litigation files and records, cost report records
relating to periods of time prior to Closing, tax returns and minute books, and (ii)&nbsp;the Excluded Assets and Excluded Liabilities to the extent that the applicable Buyer Entity does not need the same in connection with the operation of the
Facilities, as well as all records which, by law, the Seller Entities are required to maintain in their possession; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;prepaid insurance, prepaid assets dedicated to the Seller Entities&#146; benefit plans and any
reserves or prepaid expenses related to Excluded Assets and Excluded Liabilities (such as prepaid legal expenses); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all accounts receivable arising from the rendering
of services to patients at the Facilities, billed and unbilled, recorded or unrecorded, with collection agencies or otherwise, accrued and existing in respect of services rendered prior to the Effective Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any and all names, symbols, trademarks, logos or other symbols used in connection with the Facilities
and the Assets which include the names &#147;CHS,&#148; &#147;Community Health Systems&#148; or any variants thereof or any other names which are proprietary to Seller or its Affiliates and are not used exclusively in the connection with the
operation of the Facilities (the &#147;Excluded Marks&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any computer software and programs
which are proprietary to Seller or its Affiliates; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;receivables from or obligations with Seller
or its Affiliates; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;the Seller Entities&#146; insurance proceeds arising from <FONT
STYLE="white-space:nowrap">pre-Effective</FONT> Time incidents and the Seller Entities&#146; assets held in connection with any self-funded insurance programs and reserves, if any; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any claims of the Seller Entities against third parties to the extent that such claims relate to the
operation of the Facilities prior to the Effective Time or to the Excluded Assets or Excluded Liabilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all of Seller&#146;s or any Affiliate&#146;s proprietary manuals, marketing materials, policy and
procedure manuals, standard operating procedures and marketing brochures, data and studies or analyses; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all assets and rights related to the Benefit Plans and any other benefit plan, program, or
arrangement that is sponsored, maintained, contributed to or required to be contributed to by the Seller Entities&#146; or any of their Affiliates; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all assets solely relating to home health or hospice operations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all national or regional contracts of Seller or any Affiliate which are made available to any of the
Facilities by virtue of the Facilities being an Affiliate of Seller; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(p)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;the electronic funds
transfer accounts of the Facilities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(q)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all rights of the Seller Entities in any contracts,
commitments, leases and agreements which are not included in the Contracts; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(r)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any claims
against third-party payors relating to underpayments or violation of prompt pay statutes with respect to periods prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Assumed Liabilities</I></B>. In connection with the conveyance of the Assets hereunder, Buyer
shall cause the Buyer Entities to assume, as of the Effective Time, the future payment and performance of the following liabilities (the &#147;Assumed Liabilities&#148;) of the Seller Entities: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all obligations accruing from and after the Effective Time with respect to the Contracts; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;the finance lease obligations set forth in
<U>Schedule 1.3</U> hereto; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all obligations and liabilities as of the Effective Time in
respect of accrued vacation and holiday benefits of Seller Employees who are hired by the Buyer Entities as of the Effective Time, and related taxes, but only to the extent included in the determination of Net Working Capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Excluded Liabilities</I></B>. Except for the Assumed Liabilities, the Buyer Entities shall not
assume and under no circumstances shall the Buyer Entities be obligated to pay or assume, and none of the assets of the Buyer Entities shall be or become liable for or subject to any liability, indebtedness, commitment, or obligation of the Seller
Entities, whether known or unknown, fixed or contingent, recorded or unrecorded, currently existing or hereafter arising or otherwise (collectively, the &#147;Excluded Liabilities&#148;), including, without limitation, the following Excluded
Liabilities: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any debt, obligation, expense or liability that is not an Assumed Liability; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;claims or potential claims for medical malpractice or general liability relating to acts or omissions
asserted to have occurred prior to the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;those claims and obligations (if any)
specified in <U>Schedule 1.4</U> hereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any liabilities or obligations associated with or
arising out of any of the Excluded Assets; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;liabilities and obligations of the Seller Entities in
respect of periods prior to the Effective Time arising under the terms of the Medicare, Medicaid, CHAMPUS/TRICARE, Blue Cross, or other third-party payor programs, as well as under the Coronavirus Aid, Relief, and Economic Security Act (Pub. L. <FONT
STYLE="white-space:nowrap">116-136),</FONT> as amended (the &#147;CARES Act&#148;), including, without limitation, in respect of any cost report, any audit under the Medicare RAC program or any noncompliance with applicable law or contractual
obligations related to the billing or collection of services, CARES Act funding and any liability arising pursuant to the Medicare, Medicaid, CHAMPUS/TRICARE, Blue Cross, or any other third-party payor programs as a result of the consummation of any
of the transactions contemplated under this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;federal, state or local tax liabilities
or obligations of the Seller Entities in respect of periods prior to the Effective Time or resulting from the consummation of the transactions contemplated herein including, without limitation, any income tax, any franchise tax, any tax recapture,
any sales and/or use tax, and any FICA, FUTA, workers&#146; compensation, and any and all other taxes or amounts due and payable as a result of the exercise by the employees at the Facilities of such employees&#146; right to vacation, sick leave,
and holiday benefits accrued while in the employ of the Seller Entities (provided, however, that this clause (f)&nbsp;shall not apply to any and all taxes payable with respect to any employee benefits constituting Assumed Liabilities under
<U>Section</U><U></U><U>&nbsp;1.3(c)</U> hereof); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;liability for any and all claims by or on behalf of
the Seller Entities&#146; employees relating to periods prior to the Effective Time including, without limitation, liability for any compensation-related payments, pension, profit sharing, deferred compensation, equity or equity-related
compensation, incentive compensation, fringe benefit, tuition reimbursement, severance, termination pay, change in control or retention payments, bonuses or any other employee benefit plan of whatever kind or nature or any employee health and
welfare benefit plans, liability for any EEOC claim, ADA claim, FMLA claim, wage and hour claim, unemployment compensation claim, or workers&#146; compensation claim, and any liabilities or obligations to former employees of the Seller Entities
under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (provided, however, that this clause (g)&nbsp;shall not apply to any and all employee benefits constituting Assumed Liabilities under
<U>Section</U><U></U><U>&nbsp;1.3(c)</U> hereof); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any obligation or liability accruing, arising
out of, or relating to any federal, state or local investigations of, or claims or actions against, the Seller Entities or any of their Affiliates or any of their employees, medical staff, agents, vendors or representatives with respect to acts or
omissions prior to the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any civil or criminal obligation or liability accruing,
arising out of, or relating to any acts or omissions of the Seller Entities, their Affiliates or, to the extent related to their services to the Seller Entities, their directors, officers, employees and agents claimed to violate any constitutional
provision, statute, ordinance or other law, rule, regulation or order of any governmental entity; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;liabilities or obligations arising out of any breach by the Seller Entities prior to the Effective
Time of any Contract; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;liabilities or obligations arising as a result of any breach by the Seller
Entities at any time of any contract or commitment that is not expressly assumed by the Buyer Entities in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any debt, obligation, expense, or liability of the Seller Entities arising out of or incurred solely
as a result of any transaction of the Seller Entities occurring after the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;any
liability of the Seller Entities relating to violations of law, including but not limited to violations of federal or state laws regulating fraud such as the federal Anti-Kickback Law (42 U.S.C.
<FONT STYLE="white-space:nowrap">&#167;&nbsp;1320(a)-7(b)</FONT> <U>et</U> <U>seq</U>.) (the &#147;Anti-Kickback Law&#148;), the Ethics in Patient Referrals Act (42 U.S.C. &#167;&nbsp;1395mm <U>et</U> <U>seq</U>.) (the &#147;Stark Law&#148;), and
the False Claims Act (31 U.S.C. &#167; 3729 <U>et</U> <U>seq</U>.) (the &#147;False Claims Act&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;all liabilities and obligations relating to any oral agreements, oral contracts or oral
understandings with any referral sources including, but not limited to, physicians, unless reduced to writing, identified in <U>Schedule 1.1(g)</U> hereto, and expressly assumed as part of the Contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Sale of the Acquired Company Ownership Interests</I></B><B><I></I></B><B><I></I></B><B><I>.
</I></B>Subject to the terms and conditions of this Agreement, at the Closing, a Seller Entity shall sell, convey, transfer and deliver to a Buyer Entity, free and clear of all encumbrances, and the Buyer Entity shall purchase from the Seller
Entity, the Acquired Company Ownership Interests. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.6</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Purchase Price</I></B>. The purchase price
(the &#147;Purchase Price&#148;) for the Assets and the Acquired Company Ownership Interests shall be Three Hundred Twenty Million Dollars ($320,000,000), <U>plus</U> or <U>minus</U> the amount by which the Net Working Capital (as defined in
<U>Section</U><U></U><U>&nbsp;1.7(a)</U>) of the Seller Entities as of the Effective Time exceeds or is less than Five Million Six Hundred Eighty-Nine Thousand Dollars ($5,689,000), respectively, and <U>minus</U> the amount of the capitalized leases
set forth in <U>Schedule 1.3</U> that are assumed by the Buyer Entities. The Purchase Price shall be calculated as of the Closing based upon the estimated Net Working Capital (as determined in accordance with
<U>Section</U><U></U><U>&nbsp;1.7(b)</U>). The Purchase Price shall be adjusted after the Closing in accordance with <U>Section</U><U></U><U>&nbsp;1.7(a)</U> to reflect the actual Net Working Capital as of the Effective Time (as determined in
accordance with <U>Section</U><U></U><U>&nbsp;1.7(b)</U>). The Purchase Price shall be due and payable on the Closing Date by wire transfer of immediately available funds to an account designated by Seller. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.7&nbsp;&nbsp;&nbsp;&nbsp;Net Working Capital, Estimates and Audits. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Net Working Capital</I></B>. As used herein, the term &#147;Net Working Capital&#148; shall mean
the aggregate current assets of the Seller Entities conveyed to the Buyer Entities pursuant to <U>Section</U><U></U><U>&nbsp;1.1</U> hereof (excluding those Excluded Assets which would otherwise be included in current assets), <U>minus</U> the
aggregate current liabilities of the Seller Entities assumed by the Buyer Entities pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U> hereof (excluding those Excluded Liabilities which would otherwise be included in current liabilities), all as
determined in accordance with United States generally accepted accounting principles in effect from time to time in accordance with standards established by the Financial Accounting Standards Board (&#147;GAAP&#148;). In any case, with respect to
the computation of Net Working Capital (i)&nbsp;the following shall be included in current assets: petty cash, prepaid expenses and deposits, and supplies and inventory, and (ii)&nbsp;the following shall be included in current liabilities: accrued
liabilities for vacation and holiday benefits for employees of the Seller Entities who are hired by the Buyer Entities. For the avoidance of doubt, the computation of Net Working Capital shall not include any of the foregoing as they relate to the
Partial Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Estimates and Adjustments</I></B>. Attached hereto as <U>Schedule
1.7</U> is a schedule of the mutually agreed upon Net Working Capital as of December&nbsp;31, 2022, together with the principles, specifications and methodologies used in determining such Net Working Capital. At least ten (10)&nbsp;business days
prior to Closing, Seller shall deliver to Buyer a reasonable estimate of Net Working Capital as of the end of the most recently ended calendar month prior to the Closing Date for which financial statements are available and containing reasonable
detail and supporting documents showing the derivation of such estimate. The Net Working Capital shall be estimated following the same mutually agreed upon principles, specifications and methodologies used to determine the Net Working Capital as of
December&nbsp;31, 2022, as specified in <U>Schedule 1.7</U>, and shall be used for purposes of calculating the Purchase Price as of the Closing. Within ninety (90)&nbsp;days after the Closing, Seller shall deliver to Buyer its determination of the
Net Working Capital as of the Closing (following the same principles, specifications and methodologies used to determine the Net Working Capital as set forth in <U>Schedule 1.7</U> and the estimated Net Working Capital as of the Closing). Each party
shall have full access to the financial books and records pertaining to the Facilities to confirm or audit Net Working Capital computations. Should Buyer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
disagree with Seller&#146;s determination of Net Working Capital, it shall notify Seller within sixty (60)&nbsp;days after Seller&#146;s delivery of its determination of Net Working Capital. If
Seller and Buyer fail to agree within thirty (30)&nbsp;days after Buyer&#146;s delivery of notice of disagreement on the amount of Net Working Capital, such disagreement shall be resolved in accordance with the procedure set forth in
<U>Section</U><U></U><U>&nbsp;1.7(c)</U>, which shall be the exclusive remedy for resolving accounting disputes relative to the determination of Net Working Capital. The Purchase Price shall be increased or decreased based on actual Net Working
Capital as of the Closing, and within five (5)&nbsp;business days after determination thereof any increase shall be paid in cash by Buyer to Seller, and any decrease shall be paid in cash to Buyer by Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Dispute of Adjustments</I></B>. In the event that Seller and Buyer are not able to agree on the
actual Net Working Capital within thirty (30)&nbsp;days after Buyer&#146;s delivery of notice of disagreement, Seller and Buyer shall each have the right to require that such disputed determination be submitted to such independent certified public
accounting firm as Seller and Buyer may then mutually agree upon in writing (the &#147;Accounting Firm&#148;) for computation or verification in accordance with the provisions of this Agreement. The Accounting Firm shall review the matters in
dispute and, acting as arbitrators, shall promptly decide the proper amounts of such disputed entries (which decision shall also include a final calculation of Net Working Capital). The submission of the disputed matter to the Accounting Firm shall
be the exclusive remedy for resolving accounting disputes relative to the determination of Net Working Capital. The Accounting Firm&#146;s determination shall be binding upon Seller and Buyer, and such Accounting Firm&#146;s fees and expenses shall
be borne equally by Seller and Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Physical Inventory</I></B>. If requested by Buyer,
at least ten (10)&nbsp;business days prior to the Closing, Seller shall cause a physical inventory to be taken of the inventory and supplies on hand at the Facilities by employees or representatives of Seller or its Affiliates as near in time as
possible to the Closing Date and with the results extended and adjusted through the Closing Date. Seller shall permit representatives or employees of Buyer to observe such inventory process. All inventory items shall be valued at the lower of
Seller&#146;s cost or market on a <FONT STYLE="white-space:nowrap">first-in</FONT> <FONT STYLE="white-space:nowrap">first-out</FONT> basis. The parties acknowledge that the inventory to be taken pursuant to this
<U>Section</U><U></U><U>&nbsp;1.7(d)</U> will not be conducted until immediately prior to the Closing Date and, as such, the results of such inventory may not be available until sometime after the Closing Date. Accordingly, the parties agree that
for purposes of determining the estimated Net Working Capital as of the Closing Date, inventory with respect to the operation of the Facilities shall be calculated as reflected by the latest available unaudited balance sheets of the Seller Entities
if the results of such inventory are not available. For purposes of determining the actual Net Working Capital, inventory shall be valued as determined pursuant to this <U>Section</U><U></U><U>&nbsp;1.7(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.8</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Transition Patients</I></B>. To compensate the Seller Entities for services rendered and
medicine, drugs and supplies provided up to the Effective Time with respect to patients who are admitted as inpatients to the Hospitals prior to the Effective Time but who are not discharged until after the Effective Time (such patients being
referred to herein as the &#147;Transition Patients&#148; and services rendered to them being referred to herein as the &#147;Transition Services&#148;), the parties shall take the following actions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;As soon as practicable after the Closing Date, there shall be delivered to both parties a statement
itemizing the Transition Services provided by each of the parties to Transition Patients whose medical care is paid for, in whole or in part, by Medicare, Medicaid, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
TRICARE, Blue Cross or any other third-party payor who pays on a DRG, case rate or other similar basis (the &#147;DRG Transition Patients&#148;). The Buyer Entities shall pay to the Seller
Entities an amount equal to (i)&nbsp;the total DRG and outlier payments (including capital and any deposits, deductibles or <FONT STYLE="white-space:nowrap">co-payments</FONT> received by the Buyer Entities or the Seller Entities) per the remittance
advice received by the Buyer Entities on behalf of a DRG Transition Patient, multiplied by a fraction, the numerator of which shall be the total charges for the Transition Services provided to such DRG Transition Patient by the Seller Entities, and
the denominator of which shall be the sum of the total charges for all services provided to such DRG Transition Patient by the Seller Entities and the Buyer Entities both up to and after the Effective Time, minus (ii)&nbsp;any deposits, deductibles
or <FONT STYLE="white-space:nowrap">co-payments</FONT> made or payable by such DRG Transition Patients to the Seller Entities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;As of Effective Time, <FONT STYLE="white-space:nowrap">cut-off</FONT> billings (&#147;Interim
Billings&#148;) for all Transition Patients not covered by <U>Section</U><U></U><U>&nbsp;1.8(a)</U> shall be prepared and sent following the discharge of the patient from the Hospitals. Any payments received by either the Buyer Entities or the
Seller Entities for such Interim Billings are the property of the Seller Entities and shall be paid to the Seller Entities, when and as received by the Buyer Entities, within ten (10)&nbsp;business days of receipt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;If the Buyer Entities receive amounts related to any Medicare, Medicaid, Medicaid Managed Care,
TRICARE or other third-party payor program (such as the Hospitals Uncompensated Care Fund/Medicaid disproportionate share and Medicaid Managed Care Delivery System, Medicare disproportionate share payments, periodic interim payments
(&#147;PIP&#148;), <FONT STYLE="white-space:nowrap">bi-weekly</FONT> payments for Medicare bad debt, payments for costs paid on a pass-through basis, such as capital costs, and MIPS or other MACRA-based payments), associated with the operation of
the Hospitals or the Facilities prior to the Effective Time, the Buyer Entities shall tender the amount applicable to the period prior to the Effective Time to the Seller Entities within ten (10)&nbsp;business days of receipt. If the Seller Entities
receive amounts related to any Medicare, Medicaid, Medicaid Managed Care, TRICARE or other third-party payor program (such as Hospitals Uncompensated Care Fund/Medicaid disproportionate share and Medicaid Managed Care Delivery System, Medicare
disproportionate share payments, PIP payments, <FONT STYLE="white-space:nowrap">bi-weekly</FONT> payments for Medicare bad debt, or payments for pass-through costs, such as capital costs, and MIPS or other MACRA-based payments), associated with the
operation of the Hospitals or the Facilities relating to periods after the Effective Time, the Seller Entities shall tender the same to the Buyer Entities within ten (10)&nbsp;business days of receipt. It is the intent of the parties that the Buyer
Entities and the Seller Entities shall receive any and all amounts related to any other Medicare, Medicaid, Medicaid Managed Care, or other third-party payor program (such as Hospitals Uncompensated Care Fund/Medicaid disproportionate share and
Medicaid Managed Care Delivery System, Medicare disproportionate share payments, PIP payments, <FONT STYLE="white-space:nowrap">bi-weekly</FONT> payments for Medicare bad debt, and pass-through costs payments (including capital costs)) applicable to
the period of time the Hospitals or the Facilities were owned by such party, calculated as the payment multiplied by a fraction, the numerator of which shall be the number of days the Hospitals or the Facilities were owned by the party during the
period attributable to the payment and the denominator of which shall be the total number of days attributable to the payment. In conjunction with a Medicare cost report, the Medicare Audit Contractor (&#147;MAC&#148;) may apply <FONT
STYLE="white-space:nowrap">bi-weekly</FONT> payments to a party that are not applicable to its period of ownership. If this occurs, the parties agree to make payments to one another so that each party receives third party payments applicable to the
period of time it owned the Hospitals or the Facilities in accordance with the methodology delineated above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;All payments required by this
<U>Section</U><U></U><U>&nbsp;1.8</U> shall be made within ten (10)&nbsp;business days of a party&#146;s receipt of payment with respect to a Transition Patient, accompanied by copies of remittances and other supporting documentation as reasonably
required by the other party. In the event that the Buyer Entities and the Seller Entities are unable to agree on any amount to be paid under this <U>Section</U><U></U><U>&nbsp;1.8</U>, then such amount shall be determined through the binding process
provided in <U>Section</U><U></U><U>&nbsp;1.7(c)</U> at the joint equal expense of the Buyer Entities and the Seller Entities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>1.9</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Prorations</I></B>. Except as otherwise provided herein (for example, with respect to the
determination of Net Working Capital) or as settled at the Closing, within ninety (90)&nbsp;days after the Closing Date (hereinafter defined), the Seller Entities and the Buyer Entities shall prorate as of the Effective Time any amounts which become
due and payable on or after the Closing Date with respect to (i)&nbsp;the Contracts, (ii)&nbsp;ad valorem taxes, if any, on the Assets (which shall be prorated as of the Closing), (iii) personal property taxes on the Assets (which shall be prorated
as of the Closing), (iv) rent, if any, for the Leased Real Property, and (v)&nbsp;all utilities servicing any of the Assets, including water, sewer, telephone, electricity and gas service. Any such amounts which are not available within ninety
(90)&nbsp;days after the Closing Date shall be similarly prorated as soon as practicable thereafter. For purposes of this <U>Section</U><U></U><U>&nbsp;1.9</U>, the portion of any amount payable for a period that starts before the Effective Time and
ends after the Effective Time (a &#147;Straddle Period&#148;) that will be prorated and allocable to the Seller Entities shall equal the amount of such amount payable for the entire Straddle Period (or, in the case of such taxes determined on an
arrears basis, the amount of such taxes for the immediately preceding period), multiplied by a fraction, the numerator of which is the number of calendar days in the Straddle Period ending prior to the Effective Time and the denominator of which is
the number of calendar days in the entire Straddle Period. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CLOSING. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>2.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Closing</I></B>. Subject to the satisfaction or waiver by the appropriate party of all of the
conditions precedent to Closing specified in <U>Sections 7</U> and <U>8</U> hereof, the consummation of the transactions contemplated by and described in this Agreement (the &#147;Closing&#148;) shall take place via electronic exchange of closing
deliverables on the last business day of the month in which all of the conditions precedent to the obligations of the parties (other than those conditions that by their terms are to be satisfied at the Closing) have been satisfied or waived, or such
other date as the parties may mutually designate in writing (the date of consummation is referred to herein as the &#147;Closing Date&#148;). The Closing shall be effective as of 12:00:01 a.m., local time, on the first day of the next calendar month
immediately following the Closing Date, or at such other time as the parties may mutually designate in writing (such time, the &#147;Effective Time&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>2.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Actions of Seller at Closing</I></B>. At the Closing and unless otherwise waived in writing by
Buyer, Seller shall deliver to Buyer the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Deeds containing special warranty of title,
fully executed by each applicable Seller Entity in recordable form, conveying to each applicable Buyer Entity fee title to the Owned Real Property (the &#147;Deeds&#148;), and Assignments of Leases, fully executed by each applicable Seller Entity,
assigning to each applicable Buyer Entity leasehold title to the Leased Real Property (the &#147;Assignments of Leases&#148;), subject only to the Permitted Encumbrances and the Assumed Liabilities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;A General Assignment, Conveyance and Bill of Sale,
fully executed by each applicable Seller Entity, conveying to each applicable Buyer Entity all of such Seller Entity&#146;s right, title and interest in the Assets, free and clear of all liabilities, claims, liens, security interests and
restrictions other than the Assumed Liabilities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;An Assignment and Assumption Agreement (the
&#147;Assignment and Assumption Agreement&#148;), fully executed by each applicable Seller Entity, conveying to each applicable Buyer Entity such Seller Entity&#146;s interest in the Contracts; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Copies of corporate resolutions duly adopted by the Board of Directors of Seller and each Seller
Entity, authorizing and approving the performance of the transactions contemplated hereby and the execution and delivery of this Agreement and the documents described herein, certified as true and of full force as of the Closing, by the appropriate
officers of Seller and each Seller Entity; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Certificate of the President or a Vice President of
Seller, certifying as to the satisfaction of the condition precedent contained in <U>Section</U><U></U><U>&nbsp;7.1</U> of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Certificates of incumbency for the respective officers of Seller and each Seller Entity executing
this Agreement and any other agreements or instruments contemplated herein or making certifications for the Closing dated as of the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Certificates of existence and good standing of Seller and each Seller Entity from the state in which
it is incorporated or formed, dated the most recent practical date prior to the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;All
Certificates of Title and other documents evidencing an ownership interest conveyed as part of the Assets; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;A standard form owner&#146;s affidavit (modified as necessary to make factually accurate) as required
by the Title Company (as defined in <U>Section</U><U></U><U>&nbsp;6.3</U> hereof) to issue the Title Policy (as defined in <U>Section</U><U></U><U>&nbsp;6.3</U> hereof) as described in and provided by <U>Section</U><U></U><U>&nbsp;7.3</U> hereof;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;An Information Technology Transition Services Agreement under which Seller or a Seller Affiliate
will provide or arrange for the provision of information technology and related services consistent with historical practice at the Facilities during a transition period of twelve (12)&nbsp;months (the &#147;Information Services Agreement&#148;) and
a related Business Associate Agreement (the &#147;Business Associate Agreement&#148;) fully executed by Seller or an Affiliate of Seller; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;A Hospitals Transition Services Agreement under which Seller or a Seller Affiliate will provide or
arrange for the provision of billing and collection services consistent with historical practice at the Hospitals during a transition period of twelve (12)&nbsp;months (the &#147;Transition Services Agreement&#148;), fully executed by Seller or an
Affiliate of Seller; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;A Clinic Billing and Collection Agreement under which Seller or a Seller
Affiliate will provide or arrange for the provision of billing and collection services consistent with historical practice at the Facilities during a transition period of twelve (12)&nbsp;months (the &#147;Billing and Collection Agreement&#148;),
fully executed by Seller or an Affiliate of Seller; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(m)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;A license agreement under which Buyer will be
licensed to use the policy and procedure manuals used at the Facilities immediately prior to the Effective Time (the &#147;License Agreement&#148;), fully executed by Seller or an Affiliate of Seller; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(n)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;A certification (in such form as may be reasonably requested by Buyer) conforming to the requirements
of Treasury <FONT STYLE="white-space:nowrap">Regulations&nbsp;1.1445-2(c)(3)</FONT> and <FONT STYLE="white-space:nowrap">1.897-2(h);</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(o)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;An Assignment of Membership Interests representing the Acquired Company Ownership Interests, duly
executed by the appropriate Seller Entity; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(p)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Resignations of the officers and directors of the
Acquired Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(q)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Minute books of the Acquired Company; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(r)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Such other instruments and documents as the parties reasonably agree are appropriate and necessary to
effect the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>2.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Actions of Buyer at Closing</I></B>. At the
Closing and unless otherwise waived in writing by Seller, Buyer shall deliver to Seller the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;An amount equal to the Purchase Price in immediately available funds; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Assignment of Leases, fully executed by each applicable Buyer Entity, pursuant to which the Buyer
Entities shall assume the future payment and performance of the leases of the Leased Real Property as provided in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Assignment and Assumption Agreements, fully executed by each applicable Buyer Entity, pursuant to
which the Buyer Entities shall assume the future payment and performance of the Contracts and the Assumed Liabilities as provided in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Copies of resolutions duly adopted by the Board of Directors of Buyer and each Buyer Entity
authorizing and approving their respective performance of the transactions contemplated hereby and the execution and delivery of this Agreement and the documents described herein, certified as true and in full force as of the Closing, by the
appropriate officers of Buyer and each Buyer Entity; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Certificate of the President or a Vice
President of Buyer, certifying as to the satisfaction of the condition precedent contained in <U>Section</U><U></U><U>&nbsp;8.1</U> of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Certificates of incumbency for the respective officers of Buyer and each Buyer Entity executing this
Agreement and any other agreements or instruments contemplated herein or making certifications for the Closing dated as of the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Certificates of existence and good standing of Buyer and each Buyer Entity from the state in which
each is incorporated or formed, dated the most recent practical date prior to Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The
Information Services Agreement and the Business Associate Agreement attached thereto, fully executed by Buyer or its Affiliates(s), as applicable; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Transition Services Agreement, fully executed
by Buyer or its Affiliates, as applicable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Billing and Collection Agreement, fully executed
by Buyer or its Affiliates, as applicable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(k)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The License Agreement, fully executed by Buyer or its
Affiliates(s), as applicable; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(l)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Such other instruments and documents as the parties reasonably
agree are appropriate and necessary to effect the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3.</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>REPRESENTATIONS AND
WARRANTIES OF SELLER</B>. As of the date hereof, and, when read in light of any Schedules which have been updated in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as of the Closing Date, Seller represents and
warrants to Buyer and the Buyer Entities the following: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.1&nbsp;&nbsp;&nbsp;&nbsp;Existence and Capacity. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Seller is a corporation, duly organized and validly existing in good standing under the laws of the
State of Delaware. Seller has the requisite power and authority to enter into this Agreement, to perform its obligations hereunder and to conduct its business as now being conducted. Each Seller Entity is a limited partnership, limited liability
company or corporation, duly organized and validly existing in good standing under the laws of the state of its formation or incorporation, as the case may be. Each Seller Entity has the requisite power and authority to conduct its business as now
being conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Acquired Company (i)&nbsp;is a limited liability company duly organized,
validly existing and in good standing under the laws of the State of Delaware, and (ii)&nbsp;has the limited liability company power and authority to own or lease and to operate its assets and to conduct its business as currently conducted. The
Acquired Company has not engaged in any business other than certain actions taken in connection with filing a Certificate of Need Application with the North Carolina Department of Health and Human Services with respect to a specialty ambulatory
surgical facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Statesville HMA, LLC owns all of the Acquired Company Ownership Interests.
The Acquired Company Ownership Interests have been duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> There are no outstanding equity securities of the Acquired Company, including
(i)&nbsp;securities which are convertible into or exchangeable for any membership interests of the Acquired Company, (i)&nbsp;contracts, arrangements, commitments or restrictions relating to the issuance, sale, transfer, purchase or obtaining of
capital stock or other equity securities of the Acquired Company, or (iii)&nbsp;options, warrants, rights, calls or commitments of any character granted or issued by the Acquired Company governing the issuance of its membership interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Statesville HMA, LLC has good and marketable title to, and owns, the Acquired Company Ownership
Interests, beneficially and of record. The Acquired Company Ownership Interests are held free of any liens, claims, security interests or other encumbrances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Statesville HMA, LLC has full voting power over the Acquired Company Ownership Interests, subject to no proxy, shareholders&#146; agreement, voting trust or other agreement relating to the voting
of any of the Acquired Company Ownership Interests. Other than this Agreement, there is no agreement between Statesville HMA, LLC and any other person with respect to the disposition of the Acquired Company Ownership Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Powers; Consents; Absence of Conflicts With Other Agreements, Etc.</I></B> The execution,
delivery, and performance of this Agreement by Seller and all other agreements referenced herein, or ancillary hereto, to which Seller is a party, and the consummation by Seller and each Seller Entity of the transactions contemplated by this
Agreement and the documents described herein, as applicable: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;are within its corporate powers,
are not in contravention of corporate law or of the terms of its organizational documents, and have been duly authorized by all appropriate corporate action; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;except as provided in <U>Sections 5.4</U> and <U>5.5</U>, do not require any approval or consent
required to be obtained by Seller of, or filing required to be made by Seller with, any governmental agency or authority bearing on the validity of this Agreement which is required by law or the regulations of any such agency or authority; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;assuming the receipt of any consents required pursuant to the Contracts, will neither conflict with,
nor result in any breach or contravention of, or the creation of any lien, charge, or encumbrance under, any indenture, agreement, lease, instrument or understanding to which it is a party or by which it is bound; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;will not violate any statute, law, rule, or regulation of any governmental authority to which it or
the Assets may be subject; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;will not violate any judgment, decree, writ or injunction of any
court or governmental authority to which it or the Assets may be subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Binding
Agreement</I></B>. This Agreement and all agreements to which Seller or any of the Seller Entities will become a party pursuant hereto are and will constitute the valid and legally binding obligations of Seller and/or such Seller Entities,
respectively, and are and will be enforceable against it or them in accordance with the respective terms hereof or thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Financial Statements</I></B>. Seller has delivered to Buyer copies of the following financial
statements of the Seller Entities and the Partial Subsidiary (&#147;Financial Statements&#148;), which Financial Statements are maintained on an accrual basis: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Unaudited Balance Sheet dated as of September&nbsp;30, 2022 (the &#147;Balance Sheet Date&#148;);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Unaudited Income Statement for the nine-month period ended on the Balance Sheet Date; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Unaudited Balance Sheets and Income Statements for the fiscal years ended December&nbsp;31, 2021 and
2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in <U>Schedule 3.4</U>, such Financial Statements have been (and the
monthly financial statements delivered pursuant to <U>Section</U><U></U><U>&nbsp;5.6</U> will be) prepared in accordance with GAAP, applied on a consistent basis throughout the periods indicated. Such Balance Sheets present fairly in all material
respects (and, in the case of financial statements delivered pursuant to <U>Section</U><U></U><U>&nbsp;5.6</U>, will present fairly in all material respects) the financial condition of each Seller Entity and the Partial Subsidiary as of the dates
indicated thereon, and such Income Statements present fairly in all material respects (and, in the case of financial statements delivered pursuant to <U>Section</U><U></U><U>&nbsp;5.6</U>, will present fairly in all material respects) the results of
operations of each Seller Entity and the Partial Subsidiary for the periods indicated thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Absence of Certain Changes</I></B>. Except as set forth in <U>Schedule 3.5</U> hereto, since
the Balance Sheet Date there has not been any: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;event, change or circumstance that, individually
or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect (hereinafter defined); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;material damage, destruction, or loss (whether or not covered by insurance) affecting the Facilities
or the Partial Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;actual or threatened employee strike, work stoppage, or labor dispute
pertaining to the Facilities or the Partial Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;sale, assignment, transfer, or
disposition of any item of property, plant or equipment included in the Assets having a value, individually or in the aggregate, in excess of Fifty Thousand Dollars ($50,000) (other than supplies), except in the ordinary course of business
consistent with past practices; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;increases in the compensation payable by the Seller Entities or
the Partial Subsidiary to any of their employees or independent contractors outside of the ordinary course of business, or any increase in, or institution of, any bonus, retention, severance, insurance, pension, profit-sharing or other employee
benefit plan, remuneration or arrangements made to, for or with such employees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;adjustments or
write-offs in accounts receivable or reductions in reserves for accounts receivable outside the ordinary course of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;changes in the accounting methods or practices employed by the Seller Entities or the Partial
Subsidiary, or changes in depreciation or amortization policies; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;material changes in the scope
of patient care services or a reduction in staffed or licensed bed count at any of the Facilities; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;material transaction pertaining to any of the Facilities by any Seller Entity or the Partial
Subsidiary outside the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.6</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Licenses</I></B>. Each Facility is
duly licensed pursuant to the applicable laws of the State of North Carolina and is in compliance in all material respects with all state and local licensure rules and regulations. The pharmacies, laboratories, and all other ancillary departments
owned or operated by the Seller Entities and located at the Facilities or operated for the benefit of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Facilities which are required to be specially licensed are duly licensed by the appropriate licensing agency (the &#147;State Health Agency&#148;). The Seller Entities and the Partial Subsidiary
have all material licenses, registrations, permits, and approvals which are needed to operate the businesses owned or operated by them at the Facilities as currently operated. Seller has delivered to Buyer an accurate list (<U>Schedule 3.6</U>) of
all such licenses, registrations, permits and approvals owned or held by the Seller Entities and the Partial Subsidiary relating to the ownership, development, or operation of the Facilities or the Assets, all of which are now and as of the Closing
shall be in good standing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.7</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Medicare Participation/Accreditation</I></B>. Each of the
Seller Entities and the Partial Subsidiary are qualified for participation in the Medicare, Medicaid and CHAMPUS/TRICARE programs, has current and valid provider contracts with such programs, is and for the past six (6)&nbsp;years has been, in
compliance in all material respects with the conditions of participation in such programs. The Hospitals have received all approvals or qualifications necessary for capital reimbursement for the Hospitals. Except as set forth in <U>Schedule 3.7</U>,
the Hospitals are duly accredited, with no contingencies, by The Joint Commission. Copies of the most recent accreditation letters from The Joint Commission pertaining to the Hospitals have been made available to Buyer. All billing practices of the
Seller Entities and the Partial Subsidiary with respect to the Facilities to all third-party payors, including the Medicare, Medicaid and CHAMPUS/TRICARE programs and private insurance companies, have been in compliance with all applicable laws,
regulations and policies of such third-party payors and the Medicare, Medicaid and CHAMPUS/TRICARE programs, and neither the Seller Entities nor the Facilities or the Partial Subsidiary have billed or received any payment or reimbursement in excess
of amounts allowed by law. Neither the Seller Entities, the Partial Subsidiary nor any of their officers, directors, managing employees, service providers or controlling shareholders are excluded from participation in the Medicare, Medicaid or
CHAMPUS/TRICARE programs, nor to Seller&#146;s knowledge is any such exclusion threatened. Except as set forth in <U>Schedule 3.7</U>, the Seller, the Seller Entities, or the Partial Subsidiary have not received any written notice from any of the
Medicare, Medicaid or CHAMPUS/TRICARE programs, or any other third-party payor programs of any pending or, to Seller&#146;s knowledge, threatened investigations or surveys relating to the Facilities. Except as set forth in <U>Schedule 3.7</U>, no
Seller Entity or Partial Subsidiary (i)&nbsp;is a party to a Corporate Integrity Agreement with the Office of Inspector General of the United Sates Department of Health and Human Services, (ii)&nbsp;has any reporting obligations pursuant to any
settlement agreement entered into with any governmental entity, (iii)&nbsp;has been, to Seller&#146;s knowledge, within the past six (6)&nbsp;years the subject of any governmental payer program investigation conducted by any federal or state
enforcement agency, (iv)&nbsp;is and has been, to Seller&#146;s knowledge, within the past six (6)&nbsp;years a defendant in any qui tam/False Claims Act litigation, (v)&nbsp;during the past six (6)&nbsp;years has been served with or received any
search warrant, subpoena, civil investigative demand, or, to Seller&#146;s knowledge, contact letter or telephone or personal contact by or from any federal or state enforcement agency, and (vi)&nbsp;has to Seller&#146;s knowledge, during the past
six (6)&nbsp;years received any written complaints from any employee, independent contractor, vendor, physician or other person or organization that would indicate that such Seller Entity or Partial Subsidiary have violated any material healthcare
law or regulation. The Seller Entities required to be registered have registered with the QNet Exchange (&#147;QNet&#148;) as required by The Centers for Medicare and Medicaid Services (&#147;CMS&#148;) under its Hospitals Quality Initiative Program
(the &#147;HQI Program&#148;) and are listed in <U>Schedule 3.7</U>. The Seller Entities have submitted all quality data required under the HQI Program to CMS or its agent, and all quality data required under the ORYX Core Measure Performance
Measurement System (&#147;ORYX&#148;) to The Joint </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Commission, for all calendar quarters concluded prior to the date of this Agreement, except for any quarter for which the respective reporting deadlines have not yet expired. All such submissions
of quality data have been made in accordance with applicable reporting deadlines and in the form and manner required by CMS and The Joint Commission, respectively. The Seller Entities have not received notice of any reduction in reimbursement under
the Medicare program resulting from their failure to report quality data to CMS or its agent as required under the HQI Program. Seller has provided Buyer with the HQI Program &#147;validation results&#148; for all calendar quarters concluded prior
to the date of this Agreement, except for any quarter for which the respective reporting deadlines have not yet expired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.8</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Regulatory Compliance</I></B>. Except as set forth in <U>Schedule 3.8</U>, the Seller Entities
and the Partial Subsidiary are and during the past six (6)&nbsp;years have been in compliance in all material respects with all applicable statutes, rules, regulations, and requirements of the Government Entities having jurisdiction over the
Facilities and the operations of the Facilities. As used herein, &#147;Government Entity&#148; means any government or any agency, bureau, board, directorate, commission, court, department, official, political subdivision, tribunal or other
instrumentality of any government, whether federal, state or local. The Seller Entities and the Partial Subsidiary have timely and accurately filed all reports, data, and other information required to be filed with the Government Entities. Neither
the Seller Entities, the Partial Subsidiary, nor any of their employees have committed a material violation of federal or state laws regulating fraud, including but not limited to the federal Anti-Kickback Law, the Stark Law, and the False Claims
Act. The Seller Entities&#146; and the Partial Subsidiary&#146;s contracts and other arrangements with physicians are and during the past six (6)&nbsp;years have been in compliance in all material respects with all applicable state corporate
practice of medicine and <FONT STYLE="white-space:nowrap">fee-splitting</FONT> laws and regulations, as well as the federal Anti-Kickback Law and Stark Law. Except as set forth in <U>Schedule 3.8</U>, the Seller Entities and the Partial Subsidiary
are and during the past six (6)&nbsp;years have been in compliance in all material respects with the Health Insurance Portability and Accountability Act of 1996 (&#147;HIPAA&#148;) and all rules and regulations promulgated pursuant to HIPAA, and the
requirements of the federal Health Information Technology for Economic and Clinical Health Act enacted on February&nbsp;17, 2009, and all other applicable United States federal and state laws and regulations as presently existing or later adopted,
and as amended from time to time, which govern the confidentiality, privacy and security (including gathering, use, transmission, processing, receipt, reporting, disclosure, maintenance and storage) of patient information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.9</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Equipment</I></B>. Seller has delivered to Buyer a schedule as of the Balance Sheet Date which
takes into consideration all the material equipment associated with, or constituting any part of, the Facilities and the Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.10</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Real Property</I></B>. For purposes of the representation provided in this
<U>Section</U><U></U><U>&nbsp;3.10</U>, that certain real property that is leased by the Partial Subsidiary pursuant to the that certain Medical Office Space Lease, by and between Langtree Endoscopy Center, LLC and 309 Alcove, LLC dated December 07,
2018, as amended by Addendum to Medical Office Space Lease dated December&nbsp;07, 2018, as amended by First Amendment to Medical Office Space Lease dated July&nbsp;1, 2020 (106 Alexander Drive (f/k/a 309 Alcove Road), Suite 101, Mooresville, NC)
(the &#147;Partial Subsidiary Leased Real Property&#148;) shall be deemed to be included in the &#147;Real Property&#148; as a &#147;Leased Real Property.&#148; Except as set forth in <U>Schedule 3.10</U>, the Seller Entities or the Partial
Subsidiary own good and indefeasible fee simple and/or good and valid leasehold title, as the case </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may be, to the Real Property. The Real Property will be conveyed to the Buyer Entities (except for the Partial Subsidiary Leased Real Property, which will remain with the Partial Subsidiary) free
and clear of any and all liens, encumbrances or other restrictions except (i)&nbsp;any lien for taxes not yet due and payable,<B> </B>(ii)&nbsp;any lease obligations under the Contracts assumed by the Buyer Entities, (iii)&nbsp;easements,
restrictions and other matters of record, so long as such matters do not, collectively or individually, materially interfere with the operations of the Facilities in a manner consistent with the current use by the Seller Entities or the Partial
Subsidiary, (iv)&nbsp;zoning regulations and other governmental laws, rules, regulations, codes, orders and directives affecting the Real Property, (v)&nbsp;unrecorded easements, discrepancies, boundary line disputes, overlaps, encroachments and
other matters that would be revealed by an accurate survey or inspection of the Real Property, so long as such matters do not, collectively or individually, materially interfere with the operations of the Facilities in a manner consistent with the
current use by the Seller Entities or the Partial Subsidiary, (vi)&nbsp;any encumbrances or defects that do not materially interfere with the operations of the Facilities in a manner consistent with the current use by the Seller Entities or the
Partial Subsidiary, (vii)&nbsp;the matters described in <U>Schedule</U><U></U><U>&nbsp;3.10</U>, and (viii)&nbsp;with respect to the Leased Real Property, any encumbrances which encumber the fee interest in such property (collectively, the
&#147;Permitted Encumbrances&#148;). With respect to the Real Property: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in
<U>Schedule 3.10(a)</U>, neither Seller nor any of the Seller Entities or the Partial Subsidiary has received during the past three (3)&nbsp;years written notice from any Government Entity of a violation of any applicable ordinance or other law,
order or regulation with respect to the Owned Real Property, which violation has not been corrected; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Schedule 3.10(b)</U>, to the knowledge of Seller, the Owned Real Property
and its operation are in material compliance with all applicable zoning ordinances (or is considered legally nonconforming or &#147;grandfathered&#148; thereunder); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;There are no tenants or other persons or entities occupying any space in the Real Property, other
than pursuant to tenant leases described in <U>Schedule 3.10(c)</U>, and no tenants have paid rent in advance for more than one month and no improvement credit or other tenant allowance of any nature is owed to any tenant, nor is any landlord
improvement work required, nor do any rent abatements or other incentives exist, except as disclosed in <U>Schedule</U><U></U><U>&nbsp;3.10(c)</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Attached to <U>Schedule 3.10(d)</U> is a &#147;rent roll&#148; which sets forth for those leases
where a Seller Entity is landlord: (i)&nbsp;the address of the property; (ii)&nbsp;the names of then current tenants; (ii)&nbsp;the square footage leased; (iii)&nbsp;the expiration date of the lease; (iv)&nbsp;the rental payments for the then
current month under each of the leases; (v)&nbsp;a list of all then delinquent rental payments; (vi)&nbsp;a list of all tenant deposits and a description of any application thereof; and (vii)&nbsp;a list of all uncured material defaults under the
leases known to Seller; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Schedule 3.10(e),</U> neither Seller nor any
of the Seller Entities nor the Partial Subsidiary has received during the past three (3)&nbsp;years any written notice from any Governmental Entity of any existing, proposed or contemplated plans to modify or realign any street or highway, or any
existing, proposed or contemplated eminent domain proceeding that would result in the taking of all or any part of the Owned Real Property or that would materially and adversely affect the current use of any part of the Owned Real Property; and </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Schedule 3.10(f)</U>,
there are no outstanding options, including rights of first offer or rights of first refusal, granted by the Seller Entities to any party to purchase any Owned Real Property or any interest in any Owned Real Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Seller has delivered to Buyer copies of all title insurance policies and surveys relating to the
Owned Real Property in the possession of any Seller Entity. Buyer acknowledges and agrees that Seller has not made and is not making any representations or warranties relating to such items, Buyer shall have no right to rely on such items, and Buyer
utilizes such items at its own risk. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.11</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Title to Other Assets</I></B>. As of the Closing,
the Seller Entities shall own and hold good and valid title or leasehold interests, as the case may be, to all of the tangible Assets other than the Real Property, and at the Closing the Seller Entities will assign and convey to the Buyer Entities
such title or leasehold interests, as the case may be, to all of such Assets, subject only to the Permitted Encumbrances and the Assumed Liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.12&nbsp;&nbsp;&nbsp;&nbsp;Employee Benefit Plans. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<U>Schedule 3.12</U> sets forth a true, complete and correct list of all &#147;employee benefit
plans,&#148; as defined in Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974 (&#147;ERISA&#148;) (whether or not subject to ERISA), all fringe benefit plans as defined in Section&nbsp;6039D of the Internal Revenue Code of
1986, as amended, and the rules and regulations promulgated thereunder (the &#147;Code&#148;), and all other bonus, incentive compensation, deferred compensation, profit sharing, stock option, severance, supplemental unemployment, layoff, salary
continuation, retirement, pension, health, life insurance, disability, group insurance, vacation, holiday, sick leave, welfare plan or employment, change in control, confidentiality or <FONT STYLE="white-space:nowrap">non-competition</FONT>
agreement or any other similar plan, program, agreement, arrangement, policy or understanding (whether oral or written, qualified or <FONT STYLE="white-space:nowrap">non-qualified)</FONT> and any trust, escrow or other funding arrangement related
thereto (collectively, the &#147;Benefit Plans&#148;), which is sponsored, maintained or contributed to (or required to be contributed to) for or on behalf of the employees, former employees, independent contractors or directors (or any of their
dependents) of Seller, the Seller Entities or the Partial Subsidiary or pursuant to which Seller, the Seller Entities or the Partial Subsidiary or reasonably could be expected to have any liability or obligation (including contingent liability).
With respect to each Benefit Plan, the Seller has provided to Buyer (to the extent applicable) accurate and complete copies of: (i)&nbsp;the summary plan description and all summaries of material modifications thereto and (ii)&nbsp;the most recent
determination letter or <FONT STYLE="white-space:nowrap">pre-approved</FONT> plan advisory or opinion letter, if any, issued by the Internal Revenue Service. The Acquired Company and the Partial Subsidiary do not currently and have not at any time
in the past sponsored or maintained any Benefit Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;(i) Each of the Benefit Plans is and has
been maintained and administered in all material respects in compliance with its terms and applicable legal requirements (including ERISA), (ii) there have been no prohibited transactions, breaches of fiduciary duty or other breaches or violations
of any law applicable to the Benefit Plans that could subject Buyer to any liability, (iii)&nbsp;each Benefit Plan intended to be qualified under Section&nbsp;401(a) of the Code is so qualified and has a current favorable determination letter (or,
in the case of a master and prototype or regional prototype plan, a favorable opinion or notification letter, as applicable) or an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
application therefore is pending with the IRS, (iv)&nbsp;no event has occurred that would reasonably be expected to adversely affect the qualified status of such Benefit Plan under Sections
401(a) of the Code, or that would otherwise cause a distribution therefrom that is otherwise eligible for rollover treatment under Section&nbsp;408 of the Code to be ineligible to be rolled into an individual retirement account or a plan that is
qualified under Section&nbsp;401(a) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Schedule 3.12</U>,
for the past six (6)&nbsp;years, neither Seller, the Seller Entities, the Partial Subsidiary nor any ERISA Affiliate of Seller, the Seller Entities or the Partial Subsidiary sponsors, has maintained, contributed to, or been required to contribute to
an employee benefit plan that is (i)&nbsp;a &#147;multiemployer plan,&#148; as such term is defined in Section&nbsp;3(37) of ERISA, (ii)&nbsp;any defined benefit pension plan (as defined in Section&nbsp;3(35) of ERISA) that is or was at any time
subject to Title IV of ERISA, Sections 302 or 303 of ERISA or Sections 412 or 436 of the Code, (iii)&nbsp;a multiple employer plan as defined in Section&nbsp;413(c) of the Code, or (iv)&nbsp;a multiple employer welfare arrangement (as defined in
Section&nbsp;3(40) of ERISA). ERISA Affiliate shall mean any entity that at any relevant time would be treated as a single employer with Seller, the Seller Entities or any of their subsidiaries (including without limitation the Partial Subsidiary)
under Section&nbsp;414 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;None of the Benefit Plans listed in <U>Schedule 3.12</U>
that are &#147;welfare benefit plans,&#148; within the meaning of Section&nbsp;3(1) of ERISA, provide for continuing benefits or coverage after termination or retirement from employment, except for COBRA rights under a &#147;group health plan&#148;
as defined in Section&nbsp;4980(B)(g) of the Code and Section&nbsp;607 of ERISA or any similar applicable state law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Neither the execution, delivery or performance of this Agreement nor the consummation of the
transactions contemplated by this Agreement (whether alone or in combination with any other event, including, but not limited to, a termination of employment) shall (i)&nbsp;entitle any current or former employee, independent contractor, officer,
director or other service provider to any payment or any increase in payment under any Benefit Plan, (ii)&nbsp;accelerate the time of payment, funding or vesting of any benefit under any Benefit Plan, or (iii)&nbsp;result in any payments or benefits
under any agreement with the Seller or the Seller Entities, the Company that, individually or in combination with any other payment or benefit, could constitute the payment of an &#147;excess parachute payment&#148; within the meaning of
Section&nbsp;280G of the Code or in the imposition of an excise Tax under Section&nbsp;4999 or Section&nbsp;409A of the Code. Notwithstanding any other provision of this <U>Section</U><U></U><U>&nbsp;3.12(e)</U>, it is expressly understood that all
of the employees of the Facilities will, following their termination of employment with the Seller Entities, (i)&nbsp;be entitled to elect any distribution available under the terms of any of the Benefit Plans that are available to former employees
of the Seller Entities, (ii)&nbsp;shall have any rights to continuation coverage under any of the Benefit Plans pursuant to the terms of those plans and applicable law, and (iii)&nbsp;be entitled to receive any other benefits payable to former
employees of the Seller Entities; all of which are Excluded Liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.13</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Litigation or
Proceedings</I></B>. <U>Schedule 3.13</U> sets forth an accurate list of all currently pending litigation or legal proceedings with respect to the Facilities, the Partial Subsidiary and the Assets. Except as set forth in <U>Schedule 3.13</U>, there
are no claims, actions, suits, proceedings, or investigations pending, or to the knowledge of Seller, threatened, against the Seller Entities, the Partial Subsidiary, the Facilities or the Assets (or against Seller or any of its other Affiliates and
relating, in whole or in part, to the Facilities or the Assets) at law or in equity, or before or by any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
federal, state, municipal, or other governmental department, commission, board, bureau, agency, or instrumentality wherever located. There are no judgments, orders, decrees, citations, fines or
penalties heretofore assessed against the Seller Entities, the Partial Subsidiary, or their Affiliates affecting the Assets or the Assumed Liabilities under any federal, state or local law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.14</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Environmental Laws</I></B>. Except as set forth in <U>Schedule 3.14</U> hereto, (i)&nbsp;the
Owned Real Property is not, to the knowledge of Seller, subject to any material environmental hazards, risks, or liabilities, (ii)&nbsp;the Seller Entities and the Partial Subsidiary are not in violation of any federal, state or local statutes,
regulations, laws or orders pertaining to the protection of human health and safety or the environment (collectively, &#147;Environmental Laws&#148;), including, without limitation, the Comprehensive Environmental Response Compensation and Liability
Act, as amended (&#147;CERCLA&#148;), and the Resource Conservation and Recovery Act, as amended (&#147;RCRA&#148;), and (iii)&nbsp;neither Seller, any Seller Entity, nor any Partial Subsidiary has received any notice alleging or asserting either a
violation of any Environmental Law or an obligation to investigate, assess, remove, or remediate any property, including but not limited to the Owned Real Property, under or pursuant to any Environmental Law. No Hazardous Substances (which for
purposes of this <U>Section</U><U></U><U>&nbsp;3.14</U> shall mean and include polychlorinated biphenyls, asbestos, and any substances, materials, constituents, wastes, or other elements which are included under or regulated by any Environmental
Law, including, without limitation, CERCLA and RCRA) have been disposed of on or released or discharged from or onto, or threatened to be released from or onto, the Owned Real Property (including groundwater) by the Seller Entities, or to
Seller&#146;s knowledge, any third party, in violation of or which could give liability under any applicable Environmental Law. Neither the Seller Entities, nor to Seller&#146;s knowledge, any prior owners, operators or occupants of the Owned Real
Property, have allowed any Hazardous Substances to be discharged, possessed, managed, processed, released, or otherwise handled on the Owned Real Property in a manner which is in violation of or which could give liability under any Environmental
Law, and the Seller Entities have complied with all Environmental Laws applicable to any part of the Owned Real Property. True, correct and complete copies of each environmental site assessment, environmental audit, environmental investigation
report, soil or groundwater report, tank closure report, notice of noncompliance, order, citation and other material environmental report concerning the Owned Real Property in the possession or control of Seller or any of the Seller Entities has
been provided to Buyer. This <U>Section</U><U></U><U>&nbsp;3.14</U> contains the exclusive representations and warranties of Seller with respect to environmental matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.15</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Taxes</I></B>. Except as set forth in <U>Schedule 3.15</U>, each Seller Entity and the Partial
Subsidiary has timely filed all federal, state and local Tax Returns required to be filed by it (all of which are true, correct and complete in all material respects) and has duly paid or made provision for the payment of all Taxes (including any
interest or penalties and amounts due state unemployment authorities) which are owed by it (whether or not shown on any Tax Return) to the appropriate tax authorities. Except as set forth in <U>Schedule 3.15</U>, neither Seller Entity nor the
Partial Subsidiary is the beneficiary of any extension of time within which to file a Tax Return. Except as set forth in <U>Schedule 3.15</U>, no deficiencies for any of such Taxes have been asserted or to the knowledge of Seller or any Seller
Entity, as applicable, threatened, and no audit or other administrative proceedings or court proceedings with respect to Taxes is currently pending or under way or to the knowledge of Seller or any Seller Entity, as applicable, threatened. Except as
set forth in <U>Schedule </U><U>3.15</U>, there are no outstanding agreements by any Seller Entity or the Partial Subsidiary for the extension of time for the assessment of any Taxes. There are no tax liens on
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any of the Assets and no basis exists for the imposition of any such liens. No claim has even been made by an authority in a jurisdiction where any Seller Entity or the Partial Subsidiary does
not file Tax Returns that it is or may be subject to taxation by that jurisdiction. There is no dispute or claim concerning any Tax liability of any Seller Entity or the Partial Subsidiary either (a)&nbsp;claimed or raised by a tax authority in
writing or (b)&nbsp;as to which any of the directors and officers of Seller or any Seller Entity, as applicable, has knowledge. As used herein, &#147;Tax&#148; or &#147;Taxes&#148; means any federal, state, local or foreign income, gross receipts,
license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental (including taxes under Code &#167; 59A), customs duties, capital stock, franchise, profits, withholding, social security (or similar),
unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, estimated, or other tax of any kind whatsoever, whether computed on a
separate or consolidated, unitary or combined basis or in any other manner, relating to the Partial Subsidiary, the Assets, the Facilities or the operation of the Facilities, including any interest, penalty or addition thereto, whether disputed or
not and including any obligation to indemnify or otherwise assume or succeed to the Tax liability of any other person. &#147;Tax Return&#148; means any return, declaration, report, claim for refund, or information return or statement relating to
Taxes, including any schedule or attachment thereto, and including any amendment thereof. The Seller Entities and the Partial Subsidiary have (i)&nbsp;to the extent applicable, properly complied with all applicable laws in order to defer the amount
of the employer&#146;s share of any &#147;applicable employment taxes&#148; under Section&nbsp;2302 of the CARES Act, (ii)&nbsp;to the extent applicable, properly complied with all applicable laws and duly accounted for any available Tax credits
under Sections 7001 through 7005 of the Families First Coronavirus Response Act and Section&nbsp;2301 of the CARES Act and (iii)&nbsp;not deferred any payroll Tax obligations (including those imposed by Section&nbsp;3101(a) and 3201 of the Code)
(for example, by failure to timely withhold, deposit or remit such amounts in accordance with the applicable provisions of the Code and the Treasury Regulations promulgated thereunder) pursuant to or in connection with any U.S. presidential
memorandum or executive order. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.16&nbsp;&nbsp;&nbsp;&nbsp;Employee Relations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Neither the Acquired Company nor the Partial Subsidiary have or have ever had any direct employees and
all employees who currently perform or have in the past performed services on behalf of the Partial Subsidiary or the Acquired Company are or were employed by a Seller Entity. To Seller&#146;s knowledge, there is no threatened employee strike, work
stoppage, or labor dispute pertaining to the Facilities. Except as set forth in <U>Schedule 3.16</U>, no union representation question exists respecting any employees of the Seller Entities. No collective bargaining agreement exists or is currently
being negotiated by the Seller Entities, no written demand has been received for recognition by a labor organization by or with respect to any employees of the Seller Entities, no union organizing activities by or with respect to any employees of
the Seller Entities are, to the knowledge of Seller, taking place, and none of the employees of the Seller Entities is represented by any labor union or organization. There is no written unfair practice claim against the Seller Entities before the
National Labor Relations Board, nor any strike, dispute, slowdown, or stoppage pending or threatened against or involving the Facilities, and none has occurred within the last three (3)&nbsp;years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Schedule 3.16</U>, the Seller Entities have, to the knowledge of Seller,
complied in all material respects with all legal requirements relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employment, employment practices, terms and conditions of employment, equal employment opportunity, nondiscrimination, immigration, wages, hours, benefits, payment of employment, social security,
and similar taxes, occupational safety and health, and plant closing. No Seller Entity is liable for the payment of any compensation, damages, taxes, fines, penalties, interest, or other amounts, however designated, for failure to comply with any of
the foregoing legal requirements. Except as set forth in <U>Schedule 3.16</U>, there are no pending or, to the knowledge of Seller, threatened claims before the Equal Employment Opportunity Commission (or any comparable state civil or human rights
commission or other entity), complaints before the Occupational Safety and Health Administration (or any comparable state safety or health administration or other entity), wage and hour claims, or the like. Each Seller Entity has correctly
classified those individuals performing services for the applicable Seller Entity as common law employees, leased employees, independent contractors or agents of the applicable Seller Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<U>Schedule 3.16</U> states or will state the number of employees terminated by each Seller Entity
within six (6)&nbsp;months prior to the Closing Date, laid off by each Seller Entity within the six (6)&nbsp;months prior to the Closing Date, or whose hours of work have been reduced by more than fifty percent (50%) by a Seller Entity in the six
(6)&nbsp;months prior to the Closing Date, and contains a complete and accurate list of the following information for such employees: (i)&nbsp;the date of termination, layoff, or reduction in work hours; (ii)&nbsp;the reason for termination, layoff,
or reduction in work hours; and (iii)&nbsp;the location to which the employee was assigned. In relation to the foregoing, except as set forth in <U>Schedule 3.16</U>, no Seller Entity has violated the Worker Adjustment and Retraining Notification
Act (the &#147;WARN Act&#148;) or any similar state or local legal requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.17</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>The
Contracts</I></B>. Seller has made available to Buyer true and correct copies of the Contracts (including the Immaterial Contracts), and has given, and will give, the agents, employees and representatives of Buyer access to the originals of the
Contracts to the extent originals are available. &#147;Immaterial Contracts&#148; are commitments, contracts, leases and agreements which individually involve future payments, performance of services or delivery of goods or materials, to or by any
Seller Entity of any amount or value less than Fifty Thousand Dollars ($50,000) on an annual basis, and that are not with physicians or other referral sources. Seller represents and warrants with respect to the Contracts that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Contracts constitute legal, valid and binding obligations of the Seller Entities and, to the
knowledge of Seller, the other parties with respect thereto, and are enforceable against the Seller Entities and, to the knowledge of Seller, the other parties with respect thereto in accordance with their terms; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Each Contract constitutes the entire agreement by and between the respective parties thereto with
respect to the subject matter thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Assuming the receipt of any consents required in
connection with the assignment of the Contracts, all obligations required to be performed by the Seller Entities and, to the knowledge of Seller, the other parties with respect thereto prior to the date hereof under the terms of the Contracts have
been performed, and no acts or omissions by the Seller Entities and, to the knowledge of Seller, the other parties with respect thereto have occurred or failed to occur which, with the giving of notice, the lapse of time or both would constitute a
default by the Seller Entities and, to the knowledge of Seller, the other parties with respect thereto under the Contracts; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly set forth in <U>Schedule
1.1(g)</U>, none of the Contracts requires consent to the assignment and assumption of such Contracts by the Buyer Entities, and Seller will use commercially reasonable efforts to obtain any required consents prior to the Closing; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly set forth in <U>Schedule 1.1(g)</U>, the assignment of the Contracts to and
assumption of such Contracts by the Buyer Entities will not result in any penalty or premium, or variation of the rights, remedies, benefits or obligations of any party thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.18</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Supplies</I></B>. All the inventory and supplies constituting any part of the Assets are
substantially of a quality and quantity usable and salable in the ordinary course of business of the Facilities. Obsolete items have been written off the Financial Statements. Inventory and supplies are carried at the lower of cost or market, on a <FONT
STYLE="white-space:nowrap">first-in,</FONT> <FONT STYLE="white-space:nowrap">first-out</FONT> basis and are properly stated in the Financial Statements. The inventory levels are based on past practices of the Seller Entities at the Facilities and,
as of the Effective Time, each inventory item has not reached its expiration date as established by the manufacturer or vendor from whom the Seller Entity acquired the item. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.19</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Insurance</I></B>. <U>Schedule</U><U></U><U>&nbsp;3.19</U> includes a true, complete and
correct list of the current insurance policies covering the ownership and operations of the Facilities, the Partial Subsidiary and the Assets, which list reflects the policies&#146; numbers, identity of insurers, amounts, and coverage. All of such
policies are in full force and effect with no premium arrearage. The Seller Entities and the Partial Subsidiary have given, in a timely manner, to their insurers all notices required to be given under their insurance policies with respect to all of
the claims and actions covered by insurance, and no insurer has denied coverage of any such claims or actions. The Seller Entities and the Partial Subsidiary have not (a)&nbsp;received any written notice or other communication from any such
insurance company canceling or materially amending any of such insurance policies, and, to Seller&#146;s knowledge, no such cancellation or amendment is threatened or (b)&nbsp;failed to give any written notice or present any claim which is still
outstanding under any of such policies with respect to the Facilities, the Partial Subsidiary or any of the Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.20</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Third-Party Payor Cost Reports</I></B>. Each Seller Entity has duly filed all required cost
reports for all the fiscal years through and including the fiscal year specified in <U>Schedule</U><U></U><U>&nbsp;3.20</U>. All of such cost reports accurately reflect in all material respects the information required to be included thereon and
such cost reports do not claim, and neither the Facilities nor the Seller Entities have received, reimbursement in any amount in excess of the amounts provided by law or any applicable agreement. <U>Schedule 3.20</U> indicates which of such cost
reports have not been audited and finally settled and a brief description of any notices of program reimbursement, proposed or pending audit adjustments, disallowances, appeals of disallowances, and any and all other unresolved inquiries, claims or
disputes in respect of such cost reports. The Seller Entities have established adequate reserves to cover any potential reimbursement liabilities that the Seller Entities may have under such cost reports and such reserves are set forth in the Seller
Entities&#146; Financial Statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.21</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Medical Staff Matters</I></B>. Seller has provided
to Buyer true, correct, and complete copies of the bylaws and rules and regulations of the medical staff of and those holding clinical privileges at each Hospital, as well as a list of all current members of the medical staff of each Hospital.
Except as set forth in <U>Schedule</U><U></U><U>&nbsp;3.21</U>, (i) there are no adverse actions or disciplinary actions with respect to any medical staff member, individual holding clinical privileges, or any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicant for membership and/or privileges for which the medical staff member, individual holding clinical privileges, or applicant has requested an appeal which has not been scheduled or has
been scheduled but has not been completed; (ii)&nbsp;there are no pending or, to the knowledge of Seller, threatened disputes with applicants, medical staff members, or individuals holding clinical privileges; and (iii)&nbsp;all appeal periods in
respect of any medical staff member, individual holding clinical privileges or applicant against whom an adverse action has been taken have expired and there are no pending investigations of a member of the medical staff or an individual holding
clinical privileges.. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.22</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Condition of Assets</I></B>. Other than with respect to the
representations and warranties herein provided, the Seller Entities shall transfer the Assets to the Buyer Entities and the Buyer Entities shall accept the Assets from the Seller Entities AS IS WITH NO WARRANTY OF A HABITABILITY OR FITNESS FOR
HABITATION, WITH RESPECT TO THE LAND, BUILDINGS AND IMPROVEMENTS, AND WITH NO WARRANTIES, INCLUDING WITHOUT LIMITATION, THE WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE EQUIPMENT, INVENTORY, AND SUPPLIES,
AND ANY AND ALL OF WHICH WARRANTIES SELLER HEREBY DISCLAIMS. Except as set forth in <U>Schedule 3.22</U>, neither Seller nor the Seller Entities have received during the past three (3)&nbsp;years written notice indicating or asserting that the
Facilities are not in compliance with the Americans with Disabilities Act. All of the Assets shall be further subject to normal wear and tear on the land, buildings, improvements and equipment and normal and customary use and disposal of inventory
and supplies in the ordinary course of business up to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.23</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Experimental
Procedures</I></B>. The Seller Entities have not performed or permitted the performance of any experimental or research procedures or studies involving patients of any Hospital not authorized and conducted in accordance with the procedures of the
Institutional Review Board of the relevant Hospital </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.24</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Intellectual Property</I></B>.
<U>Schedule 3.24</U> lists and briefly describes all trademarks, service marks, trade names, domain names, copyrights and applications therefor (whether registered or common law) currently owned by the Seller Entities and used in connection with the
Facilities that will be transferred to the Buyer Entities (collectively, the &#147;Intellectual Property&#148;). Except as set forth in <U>Schedule 3.24</U>, the Seller Entities&#146; use and ownership (or possession of licenses or other rights to
the use) of all Intellectual Property used in the conduct of their business does not, to the knowledge of Seller, infringe any right of any person and neither the Seller nor the Seller Entities have received written notice that any proceedings have
been instituted or are pending which challenge the validity of the use or ownership by Seller or the Seller Entities of the Intellectual Property. Neither Seller nor the Seller Entities have licensed anyone to use the Intellectual Property and
Seller has no knowledge of the use or the infringement of the Intellectual Property by any other person. Seller and/or the Seller Entities own (or possess enforceable licenses or other rights to use) all the Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.25</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Compliance Program</I></B><B><I>. </I></B>Each Seller Entity and the Partial Subsidiary has in
place a compliance program that includes the elements of an effective compliance program set forth in the OIG&#146;s compliance program guidance for hospitals, including the related provisions of the Federal Sentencing Guidelines relating to
corporate compliance programs. Seller has provided to Buyer a copy of its current compliance program materials, including without limitation, all program </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
descriptions, compliance officer and committee descriptions, ethics and risk area policy materials, training and education materials, auditing and monitoring protocols, reporting mechanisms, and
disciplinary policies. <U>Schedule 3.25</U> includes a description of each audit and investigation conducted by the Seller Entities or the Partial Subsidiary pursuant to their compliance program during the last three (3)&nbsp;years relating to
material healthcare regulatory issues involving the Seller Entities or the Partial Subsidiary. For purposes of this Agreement, the term &#147;compliance program&#148; refers to provider programs of the type described in the compliance guidance
published by the Office of Inspector General of the Department of Health and Human Services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.26</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Certificates of Need</I></B>. Except as set forth in <U>Schedule 3.26</U> hereto, no
application for any Certificate of Need, Exemption Certificate (each as defined below) or declaratory ruling has been made by any Seller Entity or the Partial Subsidiary with the State Health Agency or other applicable agency which is currently
pending or open before such agency, and no such application (collectively, the &#147;Applications&#148;) filed by any Seller Entity or the Partial Subsidiary within the past three (3)&nbsp;years has been ultimately denied by any commission, board or
agency or withdrawn by such Seller Entity or Partial Subsidiary. No Seller Entity or the Partial Subsidiary has prepared, filed, supported or presented opposition to any Applications filed by another hospital or health agency within the past three
(3)&nbsp;years. Except as set forth in <U>Schedule 3.26</U> hereto, no Seller Entity or the Partial Subsidiary has any Applications pending or any approved Applications which relate to projects not yet completed. As used herein, &#147;Certificate of
Need&#148; means a written statement issued by the State Health Agency evidencing community need for a new, converted, expanded or otherwise significantly modified health care facility, health service or hospice, and &#147;Exemption
Certificate&#148; means a written statement from the State Health Agency stating that a health care project is not subject to the Certificate of Need requirements under applicable state law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.27&nbsp;&nbsp;&nbsp;&nbsp;Certain Representations with Respect to the Hospitals. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;No Seller Entity has made any misrepresentations or false attestations to any Government Entity under
or in connection with Promoting Interoperability reporting under the Merit-based Incentive Payment System or predecessor meaningful use payments under the HITECH Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Schedule 3.27</U>, at all times since March&nbsp;23, 2010, Mooresville
Hospital Management Associates, LLC has been in compliance with the requirements of the &#147;whole hospital exception&#148; under the Stark Law, as set forth in 42 U.S.C. &#167;1395nn(d)(3) and 42 C.F.R., Subpart J, &#167;&#167;411.356(c)(3) and
411.362. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Seller Entities have repaid in full to the appropriate Government Entity any
amounts due, including any accrued and unpaid interest, under all payments made to the Seller Entities under the Medicare Hospital Accelerated Payment Program as defined under Section&nbsp;3719 of the CARES Act. The Seller Entities have utilized any
Provider Relief Funds in accordance with all applicable laws and the applicable terms and conditions. The Seller Entities maintain appropriate accounting records associated with such funds, including tracking the costs and other expenses for which
stimulus funds are used and quantifying the lost revenue incurred in connection with the operation of the Facilities during the <FONT STYLE="white-space:nowrap">COVID-19</FONT> Pandemic. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>3.28&nbsp;&nbsp;&nbsp;&nbsp;Partial Subsidiary. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, the term &#147;Partial Subsidiary&#148; means Langtree Endoscopy
Center, LLC of which Statesville HMA, LLC owns 53% of the total outstanding membership interests and which membership interests will be assigned by Statesville HMA, LLC to the appropriate Buyer Entity as part of the Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<U>Schedule 3.28</U> sets forth for the Partial Subsidiary: (1)&nbsp;its name and jurisdiction of
incorporation or organization; (2)&nbsp;the number of issued and outstanding shares of each class of its capital stock or other equity or <FONT STYLE="white-space:nowrap">non-equity</FONT> interests and percentage ownership held by the appropriate
Seller Entity and which will be assigned to the appropriate Buyer Entity; and (3)&nbsp;its directors and officers, general partners or managers, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Seller Entities have delivered to the Buyer Entities accurate and complete copies, as applicable
of the articles of incorporation, charter, bylaws, operating agreement, partnership agreement, or shareholders or membership agreement, as amended to date, of the Partial Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Statesville HMA, LLC has good and marketable title to all shares of the stock or other equity or <FONT
STYLE="white-space:nowrap">non-equity</FONT> interests of the Partial Subsidiary set forth in <U>Schedule 3.28</U> and except as set forth on <U>Schedule 3.28</U>, have the absolute right to sell, assign, transfer and deliver the same to the
appropriate Buyer Entity, free and clear of all claims, security interests, liens, pledges, charges, escrows, options, proxies, rights of first refusal, preemptive rights, mortgages, hypothecations prior assignments, title retention agreements,
indentures, security agreements or any other limitation, encumbrance or restriction of any kind, except those arising under applicable federal or state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4.</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>REPRESENTATIONS AND WARRANTIES OF BUYER</B>. As of the date hereof, and, when read in light of any Schedules which
have been updated in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as of the Closing Date, Buyer represents and warrants to Seller and the Seller Entities the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Existence and Capacity</I></B>. Buyer is a <FONT STYLE="white-space:nowrap">non-profit</FONT>
corporation, duly organized and validly existing in good standing under the laws of the State of North Carolina. Buyer has the requisite power and authority to enter into this Agreement, to perform its obligations hereunder, and to conduct its
business as now being conducted. Each Buyer Entity is a North Carolina limited liability company, duly organized and validly existing in good standing under the laws of the State of North Carolina. Each Buyer Entity has the requisite power and
authority to conduct its business as now being conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Powers; Consents; Absence of
Conflicts With Other Agreements, Etc.</I></B>The execution, delivery, and performance of this Agreement by Buyer and all other agreements referenced herein, or ancillary hereto, to which Buyer is a party, and the consummation by Buyer and each Buyer
Entity of the transactions contemplated by this Agreement and the documents described herein, as applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;are within its corporate powers, are not in contravention of corporate law or of the terms of its
organizational documents, and have been duly authorized by all appropriate corporate action; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;except as provided in <U>Sections 6.1</U> and
<U>6.2</U>, do not require any approval or consent required to be obtained by Buyer of, or filing required to be made by Buyer with, any governmental agency or authority bearing on the validity of this Agreement which is required by law or the
regulations of any such agency or authority; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;will neither conflict with, nor result in any
breach or contravention of, or the creation of any lien, charge or encumbrance under, any indenture, agreement, lease, instrument or understanding to which it is a party or by which it is bound; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;will not violate any statute, law, rule, or regulation of any governmental authority to which it may
be subject; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;will not violate any judgment, decree, writ, or injunction of any court or
governmental authority to which it may be subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Binding Agreement</I></B>. This
Agreement and all agreements to which Buyer or any of the Buyer Entities will become a party pursuant hereto are and will constitute the valid and legally binding obligations of Buyer and/or such Buyer Entities, respectively, and are and will be
enforceable against it or them in accordance with the respective terms hereof and thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>4.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Availability of Funds</I></B>. Buyer has the ability to obtain funds in cash in amounts equal
to the Purchase Price by means of credit facilities or otherwise and will at the Closing have immediately available funds which will be sufficient to enable Buyer to pay the Purchase Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5.</B><B></B><B>&nbsp;&nbsp;&nbsp;&nbsp;COVENANTS OF SELLER PRIOR TO CLOSING</B>. Between the date of this Agreement and the Closing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Information</I></B>. Seller shall afford to the officers and authorized representatives and
agents (which shall include accountants, attorneys, bankers, and other consultants) of Buyer full and complete access to and the right to inspect the plants, properties, books, and records of the Facilities, and will allow Buyer reasonable access to
the medical staff and personnel of the Facilities to confirm and establish relationships, and will furnish Buyer with such additional financial and operating data and other information as to the business and properties of Seller which pertains to
the Facilities or their operations as Buyer may from time to time reasonably request. Buyer&#146;s right of access and inspection shall be exercised in such a manner as not to interfere unreasonably with the operations of the Facilities. Buyer
agrees that no inspections shall take place and no employees or other personnel of the Facilities shall be contacted by Buyer without Buyer first providing reasonable notice to Seller and coordinating such inspection or contact with Seller. Seller
shall promptly make available to Buyer any surveys, reports, site plans, engineering plans and drawings or similar material related to the Facilities and/ or the Assets as Seller or the Seller Entities may acquire at any time prior to the Closing
Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Operations</I></B>. Seller will not, and will cause the Seller Entities, the
Acquired Company, and the Partial Subsidiary not to, engage in any practice, take any action, or enter into </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any transaction outside the ordinary course of business. Without limiting the generality of the foregoing, Seller shall cause the Seller Entities, the Acquired Company, and the Partial Subsidiary
to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;use commercially reasonable efforts to carry on their business pertaining to the Facilities
in substantially the same manner as presently conducted and not make any material change in personnel, operations, finance, accounting policies, or real or personal property pertaining to the Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;use commercially reasonable efforts to maintain the Facilities and all parts thereof in good
operating condition, ordinary wear and tear excepted; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;use commercially reasonable efforts to
perform all of their obligations under agreements relating to or affecting the Facilities or the Assets; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;use commercially reasonable efforts to keep in full force and effect present insurance policies or
other comparable insurance pertaining to the Facilities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;continue to pay all Taxes in the
ordinary course of business, consistent with past practice; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;use commercially reasonable
efforts to maintain and preserve their business organizations intact, retain their present employees at the Facilities and maintain their relationships with physicians, medical staff members, suppliers, customers, and others having business
relations with the Facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Negative Covenants</I></B>. Seller shall cause the Seller
Entities, the Acquired Company, and the Partial Subsidiary not to, with respect to the business or operation of the Acquired Company, the Facilities or the Partial Subsidiary or otherwise regarding the Assets, without the prior written consent of
Buyer: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;amend, modify, terminate or cancel any of the Contracts, or enter into any new contract
or commitment, except as provided herein or in the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;increase
compensation payable or to become payable or make any bonus payment to or otherwise enter into one or more bonus agreements with any employee at the Facilities, except in the ordinary course of business or in accordance with existing personnel
policies; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;increase severance or termination obligations to any employee of a Seller Entity; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;adopt, amend, modify or terminate any Benefit Plan except as required under applicable law or as
applies uniformly to all employees and other service providers of the Seller and the Seller Entities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;acquire (whether by purchase or lease) or sell, assign, lease, or otherwise transfer or dispose of
any property, plant, or equipment except in the normal course of business with comparable replacement thereof when appropriate; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(f)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;sell any of the Owned Real Property; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(g)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;materially alter any Owned Real Property, including the buildings, fixtures and other improvements
located thereon, other than budgeted capital expenditures or routine replacement, maintenance or repairs; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(h)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;purchase capital assets or incur costs in respect of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">construction-in-progress</FONT></FONT> in excess of Two Hundred Fifty Thousand Dollars ($250,000) in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(i)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;make any material change in the scope of patient care services offered at the Facilities or reduce
the staffed or licensed bed count at the Facilities; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(j)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;take any material action outside the
ordinary course of business of the Facilities, except as may be required in order to consummate the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Governmental Approvals</I></B>. Seller shall (i)&nbsp;use reasonable efforts to obtain all
governmental approvals (or exemptions therefrom) necessary or required to allow Seller to perform its obligations under this Agreement; and (ii)&nbsp;assist and cooperate with Buyer and its representatives and counsel in obtaining all governmental
consents, approvals, and licenses which Buyer deems necessary or appropriate and in the preparation of any document or other material which may be required by any governmental agency as a predicate to or as a result of the transactions contemplated
herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Antitrust Matter</I></B><B><I>s</I></B>. Seller shall (a)&nbsp;file and cause its
Affiliates to file, within four (4)&nbsp;weeks of the date hereof or such other date as the Parties agree based on the advice of antitrust counsel, all reports, filings and other documents required or requested of it or its Affiliates by the Federal
Trade Commission (&#147;FTC&#148;), the United States Department of Justice (&#147;Justice Department&#148;) or any other Government Entity, in connection with the transactions contemplated by this Agreement, under the Sherman Act, the Clayton Act,
the Hart-Scott Rodino Antitrust Improvements Act of 1976 (the &#147;HSR Act&#148;), or the Federal Trade Commission Act, each as amended, or any other federal, state or other statutes, laws, rules, regulations, orders, decrees, administrative or
judicial doctrines that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade (collectively, the &#147;Antitrust Laws&#148;), (b) comply at the earliest practicable
date with any request received by Seller or any of its Affiliates from the FTC, the Justice Department or any such other Government Entity under any applicable Antitrust Laws for additional information concerning the transactions contemplated by
this Agreement, (c)&nbsp;cooperate with Buyer in connection with any filing under applicable Antitrust Laws with respect to the transactions contemplated by this Agreement and in connection with resolving any investigation or other inquiry
concerning such transactions that is commenced by any of the FTC, the Justice Department or any other Government Entity pursuant to any applicable Antitrust Laws, (d)&nbsp;promptly inform Buyer of any material communication made to or received by
Seller from the FTC, the Justice Department or any other Government Entity regarding any of the transactions contemplated hereby, (e)&nbsp;use commercially reasonable efforts to obtain all licenses, permits, consents, approvals, exemptions,
authorizations or waivers necessary or appropriate under the Antitrust Laws from the FTC, the Justice Department and any other Government Entity in order to avoid or terminate any action or proceeding by any of them with respect to, and to permit
the consummation of in the most expeditious manner practicable, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transactions contemplated by this Agreement, and (f)&nbsp;promptly furnish to Buyer such information concerning Seller as Buyer needs to perform its obligations under
<U>Section</U><U></U><U>&nbsp;6.2</U> of this Agreement. Without limiting the foregoing, Seller shall not (i)&nbsp;withdraw and <FONT STYLE="white-space:nowrap">re-file</FONT> its Premerger Notification and Report Form, (ii)&nbsp;extend any waiting
period or comparable period or (iii)&nbsp;enter into any agreement not to consummate the Contemplated Transactions, except, in each case, with the prior written consent of Buyer. The foregoing covenants in this <U>Section</U><U></U><U>&nbsp;5.5</U>
do not require Seller or any of its Affiliates to (A)&nbsp;defend against or oppose any formal administrative complaint, lawsuit, motion for preliminary or permanent injunction, temporary restraining order or other actions brought by any
Governmental Authority or private party seeking to block the Transaction under the Antitrust Laws, or (B)&nbsp;propose, negotiate, offer to commit to enter into or effect, by consent decree, hold separate order or otherwise, sell, offer to sell or
otherwise dispose of, any acute care hospital of the Seller Entities or hold separate such acute care hospital properties pending such sale or other disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.6</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Additional Financial Information</I></B>. Within thirty (30)&nbsp;days following the end of
each calendar month prior to Closing, Seller shall deliver to Buyer true and complete copies of the unaudited balance sheets and the related unaudited statements of income of, or relating to, each Seller Entity and the Partial Subsidiary for each
month then ended, together with a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-to-date</FONT></FONT> compilation and the notes, if any, related thereto, which shall have been prepared from and in accordance with the books
and records of the Seller Entity and the Partial Subsidiary, and shall fairly present in all material respects the financial position and results of operations of the Seller Entity, the Partial Subsidiary, and of the related Facility as of the date
and for the period indicated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.7</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I><FONT STYLE="white-space:nowrap">No-Shop</FONT>
Clause</I></B>. Seller agrees that, from and after the date of the execution and delivery of this Agreement by Seller until the termination of this Agreement, Seller will not, and will cause the Seller Entities to not, without the prior written
consent of Buyer or except as otherwise permitted by this Agreement: (i)&nbsp;offer for sale or lease all or any material portion of the Assets or any ownership interest in the Acquired Company, the Partial Subsidiary, or any entity owning any of
the Assets, (ii)&nbsp;solicit offers to buy all or any material portion of the Assets or any ownership interest in any entity owning any of the Assets, (iii)&nbsp;initiate, encourage or provide any documents or information to any third party in
connection with, discuss or negotiate with any person regarding any inquires, proposals or offers relating to any disposition of all or any material portion of the Assets or ownership interests in the Acquired Company or the Partial Subsidiary or a
merger or consolidation of the Acquired Company, the Partial Subsidiary, or any entity owning any of the Assets, or (iv)&nbsp;enter into any agreement or discussions with any party (other than Buyer) with respect to the sale, assignment, or other
disposition of all or any material portion of the Assets or any ownership interest in the Acquired Company, the Partial Subsidiary or any entity owning any of the Assets or with respect to a merger or consolidation of any entity owning any of the
Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.8</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Efforts to Clos</I></B><B><I>e</I></B>. Seller shall use its reasonable commercial
efforts to satisfy all of the conditions precedent set forth in <U>Section</U><U></U><U>&nbsp;7</U> to the extent that Seller&#146;s action or inaction can control or influence the satisfaction of such conditions, so that the Closing will occur as
promptly as practicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.9</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Estoppels and Contract Consents</I></B>. Seller shall use
commercially reasonable efforts to obtain, prior to the Closing Date, (a)&nbsp;estoppel letters, in a form reasonably acceptable to Buyer, under those leases of the Leased Real Property that are among the Contracts, and (b)&nbsp;consents from third
parties under each Contract which, by the terms of such Contract, requires such consent to convey and assign such Contract to a Buyer Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>5.10</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Employee List</I></B>. No later than
forty-five (45)&nbsp;days prior to Closing, Seller shall provide to Buyer, to one or more identified individuals for the sole purpose of preparing for the transition of payroll (and to no other persons or for any other purposes), a true, complete
and correct list of all persons who are employees, independent contractors or consultants of the Seller Entities, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or unauthorized, setting forth for each
individual the following: (i)&nbsp;name; (ii)&nbsp;classification as employee, independent contractor or consultant; (iii)&nbsp;if an employee, the individual&#146;s title or position (including whether full or part time, and exempt or <FONT
STYLE="white-space:nowrap">non-exempt</FONT> status); (iv) hire date; (v)&nbsp;current base compensation rate on an annual, monthly, <FONT STYLE="white-space:nowrap">bi-weekly</FONT> or hourly basis as appropriate to the individual&#146;s status;
(vi)&nbsp;commission, bonus or other incentive-based compensation; (vii)&nbsp;the number of such employee&#146;s accrued vacation and holiday hours; and (viii)&nbsp;a description of the fringe benefits provided to each such individual. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6.</B><B></B><B>&nbsp;&nbsp;&nbsp;&nbsp;COVENANTS OF BUYER PRIOR TO CLOSING</B>. Between the date of this Agreement and the Closing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Governmental Approvals</I></B>. Buyer shall (i)&nbsp;use reasonable efforts to obtain all
governmental approvals (or exemptions therefrom) necessary or required to allow Buyer to perform its obligations under this Agreement; and (ii)&nbsp;assist and cooperate with Seller and its representatives and counsel in obtaining all governmental
consents, approvals, and licenses which Seller deems necessary or appropriate and in the preparation of any document or other material which may be required by any governmental agency as a predicate to or as a result of the transactions contemplated
herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Antitrust Matter</I></B><B><I>s</I></B><B><I></I></B><B><I></I></B>. Buyer shall
(a)&nbsp;file and cause its Affiliates to file, within four (4)&nbsp;weeks of the date hereof or such other date as the Parties agree based on the advice of antitrust counsel, all reports, filings and other documents required or requested of Buyer
or its Affiliates by the FTC, the Justice Department, or any other Government Entity under any applicable Antitrust Laws in connection with the transactions contemplated by this Agreement, (b)&nbsp;comply at the earliest practicable date with any
request received by Buyer or any of its Affiliates from the FTC, the Justice Department or any such other Government Entity under any applicable Antitrust Laws for additional information concerning the transactions contemplated by this Agreement,
(c)&nbsp;cooperate with Seller in connection with any filing under applicable Antitrust Laws with respect to the transactions contemplated by this Agreement and in connection with resolving any investigation or other inquiry concerning such
transactions that is commenced by any of the FTC, the Justice Department or any other Government Entity pursuant to any applicable Antitrust Laws, (d)&nbsp;promptly inform Seller of any material communication made to or received by Buyer or any of
its Affiliates from the FTC, the Justice Department or any other Government Entity regarding any of the transactions contemplated hereby, (e)&nbsp;use commercially reasonable efforts to obtain all licenses, permits, consents, approvals, exemptions,
authorizations or waivers necessary or appropriate under the Antitrust Laws from the FTC, the Justice Department and any other Government Entity in order to avoid or terminate any action or proceeding by any of them with respect to, and to permit
the consummation of in the most expeditious manner practicable, the transactions contemplated by this Agreement, and (f)&nbsp;promptly furnish to Seller such information concerning Buyer or its Affiliates as Seller needs to perform its obligations
under <U>Section</U><U></U><U>&nbsp;5.5</U> of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this Agreement. Without limiting the foregoing, Buyer shall not (i)&nbsp;withdraw and <FONT STYLE="white-space:nowrap">re-file</FONT> its Premerger Notification and Report Form, (ii)&nbsp;extend
any waiting period or comparable period or (iii)&nbsp;enter into any agreement not to consummate the Contemplated Transactions, except, in each case, with the prior written consent of Seller. The foregoing covenants in this
<U>Section</U><U></U><U>&nbsp;6.2</U> do not require Buyer or any of its Affiliates to (A)&nbsp;defend against or oppose any formal administrative complaint, lawsuit, motion for preliminary or permanent injunction, temporary restraining order or
other actions brought by any Governmental Authority or private party seeking to block the Transaction under the Antitrust Laws, or (B)&nbsp;propose, negotiate, offer to commit to enter into or effect, by consent decree, hold separate order or
otherwise, sell, offer to sell or otherwise dispose of, any acute care hospital of Buyer or its Affiliates or hold separate such acute care hospital properties pending such sale or other disposition. Buyer shall be responsible for paying any
required filing fees under the HSR Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.3&nbsp;&nbsp;&nbsp;&nbsp;Title Commitment and Surveys. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Title Commitment</I></B>. Within sixty (60)&nbsp;days after the date hereof, Buyer, at its
expense, shall obtain a current title commitment with respect to the Owned Real Property (the &#147;Title Commitment&#148;), issued by Morehead Title Company, as agent for First American Title Insurance Company (the &#147;Title Company&#148;),
together with legible copies of all exceptions to title referenced therein, sufficient for the issuance of an owner&#146;s policy of title insurance for the Owned Real Property (the &#147;Title Policy&#148;). Buyer shall promptly upon its receipt
provide a copy of the Title Commitment and exception documents to Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Surveys</I></B>.
Within sixty (60)&nbsp;days after the date hereof, Buyer may, at its expense, obtain current <FONT STYLE="white-space:nowrap">as-built</FONT> ALTA/NSPS surveys of the Owned Real Property (the &#147;Surveys&#148;) or such portions thereof as Buyer
elects. Buyer shall promptly upon its receipt furnish a copy of the Surveys to Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Title Defects and Cure</I></B>. The Title Commitment and the Surveys (in each case, to the
extent obtained by Buyer pursuant to <U>Sections&nbsp;6.3(a)</U> and <U>(b)</U>), are collectively referred to as &#147;Title Evidence&#148;. Buyer shall notify Seller within twenty (20)&nbsp;days after its receipt of the last of the Title Evidence
of any liens, claims, encroachments, exceptions or defects disclosed in the Title Evidence which do not constitute Permitted Encumbrances (collectively, &#147;Defects&#148;). Seller, at its sole cost and expense, shall cure the objections on or
before the Closing or Seller may elect to not cure the objections and shall give written notice to Buyer within twenty (20)&nbsp;days of its receipt of Buyer&#146;s objections of its decision, whereupon Buyer may waive such objections and close or
may terminate this Agreement, which election by Buyer shall be made within ten (10)&nbsp;business days of its receipt of Seller&#146;s written notice. If Seller fails to timely give such notice, Seller shall be deemed to have elected not to cure the
objections, whereupon Buyer may waive such objections and close or may terminate this Agreement, which election by Buyer shall be made within twenty (20)&nbsp;days following notice of objection to Seller. Upon termination of this Agreement under the
terms of this <U>Section</U><U></U><U>&nbsp;6.3(c)</U>, no party to this Agreement shall have any further claims under this Agreement against any other party. Any matters shown by the Title Evidence to which Buyer does not object or which are waived
by Buyer as herein provided shall be deemed to be Permitted Encumbrances. Notwithstanding anything contained in this <U>Section</U><U></U><U>&nbsp;6.3(c)</U> to the contrary, at the Closing, Seller shall cause all mortgages, deeds of trust,
financing statements and other similar liens encumbering the Seller Entities&#146; fee interest in the Owned Real Property, and arising by, through or under the Seller Entities or any of their Affiliates, to be released (other than liens for taxes
not yet due and payable and any mechanic&#146;s or materialmen&#146;s liens relating to the Assumed Liabilities). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Costs</I></B>.
<U>Section</U><U></U><U>&nbsp;12.9</U> shall govern which party or parties hereto shall bear the costs and expenses of the Title Commitment, the Title Policy and the Surveys. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(e)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Buyer&#146;s Environmental Assessment. </I></B>Seller shall permit Buyer and its environmental
consultants, at Buyer&#146;s sole cost and expense, to conduct such investigations (including investigations known as &#147;Phase I&#148; and &#147;Phase II&#148; environmental assessments) of the environmental conditions of the Owned Real Property
or the operation thereat as Buyer, in its reasonable discretion, shall deem necessary or prudent (&#147;Buyer&#146;s Environmental Assessment&#148;) so long as (x)&nbsp;Buyer provides Seller with no less than five (5)&nbsp;business days&#146;
advance written notice of any such Buyer&#146;s Environmental Assessment, (y)&nbsp;Buyer&#146;s Environmental Assessment is conducted by a qualified environmental consulting firm, possessing reasonable levels of insurance, in compliance with all
applicable laws and in a manner that minimizes disruption of the operations of the Facilities, and (z)&nbsp;with respect to any Phase II environmental assessment, the environmental consulting firm has determined that there is a recognized
environmental condition, and the parties shall have entered into a mutually acceptable right of entry agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>6.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Efforts to Close</I></B>. Buyer shall use its reasonable commercial efforts to satisfy all of
the conditions precedent set forth in <U>Section</U><U></U><U>&nbsp;8</U> to the extent that Buyer&#146;s action or inaction can control or influence the satisfaction of such conditions, so that the Closing will occur as promptly as practicable.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7.</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>CONDITIONS PRECEDENT TO OBLIGATIONS OF BUYER</B>. Notwithstanding anything herein to the contrary, the
obligations of Buyer and the Buyer Entities to consummate the transactions described herein are subject to the fulfillment, on or prior to the Closing Date, of the following conditions precedent unless (but only to the extent) waived in writing by
Buyer at the Closing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Representations/Warranties</I></B>. The representations and
warranties of Seller contained in this Agreement shall be true and correct when made and, when read in light of any Schedules which have been updated in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as of the
Closing Date as though such representations and warranties had been made on and as of such Closing Date (except to the extent such representations and warranties address matters as of particular dates, in which case, such representations and
warranties shall be true and correct in all respects on and as of such dates), except to the extent that the failure of any such representations and warranties to be true and correct would not, or would not be reasonably likely to, individually or
in the aggregate, have a Material Adverse Effect. Each and all of the terms, covenants, and conditions of this Agreement to be complied with or performed by Seller on or before the Closing Date pursuant to the terms hereof shall have been duly
complied with and performed in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Governmental Approvals</I></B>. All
material consents, authorizations, orders and approvals of (or filings or registrations with) any Government Entity or other party required in connection with the execution, delivery and performance of this Agreement shall have been obtained or made
by Buyer when so required, except as for any documents required to be filed, or consents, authorizations, orders or approvals required to be issued, after the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Title Policy</I></B>. At the Closing, the
Title Company shall be ready, willing and able to issue a pro forma of the Title Policy (or marked Title Commitment containing no additional exceptions to title to the Owned Real Property) to Buyer. The Title Policy shall be issued, at Buyer&#146;s
expense, on an ALTA Form 2006 Owner&#146;s Title Policy in an amount equal to the portion of the Purchase Price being allocated to the Owned Real Property and shall insure to the Buyer Entities good and marketable title to the Owned Real Property
subject only to the Permitted Encumbrances and the standard exceptions contained in an&nbsp;owner&#146;s title policy prescribed for use in the State of North Carolina, (i)&nbsp;with the standard exception as to taxes and assessments limited to
taxes and assessments for the current and subsequent years, not yet due and payable, (ii)&nbsp;with the standard exception as to facts, rights, interests, or claims which are not shown by the public records&nbsp;deleted, and with the standard
exception as to discrepancies, conflicts in boundary lines, shortages in area, encroachments, or other facts which a correct survey would disclose modified to except matters shown on the Surveys&nbsp;(in&nbsp;each case, only to the extent that the
Surveys are sufficient for the Title Company to delete and/or modify the same), (iii) with the standard exception as to liens, or any right to liens, for services, labor or materials furnished to the Owned Real Property deleted (other than any such
liens or rights relating to Assumed Liabilities), and (iv)&nbsp;with the standard exception for unrecorded leases limited to rights of tenants under recorded or unrecorded leases included&nbsp;in the Contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Actions/Proceedings</I></B>. No action or proceeding before a court of competent jurisdiction
shall have been instituted by a Government Entity and be pending that seeks to restrain or prohibit the consummation of the transactions herein contemplated, and no order issued by a court of competent jurisdiction restraining or prohibiting the
consummation of the transactions herein contemplated shall be in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>No Material
Adverse Change.</I></B> Since the date of this Agreement, there shall not have occurred any event, change or development that has had, or would be reasonably expected to have, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.6</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Insolvency</I></B>. Neither Seller nor any Seller Entity shall (i)&nbsp;be in receivership or
dissolution, (ii)&nbsp;have made any assignment for the benefit of creditors, (iii)&nbsp;have admitted in writing its inability to pay its debts as they mature, (iv)&nbsp;have been adjudicated a bankrupt, or (v)&nbsp;have filed a petition in
voluntary bankruptcy, a petition or answer seeking reorganization, or an arrangement with creditors under the federal bankruptcy law or any other similar law or statute of the United States or any state, nor shall any such petition have been filed
against Seller or any Seller Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.7</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Material Consents</I></B>. Buyer shall have obtained
all consents of third parties (relating to the assignment of Contracts) that are material to the consummation of the transactions contemplated in this Agreement (collectively, the &#147;Material Consents&#148;) as specified in
<U>Schedule</U><U></U><U>&nbsp;7.7</U>. The Material Consents shall be in form and substance reasonably satisfactory to Buyer. Buyer shall cooperate in the assumption of the Contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.8</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Vesting/Recordation</I></B>. Seller shall have furnished to Buyer, in form and substance
reasonably satisfactory to Buyer, assignments or other instruments of transfer necessary or appropriate to transfer to and effectively vest in Buyer all right, title, and interest in and to the Assets, in proper statutory form for recording if such
recording is necessary or appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>7.9</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Closing Deliveries</I></B>. Seller shall have
delivered to Buyer, in accordance with the terms of this Agreement, all contracts, agreements, instruments, and documents required to be delivered by Seller to Buyer pursuant to <U>Section</U><U></U><U>&nbsp;2.2</U><U>.</U> <B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8.</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER</B>. Notwithstanding anything herein to the contrary, the obligations
of Seller and the Seller Entities to consummate the transactions described herein are subject to the fulfillment, on or prior to the Closing Date, of the following conditions precedent unless (but only to the extent) waived in writing by Seller at
the Closing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Representations/Warranties</I></B>. The representations and warranties of
Buyer contained in this Agreement shall be true and correct in all material respects when made and, when read in light of any Schedules which have been updated in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;12.1</U> hereof, as of
the Closing Date as though such representations and warranties had been made on and as of such Closing Date (except to the extent such representations and warranties address matters as of particular dates, in which case, such representations and
warranties shall be true and correct in all material respects on and as of such dates). Each and all of the terms, covenants, and conditions of this Agreement to be complied with or performed by Buyer on or before the Closing Date pursuant to the
terms hereof shall have been duly complied with and performed in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Governmental Approvals</I></B>. All material consents, authorizations, orders and approvals of
(or filings or registrations with) any Government Entity or other party required in connection with the execution, delivery and performance of this Agreement shall have been obtained or made by Seller when so required, except for any documents
required to be filed, or consents, authorizations, orders or approvals required to be issued, after the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Actions/Proceedings</I></B>. No action or proceeding before a court of competent jurisdiction
shall have been instituted by a Government Entity and be pending that seeks to restrain or prohibit the consummation of the transactions herein contemplated, and no order issued by a court of competent jurisdiction restraining or prohibiting the
consummation of the transactions herein contemplated shall be in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Insolvency</I></B>. Buyer shall not (i)&nbsp;be in receivership or dissolution, (ii)&nbsp;have
made any assignment for the benefit of creditors, (iii)&nbsp;have admitted in writing its inability to pay its debts as they mature, (iv)&nbsp;have been adjudicated a bankrupt, or (v)&nbsp;have filed a petition in voluntary bankruptcy, a petition or
answer seeking reorganization, or an arrangement with creditors under the federal bankruptcy law or any other similar law or statute of the United States or any state, nor shall any such petition have been filed against Buyer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>8.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Closing Deliveries</I></B>. Buyer shall have delivered to Seller, in accordance with the terms
of this Agreement, all contracts, agreements, instruments and documents required to be delivered by Buyer to Seller pursuant to <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9.</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>SELLER&#146;S COVENANT NOT TO COMPETE</B>. Seller hereby covenants that at all times from the Closing Date until
the second (2nd) anniversary of the Closing Date, Seller and its Affiliates shall not, directly or indirectly, own, operate, lease or manage an acute care hospital or ambulatory or other type of surgery center or any other business or facility that
competes with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Facilities within a forty (40)&nbsp;mile radius of each of the Hospitals without Buyer&#146;s prior written consent (which Buyer may withhold in its sole and absolute discretion). In the event of
a breach of this <U>Section</U><U></U><U>&nbsp;9</U>, Seller recognizes that monetary damages shall be inadequate to compensate Buyer and Buyer shall be entitled, without the posting of a bond or similar security, to an injunction restraining such
breach, with the costs (including attorneys&#146; fees) of securing such injunction to be borne by Seller. Nothing contained herein shall be construed as prohibiting Buyer from pursuing any other remedy available to it for such breach or threatened
breach. All parties hereto hereby acknowledge the necessity of protection against the competition of Seller and its Affiliates and that the nature and scope of such protection has been carefully considered by the parties. Seller further acknowledges
and agrees that the covenants and provisions of this <U>Section</U><U></U><U>&nbsp;9</U> form part of the consideration under this Agreement and are among the inducements for Buyer entering into and consummating the transactions contemplated herein.
The period provided and the area covered are expressly represented and agreed to be fair, reasonable and necessary. The consideration provided for herein is deemed to be sufficient and adequate to compensate for agreeing to the restrictions
contained in this <U>Section</U><U></U><U>&nbsp;9</U>. If, however, any court determines that the foregoing restrictions are not reasonable, such restrictions shall be modified, rewritten or interpreted to include as much of their nature and scope
as will render them enforceable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADDITIONAL AGREEMENTS. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Allocation of Purchase Price</I></B>. The Purchase Price shall be allocated among the various
classes of Assets in accordance with and as provided by Section&nbsp;1060 of the Code. Within ninety (90)&nbsp;days of the Closing, Seller shall provide Buyer with a preliminary allocation of the Purchase Price for Buyer&#146;s review and approval.
If Seller and Buyer cannot agree, initially, on an allocation, then the matter shall be submitted to the Accounting Firm for final resolution of all allocation matters. The parties agree that any tax returns or other tax information they may file or
cause to be filed with any governmental agency shall be prepared and filed consistently with such agreed upon allocation. In this regard, the parties agree that, to the extent required, they will each properly prepare and timely file Form 8594 in
accordance with Section&nbsp;1060 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Termination Prior to Closing</I></B>.
Notwithstanding anything herein to the contrary, this Agreement may be terminated at any time: (i)&nbsp;on or prior to the Closing Date by mutual, written consent of Seller and Buyer; (ii)&nbsp;by Buyer by written notice to Seller if any event
occurs or condition exists which causes Seller to be unable to satisfy one or more conditions to the obligations of Buyer to consummate the transactions contemplated by this Agreement as set forth in <U>Section</U><U></U><U>&nbsp;7</U>; (iii) by
Seller by written notice to Buyer if any event occurs or condition exists which causes Buyer to be unable to satisfy one or more conditions to the obligation of Seller to consummate the transactions contemplated by this Agreement as set forth in
<U>Section</U><U></U><U>&nbsp;8</U>; (iv) by Seller or Buyer if the Closing shall not have taken place on or before 5:00 p.m. central time on December&nbsp;31, 2023 (which date may be extended by mutual agreement of Seller and Buyer), provided that
the right to terminate pursuant to this subsection (iv)&nbsp;shall not be available to any party whose failure to fulfill any obligation under this Agreement has been the cause of, or resulted in, the failure of the Closing to occur by such date;
(v)&nbsp;by either Seller or Buyer pursuant to <U>Section</U><U></U><U>&nbsp;12.1</U> hereof; or (vi)&nbsp;by Buyer pursuant to <U>Section</U><U></U><U>&nbsp;6.3</U> hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Post-Closing Access to Information</I></B>. Seller and Buyer acknowledge that subsequent to
Closing each party may need access to information or documents in the control or possession of the other party for the purposes of concluding the transactions herein contemplated, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Buyer Entities&#146; operation of the Facilities, audits, compliance with governmental requirements and regulations, and the prosecution or defense of third party claims. Accordingly, Seller
and Buyer agree that for a period of six (6)&nbsp;years after Closing each will, unless prohibited by law or regulation, make reasonably available to the other&#146;s agents, independent auditors, counsel, and/or governmental agencies upon written
request and at the expense of the requesting party such documents and information as may be available relating to the Assets for periods prior and subsequent to Closing to the extent necessary to facilitate concluding the transactions herein
contemplated, the Buyer Entities&#146; operation of the Facilities, audits, compliance with governmental requirements and regulations, and the prosecution or defense of claims. Seller and Buyer shall cause their respective Affiliates to retain their
books and records for the periods specified in their respective document retention policies. All reasonable documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses associated with the
delivery of the requested documents shall be promptly paid by a requesting party to the other party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Preservation and Access to Records After the Closing</I></B>. After the Closing, Buyer shall
cause the Buyer Entities to, in the ordinary course of business and as required by law, keep and preserve in their original form all medical and other records of the Facilities existing as of the Closing, and which constitute a part of the Assets
delivered to the Buyer Entities at the Closing. For purposes of this Agreement, the term &#147;records&#148; includes all documents, electronic data and other compilations of information in any form. Buyer acknowledges that as a result of entering
into this Agreement and operating the Facilities the Buyer Entities will gain access to patient and other information which is subject to rules and regulations regarding confidentiality. Buyer agrees to cause the Buyer Entities to abide by any such
rules and regulations relating to the confidential information the Buyer Entities acquire. Buyer agrees to cause the Buyer Entities to maintain the patient and personnel records delivered to the Buyer Entities at the Closing at the Facilities after
Closing in accordance with applicable law (including, if applicable, Section&nbsp;1861(v)(i)(I) of the Social Security Act (42 U.S.C. &#167; 1395(v)(l)(i)), the privacy requirements of HIPAA and applicable state requirements with respect to medical
privacy, and requirements of relevant insurance carriers, all in a manner consistent with the maintenance of patient and personnel records generated at the Facilities after the Closing. Upon reasonable notice, during normal business hours, at the
sole cost and expense of Seller and upon the applicable Buyer Entity&#146;s receipt of any legally required consents and authorizations, such Buyer Entity will afford to the representatives of Seller, including its counsel and accountants, full and
complete access to, and copies of, the patient records transferred to the Buyer Entities at the Closing (including, without limitation, access to patient records in respect of patients treated by the Seller Entities at the Facilities). Upon
reasonable notice, during normal business hours and at the sole cost and expense of Seller, the Buyer Entities shall also make their officers and employees available to Seller at reasonable times and places after the Closing. Any access to the
Facilities, their records or the applicable Buyer Entity&#146;s personnel granted to Seller in this Agreement shall be upon the condition that any such access be consistent with applicable law and not materially interfere with the business
operations of any Buyer Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Tax and Medicare Effect</I></B>. None of the parties (nor
such parties&#146; counsel or accountants) has made or is making any representations to any other party (nor such party&#146;s counsel or accountants) concerning any of the tax or Medicare effects of the transactions provided for in this Agreement
as each party hereto represents that each has obtained, or may obtain, independent tax and Medicare advice with respect thereto and upon which it, if so obtained, has solely relied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.6</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Reproduction of Documents</I></B>. This
Agreement and all documents relating hereto, including, without limitation, (a)&nbsp;consents, waivers and modifications which may hereafter be executed, (b)&nbsp;the documents delivered at the Closing, and (c)&nbsp;financial statements,
certificates and other information previously or hereafter furnished to Seller or to Buyer may, subject to the provisions of <U>Section</U><U></U><U>&nbsp;12.10</U> hereof, be reproduced by Seller and by Buyer by any photographic, photostatic,
microfilm, micro-card, miniature photographic or other similar process and Seller and Buyer may destroy any original documents so reproduced. Seller and Buyer agree and stipulate that any such reproduction shall be admissible in evidence as the
original itself in any judicial, arbitral or administrative proceeding (whether or not the original is in existence and whether or not such reproduction was made by the Seller or Buyer in the regular course of business) and that any enlargement,
facsimile or further reproduction of such reproduction shall likewise be admissible in evidence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.7</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Cooperation on Tax Matters</I></B>. Following the Closing, the parties shall cooperate
reasonably with each other and shall make available to the other, as reasonably requested and at the expense of the requesting party, and to any taxing authority, all information, records or documents relating to tax liabilities or potential tax
liabilities of Seller for all periods on or prior to the Closing and any information which may be relevant to determining the amount payable under this Agreement, and shall preserve all such information, records and documents (to the extent a part
of the Assets delivered to the Buyer Entities at the Closing) until the later of the seventh (7<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) anniversary of the Closing Date or the expiration of any applicable statute of limitations or
extensions thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.8</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Cost Reports</I></B>. Seller, at its expense, shall prepare and
timely file all terminating and other cost reports required or permitted by law to be filed under the Medicare and Medicaid or other third-party payor programs and the State Health Agency for periods ending on or prior to the Effective Time, or as a
result of the consummation of the transactions described herein (&#147;Seller Cost Reports&#148;). In addition, Buyer shall assist Seller in providing certain information needed by Seller when preparing the terminating cost report, including but not
limited to completion of Seller&#146;s standard Hospitals data collection template, invoice and general ledger analysis, and other documentation historically prepared by the Hospitals for cost reporting purposes. If requested by the Seller Entities,
the applicable Buyer Entity shall include the applicable Seller Entity&#146;s Medicare bad debts that are returned from collection agencies subsequent to the Closing Date on the applicable Buyer Entity&#146;s cost report for the respective period to
which the Medicare bad debt relates. The Seller Entity shall provide detailed supporting information, as required by Medicare regulations, for the Medicare bad debt account amounts to be included on the Buyer Entity&#146;s Medicare cost report. The
applicable Buyer Entity shall forward to Seller any and all correspondence relating to the Seller Cost Reports within five (5)&nbsp;business days after receipt by such Buyer Entity. The applicable Buyer Entity shall remit any receipts of funds
relating to the Seller Cost Reports promptly after receipt by such Buyer Entity and shall forward to Seller any demand for payments within three (3)&nbsp;business days after receipt by such Buyer Entity. Notwithstanding anything to the contrary in
this Agreement, Seller shall retain all rights to the Seller Cost Reports including any amounts receivable or payable in respect of such reports or reserves relating to such reports and all liabilities relating thereto. Such rights shall include the
right to appeal any Medicare or Medicaid determinations relating to the Seller Cost Reports. Seller shall retain the originals of the Seller Cost Reports, correspondence, work papers and other documents relating to the Seller Cost Reports. Seller
will furnish copies of such cost reports to any Buyer Entity upon request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.9</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Misdirected Payments, Etc.</I></B> Seller
and Buyer covenant and agree to remit, with reasonable promptness (within five (5)&nbsp;business days after receipt) to the other any payments received, which payments are on or in respect of accounts or notes receivable owned by (or are otherwise
payable to) the other. In addition, and without limitation, in the event of a determination by any governmental or third-party payor that payments to the Seller or the Facilities resulted in an overpayment or other determination that funds
previously paid by any program or plan to the Seller or the Facilities must be repaid, Seller shall be responsible for repayment of said monies (or defense of such actions) if such overpayment or other repayment determination was for services
rendered prior to the Effective Time and Buyer shall be responsible for repayment of said monies (or defense of such actions) if such overpayment or other repayment determination was for services rendered after the Effective Time. In the event that,
following Closing, Buyer or any Buyer Entity suffers any offsets against reimbursement under any third-party payor or reimbursement programs due to Buyer or any Buyer Entity, relating to amounts owing under any such programs by Seller or any of its
Affiliates, Seller shall within five (5)&nbsp;business days after notice from Buyer or any Buyer Entity pay to Buyer or such Buyer Entity the amounts so billed or offset. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.10&nbsp;&nbsp;&nbsp;&nbsp;Employee Matters. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;As of the Effective Time, Seller shall cause the Seller Entities to terminate all of the employees at
the Facilities, and Buyer shall cause the Buyer Entities to offer or cause to be offered employment (subject to standard drug and related employment screening and background checks) to all active employees (including any employees who are on
statutory family or medical leave, military leave, short-term disability, or other short-term leave of up to 90 days) who are in good standing in positions and at salary or base wage levels generally consistent with those provided by the Seller
Entities. Nothing herein shall be deemed to affect or limit in any way normal management prerogatives of the Buyer Entities with respect to employees or to create or grant to any such employees third-party beneficiary rights or claims of any nature.
All such employees who accept such offers and commence employment with a Buyer Entity (together, the &#147;Buyer Employees&#148;) shall be credited with employment service with the Seller Entities for purposes of eligibility and vesting purposes
(but not for purposes of benefit accrual) under Buyer&#146;s or the Buyer Entities&#146; employee benefit plans or programs (the &#147;Buyer Plans&#148;), unless such service credit is not allowed pursuant to the express terms of any insurance
policy (or policies) used to fund the benefits provided under such Buyer Plans, in which case such service credit will not be allowed just for such insured plan(s). Notwithstanding anything contained herein to the contrary, this
<U>Section</U><U></U><U>&nbsp;10.10(a)</U> shall not apply to any physician employee of any Seller Entity who has entered into an employment agreement with any Seller Entity, and such persons shall not be deemed to be Buyer Employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Buyer shall cause the Buyer Entities to offer or cause to be offered enrollment in the appropriate
Buyer Plan that is a group health plan to any Buyer Employee together with the eligible dependents of such Buyer Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Within the period of ninety (90)&nbsp;days prior to the Closing, the Seller Entities shall not
violate the WARN Act, 29 U.S.C. &#167;2101 <U>et</U> <U>seq</U>. and/or the regulations thereunder. With respect to terminations of employees prior to the Closing, the Seller Entities shall be responsible for any legally required notifications. With
respect to terminations of employees following the Closing, the Buyer Entities shall be responsible for any legally required notifications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(d)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;This <U>Section</U><U></U><U>&nbsp;10.10</U> shall
be binding upon and inure solely to the benefit of each of the Parties. Nothing contained in this <U>Section</U><U></U><U>&nbsp;10.10</U> or any other provision of this Agreement, express or implied: (i)&nbsp;shall be construed to establish, amend,
or modify any benefit plan, program, agreement or arrangement, including any Benefit Plan or Buyer Plan; (ii)&nbsp;is intended to confer upon any current or former employee any right to employment or continued employment for any period of time, or
any right to a particular term or condition of employment; or (iii)&nbsp;is intended to confer upon any Person (including, for the avoidance of doubt, any current or former employee, director, officer or other service provider or any participant in
a Benefit Plan, Buyer Plan or other plan, policy, program, agreement or arrangement providing benefits or compensation) any right as a third-party beneficiary of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.11</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Indigent Care Policies</I></B><B><I>. </I></B>The Buyer Entities shall adopt and maintain
reasonable policies for the treatment of indigent patients of the Hospitals. The Buyer Entities shall cause the Hospitals to treat any patient presented to the emergency room who has a medical emergency or who, in the judgment of a staff physician,
has an immediate emergency need. No such patient will be turned away because of age, race, gender or inability to pay. The Buyer Entities shall cause the Hospitals to continue to provide services to patients covered by the Medicare and Medicaid
programs and those unable to pay for emergent and medically necessary care. This covenant shall be subject in all respects to changes in governmental policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.12</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Use of Controlled Substance Permits</I></B>. To the extent permitted by applicable law, each
applicable Buyer Entity shall have the right, for a period not to exceed one hundred eighty (180)&nbsp;days following the Closing Date, to operate under the licenses and registrations of the corresponding Seller Entities (and the Partial Subsidiary,
if applicable) relating to controlled substances and the operations of pharmacies and laboratories, until such Buyer Entity is able to obtain such licenses and registrations for itself. In furtherance thereof, the Seller Entities (and the Partial
Subsidiary, if applicable) shall execute and deliver to the corresponding Buyer Entities at or prior to the Closing limited powers of attorney substantially in the form of <U>Exhibit C</U> hereto. Buyer shall cause the Buyer Entities to apply for
all such licenses and permits as soon as reasonably possible before and after the Closing and shall diligently pursue such applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.13</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Medical Staff Matters</I></B>. As a result of the acquisition of the Assets by the Buyer
Entities, without the consent of the medical staff of the Hospitals, there will be no change or modification to the current staff privileges for physicians on the medical staff of the Hospitals; provided, however, that the consummation of the
transactions contemplated hereby will not limit the ability of the Board of Trustees or medical executive committee of the Hospitals to grant, withhold or suspend medical staff appointments or clinical privileges in accordance with the terms and
provisions of the medical staff bylaws. The applicable Buyer Entity shall adopt the current medical staff bylaws of the Hospitals as the medical staff bylaws of the Hospitals following the Closing, except to the extent that any modifications thereof
are required to comply with accreditation standards or legal or regulatory requirements, and except to the extent that modifications thereto may be proposed by the medical staff and agreed to by such Buyer Entity. Nothing herein shall prohibit the
amendment of the Hospitals&#146; medical staff bylaws following the Closing Date to meet any minimum Buyer medical staff standards or to synchronize the Hospitals&#146; medical staff bylaws with the medical staff bylaws of other Hospitals owned by
Buyer or its Affiliates in accordance with the same process that applies to such other Hospitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.14</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Information Services Agreement</I></B>. At
the Closing, an Affiliate of Seller and Buyer will enter into an Information Technology Transition Services Agreement in a form mutually agreeable to Buyer and Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.15</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Transition Services Agreement</I></B>. At the Closing, an Affiliate of Seller and Buyer will
enter into a Hospitals Transition Services Agreement in a form mutually agreeable to Buyer and Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.16</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Billing and Collection Agreement</I></B>. At the Closing, an Affiliate of Seller and Buyer
will enter into a Clinic Billing and Collection Agreement in a form mutually agreeable to Buyer and Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.17</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>License Agreement</I></B>. At the Closing, Seller and Buyer will enter into a License
Agreement for Policy and Procedure Manuals in a form mutually agreeable to Buyer and Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.18</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Access to Records Including as to Recovery and Audit Information</I></B>. If any entity,
governmental agency or person makes a claim, inquiry or request to any Buyer Entity or Seller Entity relating to the Seller Entities&#146; operation of the Hospitals prior to the Effective Time (including but not limited to a notice to any Buyer
Entity or Seller Entity from a person responsible for retroactive payment denials, including recovery audit contractors) of their intent to review the Seller Entities&#146; claims with respect to the operation of the Hospitals prior to the Effective
Time, or otherwise seeks information pertaining to the Seller Entities, the Buyer Entities shall: (i)&nbsp;comply with all requests from such entity or person in a timely manner; (ii)&nbsp;comply with all other applicable laws and regulations;
(iii)&nbsp;forward to the Seller Entities all communications and/or documents sent to such person or entity or received from such person or entity within five (5)&nbsp;business days of the Buyer Entities&#146; delivery or receipt of such
communications and/or documents and (iv)&nbsp;provide the Seller Entities and their agents and attorneys upon reasonable request with reasonable access to records, information and personnel necessary for any appeal or challenge regarding any such
retroactive payment denials (with the understanding that the Seller Entities shall be solely responsible for handling any appeals). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.19</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Continuation of Insurance</I></B>. For a period of at least ten (10)&nbsp;years following the
Closing, the Seller Entities shall maintain in effect insurance on all claims-made professional and general liability insurance policies of the Hospitals for claims related to the period of the Seller Entities&#146; ownership and operation of the
Hospitals. The insurance shall have coverage levels equal to the coverage maintained by Seller for other comparable healthcare facilities operated by Seller. If such insurance is cancelled or terminated during such ten (10)&nbsp;year period, the
Seller Entities shall purchase tail insurance with a successor indemnification endorsement and <FONT STYLE="white-space:nowrap">co-defendant</FONT> endorsement, each in favor of the Buyer Entities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.20</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Quality Reporting</I></B><B><I>. </I></B>The Seller Entities shall submit all quality data
required under the HQI Program to CMS or its agent, and all quality data required under ORYX to The Joint Commission, for any calendar quarter with reporting deadlines between the date of this Agreement and the Closing Date. If a calendar quarter
ends prior to the Closing Date, but the reporting deadline for such quarter ends after the Closing Date, the Seller Entities shall prepare and submit </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the quality data for the Facilities required under the HQI Program and ORYX in accordance with applicable filing deadlines and in the form and manner required by CMS and The Joint Commission,
respectively, or, at the sole option to Buyer, the Seller Entities shall transmit such quality data to Buyer in a form mutually agreeable to Buyer and Seller or allow Buyer access to such data, to enable the Buyer Entities to submit quality data for
the Facilities required under the HQI Program and ORYX for such quarter. If the Closing Date falls between the first and last day of a calendar quarter, the Seller Entities shall cooperate with Buyer to ensure that all quality data required to be
submitted for the Facilities under the HQI Program and ORYX for the portion of the quarter during which Seller owned the Facilities can be aggregated with the quality data for the portion of the quarter during which Buyer owned the Facilities, to
enable the Buyer Entities and/or the Seller Entities to submit quality data for the Facilities required under the HQI Program and ORYX in accordance with applicable filing deadlines and in the form and manner required by CMS and The Joint
Commission, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.21</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Telephone Access</I></B>. The parties shall take all steps
necessary to transition over to Buyer or an Affiliate all local and long distance telephone services at the Facilities as of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.22</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Guaranties</I></B>. To the extent that Seller has guaranteed the obligations of any Seller
Entity under any of the Contracts (a &#147;Seller Guaranty&#148;), at the request of Seller, Buyer shall use commercially reasonable efforts to have Seller released as guarantor. If required to obtain a release from a Seller Guaranty, Buyer shall
execute a guaranty in the form of the existing Seller Guaranty, or such other form as may be agreed to by Buyer and the beneficiary of such guaranty. If Buyer is unable to obtain a release for any Seller Guaranty as set forth in this
<U>Section</U><U></U><U>&nbsp;10.22</U>, Buyer (i)&nbsp;shall indemnify and hold harmless Seller against any liabilities arising from or relating thereto as if the obligations accruing from and after the Effective Time under such Seller Guaranty
were Assumed Liabilities, and (ii)&nbsp;agrees not to amend, modify, supplement, extend or renew (or allow the applicable Buyer Entity to amend, modify, supplement, extend or renew) the underlying Contract in any manner that would reasonably be
expected to materially increase the obligations of Seller under the Seller Guaranty, without the prior written consent of Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>10.23</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Medicare Transition Agreement</I></B>. The parties have agreed to execute and deliver at the
Closing a Medicare Transition Agreement in a form mutually agreeable to Seller and Buyer. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INDEMNIFICATION. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Indemnification by Buyer</I></B>. Subject to the limitations set forth in
<U>Section</U><U></U><U>&nbsp;11.3</U> hereof, Buyer shall defend, indemnify and hold harmless Seller and its Affiliates, and its and their respective officers, directors, employees, agents or independent contractors (collectively, &#147;Seller
Indemnified Parties&#148;), from and against any and all losses, liabilities, damages, costs (including, without limitation, court costs and costs of appeal) and expenses (including, without limitation, reasonable attorneys&#146; fees and fees of
expert consultants and witnesses) that such Seller Indemnified Party incurs as a result of, or with respect to (i)&nbsp;any misrepresentation or breach of warranty by Buyer under this Agreement, (ii)&nbsp;any breach by Buyer of, or any failure by
Buyer to perform, any covenant or agreement of, or required to be performed by, Buyer under this Agreement, (iii)&nbsp;any of the Assumed Liabilities, or (iv)&nbsp;any claim made by a third party with respect to the operation of the Facilities or
acts or omissions of the Buyer Entities following the Effective Time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Indemnification by Seller</I></B>. Subject
to the limitations set forth in <U>Section</U><U></U><U>&nbsp;11.3</U> hereof, Seller shall defend, indemnify and hold harmless Buyer and its Affiliates, and its and their respective officers, directors, employees, agents, or independent contractors
(collectively, &#147;Buyer Indemnified Parties&#148;), from and against any and all losses, liabilities, damages, costs (including, without limitation, court costs and costs of appeal) and expenses (including, without limitation, reasonable
attorneys&#146; fees and fees of expert consultants and witnesses) that such Buyer Indemnified Party incurs as a result of, or with respect to (i)&nbsp;any misrepresentation or breach of warranty by Seller under this Agreement, (ii)&nbsp;any breach
by Seller of, or any failure by Seller to perform, any covenant or agreement of, or required to be performed by, Seller under this Agreement, (iii)&nbsp;any of the Excluded Liabilities, (iv)&nbsp;any actual or alleged violation of law by the Seller
Entities, including but not limited to violations of federal or state laws regulating fraud such as the federal Anti-Kickback Law, the Stark Law, and the False Claims Act, in connection with which Buyer or its Affiliates incurs liability as a result
of Buyer&#146;s assumption of a Seller Entity provider number or provider agreement, (v)&nbsp;any claim made by a third party with respect to the operation of the Facilities or acts or omissions of the Seller Entities prior to the Effective Time,
and (vi)&nbsp;any claim made by a third party against Buyer or any of the Buyer Entities with respect to the operation, acts or omissions of the Partial Subsidiary prior to the Effective Time that is not borne by the Partial Subsidiary or covered by
the Partial Subsidiary&#146;s insurance policies (not including any diminution in the value of the Partial Subsidiary). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Limitations</I></B>. Buyer and Seller shall be liable under
<U>Section</U><U></U><U>&nbsp;11.1(i)</U> or <U>Section</U><U></U><U>&nbsp;11.2(i)</U> (i.e., for misrepresentations and breaches of warranties), as applicable, only when total indemnification claims exceed One Million Six Hundred Thousand Dollars
($1,600,000) (the &#147;Basket Amount&#148;), after which Buyer or Seller, as applicable, shall be liable only for the amount in excess of the Basket Amount. No party shall be liable for any indemnification pursuant to
<U>Section</U><U></U><U>&nbsp;11.1(i)</U> or <U>Section</U><U></U><U>&nbsp;11.2(i)</U>, as applicable, for any claims for misrepresentations and breaches of warranty which are the basis upon which any other party shall have failed to consummate the
transactions described herein pursuant to <U>Section</U><U></U><U>&nbsp;7.1</U> or <U>Section</U><U></U><U>&nbsp;8.1</U>, as applicable, or which are based upon misrepresentations and breaches of warranty which have been waived pursuant to the
initial paragraph of <U>Section</U><U></U><U>&nbsp;7</U> or <U>Section</U><U></U><U>&nbsp;8</U>, as applicable. The liability of Buyer and Seller for indemnification under <U>Section</U><U></U><U>&nbsp;11.1(i)</U> or
<U>Section</U><U></U><U>&nbsp;11.2(i)</U>, respectively, shall be limited to an amount equal to 25% of the Purchase Price. Notwithstanding the foregoing provisions of this <U>Section</U><U></U><U>&nbsp;11.3</U>, the limitation on liability and the
Basket Amount shall not apply to claims arising under <U>Section</U><U></U><U>&nbsp;11.1(i)</U> or <U>Section</U><U></U><U>&nbsp;11.2(i)</U> and resulting from intentional misrepresentation or fraud by the indemnifying party or from a breach by
Seller of the representations and warranties contained in <U>Section</U><U></U><U>&nbsp;3.27(b)</U> (the Basket Amount shall apply, the limitation of liability shall be limited to an amount equal to the Purchase Price). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Notice and Control of Litigation</I></B>. If any claim or liability is asserted in writing by
a third party against a party entitled to indemnification under this <U>Section</U><U></U><U>&nbsp;11</U> (the &#147;Indemnified Party&#148;) which would give rise to a claim under this <U>Section</U><U></U><U>&nbsp;11</U>, the Indemnified Party
shall notify the person giving the indemnity (the &#147;Indemnifying Party&#148;) in writing of the same within fifteen (15)&nbsp;days of receipt of such written assertion of a claim or liability. The Indemnifying Party shall have the right to
defend a claim and control the defense, settlement, and prosecution of any litigation. If the Indemnifying Party, within ten (10)&nbsp;days after receipt of such written notice of such claim, fails to agree to defend such claim, the Indemnified
Party shall (upon further notice to the Indemnifying Party) have the right to undertake the defense, compromise, or settlement of such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
claim on behalf of and for the account and at the risk of the Indemnifying Party, subject to the right of the Indemnifying Party to assume the defense of such claim at any time prior to
settlement, compromise, or final determination thereof. Anything in this <U>Section</U><U></U><U>&nbsp;11.4</U> notwithstanding, (i)&nbsp;in the event that a proposed settlement requires the Indemnified Party to admit any wrongdoing or take or
refrain from taking any action, then the proposed settlement shall not be entered into unless it is reasonably acceptable to both the Indemnifying Party and the Indemnified Party, and (ii)&nbsp;the Indemnifying Party shall not, without the written
consent of the Indemnified Party, settle or compromise any claim or consent to the entry of any judgment which does not include as an unconditional term thereof the giving by the claimant to the Indemnified Party of a release from all liability in
respect of such claim. The foregoing rights and agreements shall be limited to the extent of any requirement of any third-party insurer or indemnitor. All parties agree to cooperate fully as necessary in the defense of such matters. Should the
Indemnified Party fail to notify the Indemnifying Party in the time required above, the indemnity with respect to the subject matter of the required notice shall be limited to the damages that would have resulted absent the Indemnified Party&#146;s
failure to notify the Indemnifying Party in the time required above after taking into account such actions as could have been taken by the Indemnifying Party had it received timely notice from the Indemnified Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Notice of Claim</I></B>. If an Indemnified Party becomes aware of any breach of the
representations or warranties of the Indemnifying Party hereunder or any other basis for indemnification under this <U>Section</U><U></U><U>&nbsp;11</U> (except as otherwise provided for under <U>Section</U><U></U><U>&nbsp;12.3</U>), the Indemnified
Party shall notify the Indemnifying Party in writing of the same within thirty (30)&nbsp;days after becoming aware of such breach or claim, specifying in detail the circumstances and facts which give rise to a claim under this
<U>Section</U><U></U><U>&nbsp;11</U>. Should the Indemnified Party fail to notify the Indemnifying Party within the time frame required above, the indemnity with respect to the subject matter of the required notice shall be limited to the damages
that would have nonetheless resulted absent the Indemnified Party&#146;s failure to notify the Indemnifying Party in the time required above after taking into account such actions as could have been taken by the Indemnifying Party had it received
timely notice from the Indemnified Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.6</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Mitigation</I></B>. The Indemnified Party shall
take all reasonable steps to mitigate all liabilities and claims, including availing itself as reasonably directed by the Indemnifying Party of any defenses, limitations, rights of contribution, claims against third parties (other than the
Indemnified Party&#146;s insurance carriers) and other rights at law, and shall provide such evidence and documentation of the nature and extent of any liability as may be reasonably requested by the Indemnifying Party. Each party shall act in a
commercially reasonable manner in addressing any liabilities that may provide the basis for an indemnifiable claim (that is, each party shall respond to such liability in the same manner that it would respond to such liability in the absence of the
indemnification provided for in this Agreement). Any request for indemnification of specific costs shall include invoices and supporting documents containing reasonably detailed information about the costs or damages for which indemnification is
being sought. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>11.7</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Exclusive Remedy</I></B>. The representations and warranties contained in
or made pursuant to this Agreement shall be terminated and extinguished upon the earlier of the end of the Survival Period (hereinafter defined) or any termination of this Agreement. Thereafter, none of Seller, Buyer or any shareholder, partner,
officer, director, principal or Affiliate of any of the preceding shall be subject to any liability of any nature whatsoever with respect to any such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
representation or warranty. Moreover, the sole and exclusive remedy for any breach or inaccuracy, or alleged breach or inaccuracy, of any representation and warranty made by Seller or Buyer shall
be the remedies provided by this <U>Section</U><U></U><U>&nbsp;11</U>. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MISCELLANEOUS. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.1</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Schedules and </I></B><B><I>Exhibits</I></B>. Each Schedule and Exhibit to this Agreement shall
be considered a part hereof as if set forth herein in full. From the date hereof until the Closing Date, the Seller Entities or the Buyer Entities may update their Schedules, subject to the other party&#146;s approval rights described below. If a
party, after having a period of ten (10)&nbsp;business days to review any modification or amendment to a Schedule proposed by another party, determines in its reasonable discretion that it should not consummate the transactions contemplated by this
Agreement because the modification or amendment to such Schedule discloses facts or circumstances having a Material Adverse Effect not disclosed in the original Schedules, then such party may terminate this Agreement on or before the Closing by
giving a written notice to the other party (a &#147;Termination Notice&#148;), whereupon the other party shall be entitled, for a period of ten (10)&nbsp;business days after its receipt of the Termination Notice, to cure the matter that has
triggered such Termination Notice. Notwithstanding anything contained herein to the contrary, the inclusion of new or different information on a Schedule after the date of this Agreement shall not prejudice or otherwise affect a party&#146;s right
to seek relief for the other party&#146;s breach of a representation or warranty or affect the party&#146;s right to indemnification under <U>Section</U><U></U><U>&nbsp;11. 1</U> or <U>Section</U><U></U><U>&nbsp;11.2</U> (based upon the Schedule as
of the date of this Agreement without taking into account any modification, update or amendment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.2</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Additional Assurances</I></B>. The provisions of this Agreement shall be self-operative and
shall not require further agreement by the parties except as may be herein specifically provided to the contrary; provided, however, at the request of a party, the other party or parties shall execute such additional instruments and take such
additional actions as are consistent with this Agreement and are necessary or convenient to consummate the transactions contemplated hereby, with each party bearing its own costs and expenses incurred by such party related thereto. In addition and
from time to time after the Closing, Seller and the Seller Entities shall execute and deliver (and shall cause the Acquired Company and the Partial Subsidiary to execute and deliver) such other instruments of conveyance and transfer, and take such
other actions as Buyer reasonably may request, more effectively to convey and transfer full right, title, and interest to, vest in, and place the Buyer Entities in legal and actual possession of, any and all of the Facilities and the Assets, as well
as the Acquired Company Ownership Interests and Statesville HMA, LLC&#146;s ownership interests in the Partial Subsidiary, in a manner consistent with this Agreement with each party bearing its own costs and expenses associated therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.3</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Consented Assignment</I></B>. Anything contained herein to the contrary notwithstanding, this
Agreement shall not constitute an agreement to assign any claim, right, contract, license, lease, commitment, sales order, or purchase order if an attempted assignment thereof without the consent of the other party thereto would constitute a breach
thereof or in any material way affect the rights of Seller thereunder, unless such consent is obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.4</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Consents, Approvals and Discretion</I></B>. Except as herein expressly provided to the
contrary, whenever this Agreement requires any consent or approval to be given by a party, or whenever a party must or may exercise discretion, the parties agree that such consent or approval shall not be unreasonably withheld or delayed and such
discretion shall be reasonably exercised. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.5</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Legal Fees and Costs</I></B>. In the event a
party elects to incur legal expenses to enforce or interpret any provision of this Agreement by judicial proceedings, the prevailing party will be entitled to recover such legal expenses, including, without limitation, reasonable attorneys&#146;
fees, costs, and necessary disbursements at all court levels, in addition to any other relief to which such party shall be entitled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.6</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Choice of Law</I></B>. The parties agree that this Agreement shall be governed by and
construed in accordance with the laws of the State of North Carolina, without regard to conflict of laws principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.7</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Benefit/Assignment</I></B>. Subject to provisions herein to the contrary, this Agreement shall
inure to the benefit of and be binding upon the parties hereto and their respective legal representatives, successors, and assigns. No party may assign this Agreement without the prior written consent of the other parties, which consent shall not be
unreasonably withheld; provided, however, that any party may, without the prior written consent of the other parties, assign its rights and delegate its duties hereunder to one or more Affiliates (as defined in
<U>Section</U><U></U><U>&nbsp;12.18</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.8</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>No Brokerage</I></B>. Buyer and Seller each
represent and warrant to the other that it has not engaged a broker in connection with the transactions described herein. Each party agrees to be solely liable for and obligated to satisfy and discharge all loss, cost, damage, or expense arising out
of claims for fees or commissions of brokers employed or alleged to have been employed by such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.9</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Cost of Transaction</I></B>. Whether or not the transactions contemplated hereby shall be
consummated, the parties agree as follows: (i)&nbsp;Seller shall pay the fees, expenses, and disbursements of Seller and its agents, representatives, accountants, and legal counsel incurred in connection with the subject matter hereof and any
amendments hereto; (ii)&nbsp;Buyer shall pay the fees, expenses, and disbursements of Buyer and its agents, representatives, accountants and legal counsel incurred in connection with the subject matter hereof and any amendments hereto;
(iii)&nbsp;Buyer shall pay for the Title Commitment, the Title Policy, the Surveys, the filing fees required to be paid under the HSR Act, any environmental engineering reports, licensure application fees, recording fees, and mechanical, structural,
electrical and roofing engineering costs; and (iv)&nbsp;Seller and Buyer shall each pay <FONT STYLE="white-space:nowrap">one-half</FONT> of any and all real estate transfer or excise taxes in connection with the transfer of the Assets. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>12.10</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Confidentiality</I></B>.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(a)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;It is understood by the parties hereto that the information, documents, and instruments delivered to
Buyer by Seller and its agents and the information, documents, and instruments delivered to Seller by Buyer and its agents are of a confidential and proprietary nature. Each of the parties hereto agrees that prior to the Closing it will maintain the
confidentiality of all such confidential information, documents, or instruments delivered to it by each of the other parties hereto or their agents in connection with the negotiation of this Agreement or in compliance with the terms, conditions, and
covenants hereof and will only disclose such information, documents, and instruments to its duly authorized officers, members, directors, representatives, and agents </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(including consultants, attorneys, and accountants of each party) and applicable governmental authorities in connection with any required notification or application for approval or exemption
therefrom. Each of the parties hereto further agrees that if the transactions contemplated hereby are not consummated, it will return all such documents and instruments and all copies thereof in its possession to the other parties to this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(b)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Seller acknowledges that the success of transactions contemplated under this Agreement after the
Closing depends upon the continued preservation of the confidentiality of certain information possessed by Seller or its Affiliates, agents and representatives, that the preservation of the confidentiality of such information by the Seller is an
essential premise of the bargain between Seller and Buyer, and that Buyer would be unwilling to enter into this Agreement in the absence of this <U>Section</U><U></U><U>&nbsp;12.10</U>. Accordingly, Seller hereby agrees that (i)&nbsp;at the Closing
Seller will assign to Buyer all of its rights under confidentiality agreements with other bidders that relate to the proposed sale of the Assets or to the Facilities or any other related information and (ii)&nbsp;Seller will not, and Seller will
cause its Affiliates, agents and representatives not to, at any time on or after the Closing Date, directly or indirectly, without the prior written consent of Buyer, disclose or use any confidential or proprietary information involving or relating
to the Assets, the Facilities or the operations thereof; provided, however, that the information subject to the foregoing provisions of this sentence will not include any information generally available to, or known by, the public (other than as a
result of disclosure in violation hereof); and provided, further, that the provisions of this <U>Section</U><U></U><U>&nbsp;12.10</U> will not prohibit any retention of copies of records or disclosure (a)&nbsp;required by any applicable legal
requirement so long as reasonable prior notice is given of such disclosure and a reasonable opportunity is afforded to contest the same or (b)&nbsp;made in connection with the enforcement of any right or remedy relating to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>(c)</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Each of the parties hereto recognizes that any breach of this <U>Section</U><U></U><U>&nbsp;12.10</U>
would result in irreparable harm to the other party to this Agreement and its Affiliates (as defined in <U>Section</U><U></U><U>&nbsp;12.18</U> below) and that therefore either Seller or Buyer shall be entitled to an injunction to prohibit any such
breach or anticipated breach, without the necessity of posting a bond, cash, or otherwise, in addition to all of its other legal and equitable remedies. Nothing in this <U>Section</U><U></U><U>&nbsp;12.10</U>, however, shall prohibit the use of such
confidential information, documents, or information for such governmental filings as in the opinion of Seller&#146;s counsel or Buyer&#146;s counsel are required by law or governmental regulations or are otherwise required to be disclosed pursuant
to applicable state law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.11</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Public Announcements</I></B>. Seller and Buyer mutually agree
that no party hereto shall release, publish, or otherwise make available to the public in any manner whatsoever any information or announcement regarding the transactions herein contemplated without the prior written consent of Seller and Buyer,
except for information and filings reasonably necessary to be directed to governmental agencies to fully and lawfully effect the transactions herein contemplated or required in connection with securities and other laws. Nothing contained in this
Agreement will limit Seller or its Affiliates from making any disclosures or filing any agreements that they deem necessary or advisable to be made in any filings with the Securities and Exchange Commission or in connection with any future
securities offerings of Seller or its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.12</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Waiver of Breach</I></B>. The waiver
by any party of a breach or violation of any provision of this Agreement shall not operate as, or be construed to constitute, a waiver of any subsequent breach of the same or any other provision hereof. Any waiver of a breach or violation of any
provision of this Agreement must be in writing and signed by the party waiving such breach or violation to be effective. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.13</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Notice</I></B>. Any notice, demand, or
communication required, permitted, or desired to be given hereunder shall be deemed effectively given when personally delivered, when received by receipted overnight delivery, or five (5)&nbsp;days after being deposited in the United States mail,
with postage prepaid thereon, certified or registered mail, return receipt requested, addressed as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Seller:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CHS/Community Health Systems, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4000 Meridian Boulevard</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: Vice President - Development</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">With a simultaneous copy to:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CHSPSC, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4000 Meridian
Boulevard</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: General
Counsel</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Buyer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novant
Health, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2085 Frontis Plaza Boulevard</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Winston-Salem, NC
27103</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">With a simultaneous copy (which shall not constitute notice) to:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Legal Officer</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novant Health,
Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2085 Frontis Plaza Boulevard</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Wintson-Salem, NC
27103</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address, and to the attention of such other person or officer as any party may designate, with copies thereof
to the respective counsel thereof as notified by such party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.14</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Severability</I></B>. In
the event any provision of this Agreement is held to be invalid, illegal or unenforceable for any reason and in any respect, such invalidity, illegality, or unenforceability shall in no event affect, prejudice, or disturb the validity of the
remainder of this Agreement, which shall be and remain in full force and effect, enforceable in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.15</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Gender and Number</I></B>. Whenever the context of this Agreement requires, the gender of all
words herein shall include the masculine, feminine, and neuter, and the number of all words herein shall include the singular and plural. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.16</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Divisions and Headings</I></B>. The
divisions of this Agreement into sections and subsections and the use of captions and headings in connection therewith are solely for convenience and shall have no legal effect in construing the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.17</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Survival</I></B>. All of the representations, warranties, covenants, and agreements made by
the parties in this Agreement or pursuant hereto in any certificate, instrument, or document shall survive the consummation of the transactions described herein, and may be fully and completely relied upon by Seller and Buyer, as the case may be,
notwithstanding any investigation heretofore or hereafter made by any of them or on behalf of any of them, and shall not be deemed merged into any instruments or agreements delivered at the Closing or thereafter. The representations and warranties
contained in or made in <U>Sections 3.1</U>, <U>3.2</U>, <U>3.3</U>, <U>4.1</U>, <U>4.2</U> and <U>4.3</U> shall survive the Closing indefinitely and the representations and warranties contained in <U>Sections 3.7</U>, <U>3.8</U>, <U>3.14</U> and
<U>3.27(a)</U> <U>and (c)</U>&nbsp;shall survive for a period of four (4)&nbsp;years after the Closing; all other representations and warranties made pursuant to this Agreement shall survive the Closing for a period of two (2)&nbsp;years following
the Closing Date (the &#147;Survival Period&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.18</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Affiliates</I></B>. As used in this
Agreement, the term &#147;Affiliate&#148; means, as to the entity in question, any person or entity that directly or indirectly controls, is controlled by or is under common control with, the entity in question and the term &#147;control&#148; means
possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of an entity whether through ownership of voting securities, by contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.19</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Material Adverse Effect</I></B>. As used in this Agreement, the term &#147;Material Adverse
Effect&#148; means an event, change or circumstance which, individually or together with any other event, change or circumstance, would reasonably be expected to have a material adverse effect on the business (but not the prospects), financial
condition, or results of operations of the Facilities, taken as a whole. Notwithstanding anything to the contrary contained in this Agreement, none of the following occurring after the date hereof shall constitute a Material Adverse Effect or be
taken into account in determining whether a Material Adverse Effect has occurred: (a)&nbsp;changes or proposed changes to any law, reimbursement rates or policies of governmental agencies or bodies that are generally applicable to hospitals or
health care facilities; (b)&nbsp;changes or proposed changes in requirements, reimbursement rates, policies or procedures of third-party payors or accreditation commissions or organizations that are generally applicable to hospitals or health care
facilities; (c)&nbsp;any changes or any proposed changes in GAAP after the date of this Agreement; (d)&nbsp;any hostilities, acts of war, sabotage, terrorism or military actions, or any escalation or worsening of any such hostilities, acts of war,
sabotage, terrorism or military actions; (e)&nbsp;changes resulting from the public announcement of this Agreement or the pendency of the transactions contemplated hereby (including, without limitation, changes in private payor agreements or
policies and their effects and the departure of employees), or Buyer being the proposed purchaser of the Assets; (f)&nbsp;the effect of physicians or payors moving proposed medical procedures from the Facilities to facilities not owned by the Seller
Entities (including, without limitation, facilities owned or operated by Buyer or its Affiliates); (g) compliance with the terms of, or the taking of any action required, by this Agreement or consented to by Buyer; or (h)&nbsp;any failure in and of
itself to meet internal or published projections, estimates or forecasts of revenues, earnings, cash flow, or other measures of financial or operating performance for any period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.20</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Waiver of Jury Trial</I></B>. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHTS
IT MAY HAVE TO DEMAND THAT ANY ACTION, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT OR THE RELATIONSHIPS OF THE PARTIES HERETO BE TRIED BY JURY. THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND
A TRIAL BY JURY ARISING FROM ANY SOURCE INCLUDING, BUT NOT LIMITED TO, THE CONSTITUTION OF THE UNITED STATES OR ANY STATE THEREIN, COMMON LAW OR ANY APPLICABLE STATUTE OR REGULATIONS. EACH PARTY HERETO ACKNOWLEDGES THAT IT IS KNOWINGLY AND
VOLUNTARILY WAIVING ITS RIGHT TO DEMAND TRIAL BY JURY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.21</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Accounting Date</I></B>. The
transactions contemplated hereby shall be effective for accounting purposes as of 12:01 a.m. on the day following the Closing Date, unless otherwise agreed in writing by Seller and Buyer. The parties will use commercially reasonable efforts to cause
the Closing to be effective as of a month end, with equitable adjustments made to the Purchase Price necessary to give effect to the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.22</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>No Inferences</I></B>. Inasmuch as this Agreement is the result of negotiations between
sophisticated parties of equal bargaining power represented by counsel, no inference in favor of, or against, either party shall be drawn from the fact that any portion of this Agreement has been drafted by or on behalf of such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.23</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Limited Third Party Beneficiaries</I></B>. The terms and provisions of this Agreement are
intended solely for the benefit of Buyer, Seller, their Affiliates and their respective permitted successors or assigns, and it is not the intention of the parties to confer, and this Agreement shall not confer, third-party beneficiary rights upon
any other person other than the Seller Entities and the Buyer Entities, which the parties agree are express third party beneficiaries of the rights of Seller and Buyer, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.24</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Entire Agreement/Amendment</I></B>. With the exception of the Agreement for Use and <FONT
STYLE="white-space:nowrap">Non-Disclosure</FONT> of Confidential Information dated as of August&nbsp;1, 2022, between CHSPSC, LLC and Buyer, this Agreement supersedes all previous contracts, and constitutes the entire agreement of whatsoever kind or
nature existing between or among the parties respecting the within subject matter, and no party shall be entitled to benefits other than those specified herein. As between or among the parties, no oral statements or prior written material not
specifically incorporated herein shall be of any force and effect. The parties specifically acknowledge that in entering into and executing this Agreement, the parties rely solely upon the representations and agreements contained in this Agreement
and no others. All prior representations or agreements, whether written or verbal, not expressly incorporated herein are superseded, and no changes in or additions to this Agreement shall be recognized unless and until made in writing and signed by
all parties hereto. This Agreement may be executed in two or more counterparts, each and all of which shall be deemed an original and all of which together shall constitute but one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.25</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Risk of Loss</I></B>. Notwithstanding any other provision hereof to the contrary, the risk of
loss or damage to any of the Assets, the Hospitals and all other property, transfer of which is contemplated by this Agreement, shall be borne by Seller until the Effective Time and by Buyer after the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>12.26</I></B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Other Definitions</I></B><B></B><B></B>. &#147;Knowledge of Seller&#148; or
&#147;Seller&#146;s knowledge&#148; or any other similar knowledge qualification with respect to any representation, warranty or other statement in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this Agreement means (i)&nbsp;all matters with respect to which Seller or any Seller Entity has received written notice from a governmental authority, governmental entity, or third party;
(ii)&nbsp;the actual knowledge of the following officers of the Hospitals or any Seller Entity: Chief Executive Officer, Chief Financial Officer, Chief Compliance Officer, Chief Operating Officer, Chief Medical Officer and/ or Chief Nursing Officer
as well as the VP, Senior Acquisitions and Development Officer of Seller, and President, Region 3 Operations and Chief Compliance Officer of Seller, in each case after reasonable inquiry of such person&#146;s immediate subordinates. The term
&#147;Person&#148; means any individual, partnership, limited liability company, corporation, joint venture, trust, business trust, cooperative or other association or entity, including any Government Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties hereto have caused this Agreement to be executed in
multiple originals by their authorized officers, all as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CHS/COMMUNITY HEALTH SYSTEMS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Terry H. Hendon</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Vice President</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">(&#147;Seller&#148;)</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>NOVANT HEALTH, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carl Armato</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">(&#147;Buyer&#148;)</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d449097dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g449097g0228104203821.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMUNITY HEALTH SYSTEMS ANNOUNCES DEFINITIVE AGREEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO SELL TWO NORTH CAROLINA HOSPITALS TO NOVANT HEALTH </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FRANKLIN, Tenn. (February 28, 2023) &#150; Community Health Systems, Inc. (NYSE: CYH) announced today that subsidiaries of the Company have signed a
definitive agreement to&nbsp;sell <FONT STYLE="white-space:nowrap">123-bed</FONT> Lake Norman Regional Medical Center, an acute care hospital in Mooresville, NC, and Davis Regional Medical Center in Statesville, NC, which is in the process of
transitioning from a general acute care hospital to an inpatient behavioral health hospital,&nbsp;and their associated assets, to subsidiaries of Novant Health for cash consideration of approximately $320&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is expected to close later this year, subject to customary regulatory approvals and closing conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The hospitals included in this transaction are among the additional potential divestitures discussed on the Company&#146;s fourth quarter and <FONT
STYLE="white-space:nowrap">year-end</FONT> 2022 earnings call. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Community Health Systems, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Community Health Systems, Inc. is one of the nation&#146;s largest healthcare companies. The Company&#146;s affiliates are leading providers of healthcare
services, developing and operating healthcare delivery systems in 45 distinct markets across 16 states. CHS subsidiaries own or lease 79 affiliated hospitals with approximately 13,000 beds and operate more than 1,000 sites of care, including
physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. Shares in Community Health Systems, Inc. are traded on the New York Stock
Exchange under the symbol &#147;CYH.&#148; More information about the Company can be found on its website at www.chs.net. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor Contacts:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Kevin J. Hammons</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President and Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-465-7000</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">or</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shelly K. Schussele, CMA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Director, Investor Relations</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-465-2732</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">or</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Media Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rebecca Ayer Pitt</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Corporate Communications</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">615-465-2750</FONT></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-END- </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cyh-20230228.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/1/2023 2:25:10 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:cyh="http://www.chs.net/20230228"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.chs.net/20230228"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cyh-20230228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cyh-20230228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cyh-20230228_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/1/2023 2:25:10 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cyh-20230228_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/1/2023 2:25:10 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cyh-20230228.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g449097g0228104203821.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g449097g0228104203821.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L 6 # 2(  A$! Q$!_\0
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7W%6Z.@P**DT04444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495742473984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COMMUNITY HEALTH SYSTEMS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001108109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 28,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3893191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4000 Meridian Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">465-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d449097d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cyh-20230228.xsd" xlink:type="simple"/>
    <context id="duration_2023-02-28_to_2023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001108109</identifier>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-02-28_to_2023-02-28"
      id="Hidden_dei_EntityRegistrantName">COMMUNITY HEALTH SYSTEMS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-02-28_to_2023-02-28">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-02-28_to_2023-02-28"
      id="Hidden_dei_EntityCentralIndexKey">0001108109</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-02-28_to_2023-02-28">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-02-28_to_2023-02-28">2023-02-28</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-02-28_to_2023-02-28">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-02-28_to_2023-02-28">001-15925</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-02-28_to_2023-02-28">13-3893191</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-02-28_to_2023-02-28">4000 Meridian Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-02-28_to_2023-02-28">Franklin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-02-28_to_2023-02-28">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-02-28_to_2023-02-28">37067</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-02-28_to_2023-02-28">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-02-28_to_2023-02-28">465-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-02-28_to_2023-02-28">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-02-28_to_2023-02-28">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-02-28_to_2023-02-28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-02-28_to_2023-02-28">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-02-28_to_2023-02-28">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-02-28_to_2023-02-28">CYH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-02-28_to_2023-02-28">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-02-28_to_2023-02-28">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" #@@UQ6EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #@@UQ6!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( ."#7%8)TI,5[P   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ."#7%:97)PC$ 8  )PG   3
M          "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
MX(-<5MC;K\=0!   C1   !@              ("!#@@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ."#7%:?H!OPL0(  .(,   -
M          "  90,  !X;"]S='EL97,N>&UL4$L! A0#%     @ X(-<5I>*
MNQS     $P(   L              ( !< \  %]R96QS+RYR96QS4$L! A0#
M%     @ X(-<5APX9>H_ 0  / (   \              ( !61   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( ."#7%8D'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( ."#7%9ED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d449097d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d449097d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d449097d8k.htm">d449097d8k.htm</File>
    <File>cyh-20230228.xsd</File>
    <File>cyh-20230228_lab.xml</File>
    <File>cyh-20230228_pre.xml</File>
    <File>d449097dex21.htm</File>
    <File>d449097dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d449097d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d449097d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cyh-20230228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cyh-20230228_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cyh-20230228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cyh",
   "nsuri": "http://www.chs.net/20230228",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d449097d8k.htm",
      "contextRef": "duration_2023-02-28_to_2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d449097d8k.htm",
      "contextRef": "duration_2023-02-28_to_2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230228/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-23-053968-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-053968-xbrl.zip
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M[OZR[0N\VNE?]':K'33T\Q]02P,$%     @ X(-<5L+/*A9?!@  O4,  !0
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MSA8:+6)9MUN*=76BRT@_NM0[B<UO;-ML8=U+[G1E+;."%4'N:ZM5D'9QS4I
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MQBS,0UU_;NHD@5? =X6".?=+5T+H[(+.O1CFF !_D81;@<D]3L>%B9+<^W;
M-J[,UN%M$[M(2S^;#RZWX":A:\<6V+&IZ=@P&+<^:L# G9C0UN[_6+@>G2_?
M 4W'@L699VNM-7<\LXTX=G@K^0C-?NKA*_AA+\?<82PTF+;2.#!>"CR2"(!I
M&)<98JQK27R2*U%LF58HT(@D]Y1:I,E"L]$L7J3AK M40"\#[3NA*;,\39Q+
MK8-:J\_019C@7SG2M!#<7 \L![ *AE2E$T>Z8CI=IC-(2'<Q0P,C5O-#1JYA
M+@P9MJ3'QR;":GEN=$@[1. XL:?]MD=Q2]*1$:;B(-+TPE("Y_"1(R([B/K
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M/;PW\&L$FA@1;&6OE;V&R=ZN%AZ\"R(_&@5^Z%UG?L8'8"M^K?@U3/QVM?+
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M.>"/UE-J9:]:]G85=GP39"%BCF>S($-_B8+KUWERIQ;;$\.V^V,KAM5BN*L
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M[ZV:@Q@V9_U:&V83CMF&-UAN5W##=EM-U)ZS=ODV9\7HC^]4 NLXF$Q44]Q
MK'MM&3#7KF&3>X:V.G2#!?QX'[6'X/>\@)<JF059!HLXB$;Y;$@DPLT)QK3<
ML^M7,$]&4[!%00"#IO _'[6]0]<OW-7I57,P8VWH98,.6^TI]YTNW36R [?5
MD=_MRC60&/_H\%%9]5^_:_+#76<_Q*7\/FD"C[\=3> /1X G.J>1)=G\ZWY[
M<&RXB$VN[FU+V-:O(L*,O?=@>6=3KW^KHE%#+.^3UL/=8/7RY$XM&B)PSP].
MVC[@FW2EPHA@Q B#BSAK3DRIK?G=9/6"+%3@+LUF08,0!2A[;9SB :LW]Z.&
M''3MTCUDZ2[C,&B*B=*NW&8K]V?_ZJ(Y '+L=_HXTM?N=]Y98^>C2W_97/[Z
MYK?^]?7@QKO\X^KT??]ZX/5_OQH,/L#H/6Z 4.RLX4[F<<UX7#E[^I\/%#$8
MT,W[LVNO;E0X*&\/VTO]UW\</7WQVD"R\,^7K_>]((4QC17Q-=-+@CL?1%GL
M^=1P[)T:)KF?+'CC'K_L><>'QR<];[B@7PQ5=J]4!*_\YK?3]]<_GW[\\.&/
MB[.;?WCO!_WSF_?>]3^N;P8?KGO>V<7I 0ZFY_G>6Q7Z]WZBO%&<S..$+>(]
M'B!'%V1T/7H(W/OBX]_[,,5\T^+-+N($/-A3/X$#(O*]7]]]A OUIID&F7J2
MSOV1^B6*[Q,?5&,41T_F23P)0"WAM;\51@&_&$UQ4M1G-0,)GB3QS)NHL4K\
M$.9E%,^4E_F?<79\>.TXN?6CX-_\V[%*1TDPI GTI#,&S]NSPR/0/'LG^SBE
MN!A((*/?F,C2Y(4/O'K=</STVVSHJ\'IV4W__/J7K>W@/C[XP#T%W/]*O"F^
MCV!')K!:F.8)TYXW#A*8Y'"!G\+3Y:\>3;"[,*D7!BD",6+<J'_\-O@\#8:X
M_'_\!G_)_YCPWQ^_>7Z6^:,I_& *X@"BL*?@3]AJ[@Z5.D1>-]JF67RKX-&)
M9Z6M%.\L+/)?/<EO5DXR,_;])7/\9H,Y=J@[UTQQD>1SJS-\NG*&;V#(I?U0
M,[NX#/2ZF!#'*-VY_TFAGH,'>5?J%J8;E)'NC,QG)?R\V_D0PUF<W@7PD%Y)
M+[(F?>O?@6JKOP63#U3?@5>H9Y9(EW4ZRS.*J55L<*?T%BE>NMWE>;N)E@$=
M#JN08D_&D9^GBMZBO&SP90H?Z<:-Q2U(,\$?5=VLVRE=#E_.-= HS8=IYD?8
M41"V ?Q'GQ<^,>GHO\KCX4,+#]2:#97 @8O"F<4]+U(CE:9PI,.$)3V\,$_Y
MR *IC_C4HOZ4(N2T!Z5_<Z%-9<^*([6S'$FO2_VPH3!@J[37[<#1&>9C1*,.
M\\R+X@STQ2S@,7DSV8?Q9()5&\,\"/%2>$*<9W-X.M9]C_#])H;AI.?-IXLT
M& 4@$W.L<Z1Z'9Q[Y-$(0WS!5)?Q[+D[DT=;?A6S62V)BC%"X.7Q>Y"162H;
M79I:I_",#"<2[AC@58%3,W2 UG;=:?[-MOF +*.Z;=XO;)X%:WQGHP5IFJLQ
M:Y\\P\U(BS93LZ%*TFDP1^,0-'8*N]$U*T?_R@,T'27"TNT@?I5_<*9_8$S.
MR+L,U'@&+^)=YS !C@Z"80P^CW"(T0A4T/GY:<%@U)LF%'ZB!2P%/7#58+:J
M==ZM7([K' 2WN"*.TM!*QG=5#!O>5N^8ZZ=^5K[2*!8T8[L=TB3S>0@3/@Q5
MZ;GX97GFO(I5?+PXK)K_;V7<&D?(6K=_L3Q>?/P3]-_-^\'5X-W'JP&[+3!%
M-'.L=3'V4U2R\T3-@E04&GXPRZD#NZ\G$Y9A%-^IR*=_)L7VPGS8@\ D>);
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MI0;/NE+)Z8!2]8!JRN:<V@\X$V)R^&L'E>8S0YRR-#Z&K7^5056!U,D)Q;.
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M&0R#)_=*?0H76AT4NN":80W]L=3D%K['")G8W606S?TT?:(#?F0#]4QYY\B
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M8"D[MM94HSQS()I.-+-(C$EMH"@V*0;C3!-D2A:J_/,"P^4$(Z_X9*VG/E)
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MS>B<T[E@*AWH[/#(>&=RL"/R48)+S@MPD&G,T>- __U)>PW%1"<9OE(0PI4
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M_?R,0R&TJ8NEWR4+M< Z1ZU=F _:$D"7;%/=23>DV.^5RO(D6NIAPK^& R#
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M!FC3\BYE-LP[/K%NBSGAQVO+P#!'40JD;2%!W1^^D$[ EMV!EO[HQK\<+(+
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M9"+IB,O$<36VL?9O;VV2O>-%WQCJF2[=QLDNUKPY34:)E(PW!+?1PZZ+M/O
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M,W?..?.-PLZ0'?K#F>"(5',K:%XBI3N10I;(6TQL&VA4SI5JP0W$33;,,%=
M]>$&C>\E&3E:CZ<=<>&@STU)*S=ZLR(O(-SU;Z4YP<>!*8Y["D>KFX]69^;$
M#8 .^<YPEY")2[&*TJ2$ (NF>"A7,M:K C4P:*-X#8M 18*]L=K648)-MS>H
M8<V5+M\VAT$'EZ(4"4F$*.P>49!Z@*%%#KH=,')/E*%>M3M@E8?;8V>T*SFU
MEONS90-",[D>J1'5JK6Y+<'PT,K)EA:0I*[PVH54YKH]2&YWB?>WC Y.0M
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MR,C!&&!]:72$^(.]Z C)9EF.4O")$(F+/=HDYE:&-GBP4:A'9*FE8UK$!.X
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M8_H).NY^V-Z:9:.RF&3361SA/Y^,$#D!@B<$=+-?]B@0P0!C-1Y')AKA-YC
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MQXC'_ZXP*[?WT3\R[.T]B\>)V N8'#E5TJ_PP-H(&KZ@3D3:!Y\^#CM08[[
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MGJY&CR6J;^=)#=*<.LL]8^9':/:=9'+X,]M;.QR*;'Q5""?= )2+9+K+UU%
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MA4/DL;OIZ5[_.I4@T"@WGB&S#9GE+6OO0Y2L79.>!23SUKJ@4&7<Z[8">SV
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MAL4=U\EXDZDM;BE'%S7)NQ.&/5M+[IJCRBD=BTO#VUD%N)(AK;ZVI<#A2!"
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M3HG/,6*ATV%9UY/<M#S6+ FQA .8UEC]XPR4HCE_0M9U1=$,B(V'(*JH6V"
MCT++M2H"0O#%E;V@VB?I"#1HBC*[$X&6AC$<'<[W7/@;#<;N&JD$48H-EZ<H
M:47A)@QS1F:Z,97"0D@EW@/>-DOK*YJQZ23/81<@0!@X+9#4L\?-A>2)!JZ,
M%4BA2<44WF-T4*S.)M2-DCL(BZAIY:Q96[0@:0EHVAO>T6P,,MJ,%MQ9#B?A
M$KE)($#DQO,:=S4.8//[GRC1FY(3)2)^4(D.#D^&FJ\(D_2>$=SGYF#2,OH.
MDB^?)',FP1^+,0:%+:,I:W<GX=;''8^U,\!X"DF=+)UH'K7EK/"1XJ1N?AA#
M"+<#O1"-\,8KNX$O:].:44^H(E490=#8X!'Q2-5!K1!9OV)4-:?7$J:K'V2Q
MG,#V*-@@$NJ@;Y'58*RI02@OQ"!1G16FB?]K<3<A*O:$4?1W>)D:0)#$/Q4E
MXJM0..0C,2T?X^<XD4AF<%0"8SQJK]:V6:O"3)/F))%[I'X6%66- D?X B@J
MZX<J0RE-3QZ+D4;B7#6?,F%<"/6CW5#-96G51Q(3H>YC/OM(Z=^[-,_X7NE]
M>9$Z3LR"\CY"-73^/@<Q@<_)5&=I(1;6HC#WD;E)E"!49*2.<QT0FFP*+6/A
M0T'_VV#_"TC.VPR<;A6M'1^5])?P8,11]4.@ ,U]1K^EPJ*=_6'7LL'86:5(
M[%VZ3"3DB:,]P145SCB3+OO))OO,1+]@*?/Z SJ1,F665P3P\L2Z5P6O09M1
MU./P9N1:0L1 (-5X'-W!/[*<$6739-3*PN6V#^GCX!*CTJM;K/#CRR@.BO^:
M-3TRK*1+A1CI^Q2L82Z::LS#F7+#'G-SZ2&74(55W65NUJ-W[P=Q=')R*%>#
MYY/-]#MLZK2(T!$-!T=1U^RL1^R"I*J*4>97/#QBDZ=YS_*80T*+N%:[J<JN
M\YKB0%]SI8D;JIO"_F1'6>%L3OO*G.L$DG)M\'B66):SU*_&(B@7(YTR0?YF
MV9P 4E4R19\'@X%P- O,&'^% GPY\!6X4P^#G-ICQ;>L$$JSQSZ?:1R$MQW2
MPDMY(H75B=&';760%C7FCL_D2#&F)L9CP2P1*(8;Y)8J$46!CNGF5EA/Y#2O
M,'<(#-AQI)WS1KTNXU[K7<[+C(6JFS<X8J784H;Z)PR\UG:Q(M&HHI5GL_0.
M+-6O0@(\I_) ON4QE<#/% SV;%'AE^%D=M=".0(KV7N.<6"3,%9(2X;;7A[@
MU!:Y.?Q1-"XET3AWZR1+#LC3Y6&\536ES)>E;>.OF$'AY;=P\^?>K#WQ02=X
MZ[^5\OA#N.<,2,A"0"7$$Z53$0!&2Y M![T8D1/5C3IYF'A3NSW-PM#=(O6P
M(=$QQ=HM$*G!O SK9K@G2'I=BH[#F( H)=P):US8*I.H?RC!C;-;4^4T(#O*
M&^!N<PX73)R.^7&BB@5> R*LCSFYG F;K\<]L3<-UPKF,8TMW0AY;/+<[PF^
M.+PI&&IVDMRW<ZV98[++221Y'8GIC0DBZVQNBFJUR?U9Q4FT'N&'4PRO'B9E
MX=9,XJ><-##8H)XXVV+.; *5Y NGFR2W/^B;,?X9R2;GW[49<8:5RSCFW6&G
MMB!VEC. ";$.]#*!T;M9&F84WM*@B;+I,?UC&Y4)[4@;%;JC #0K&_#F(BNM
M,E6_< 6SI=@5@+E905\8&G.DCXL;3CYC;^;MK=:KN5N9EO3NN9D]"15;6L3]
MPS"EAST[:P YFO'WXX4.,</U"E0&!R,%/$9#%[&35)*![\._=H"Z6A]^VMT8
M5.)@KZ>PEUL4/Y?%1Y3]6%'?3S:YKC6;^PP#U)(  &Y=6 %I?IU<8]YFB*]I
MH^IH1%;JI=4!%HE92,GV9&6<H'Q]++2==(M5;F-43"$$MM^-&_%4.7?H'A*J
M'31=^8[3ZE>W_#!P:0K1)ZQJ/%)>:CPRJ8N5\ F-;699&'L14Z@?"$(^FSPG
M>ROW4$#ORD^77S6_W:2X!HJ2.&)[!,STHJ*+B4)MXS9G(!&^L\KH>P7L$[<)
M!3;)O/"6"D^\L2M"&465% %48/TTY?!SHHK&=.K"+ZMTZF-W'<NZ!J65M"4<
MR_G22!#+26^EQBQKXX/Z%E)C]>G:Y^Y9U.Q8((%6[YID0*[ ."-5!PY)^-^2
MYF*L4"EG4-(/S#./>[).K91D 8G]Y07Q!9$"X5U6%J(\Z,XI=[JG):'H &17
M2:P$$99$4(!#0'- ,F+R8IJ)60KB[A R=]>P,[)&\T7I_KV]A29^F0DG>UD4
M$_BF?2F:PS]R&=1=N+Z5V5;"M70:+M=K$[G[[ F4[(DN$2-9)/!8@JA92DQ-
M&@;%(Q#=\WGR)P4S.T_LB4>R4:BR>89] ZD\_Z?OE(>A\!]?K$.P,!JCITC3
MH3/# 34,T=ML[I&/7R  YG-#7;Y_W.6WD^RN&]KC.=',HVI?48SK*32VTE7(
MSR268P_4E6R"3WEP2@2/*Z$[]1BR\ #7E,!C'BZ/#$CV[;.Y-@F].%D^4C3O
MS.YTCC%J1&JR,2: SYJCPL89C$2KK!4@KS,KP">Q2+MJL2TH%T9>A6]25^>+
MLKOO&<9"3,55Z"M(T^D*\CJ3'<=>GEX7KBGMP%N.5J-(:!:ZU0 *06N3*T-I
MQJ#KQ!18V2L4APB9G02$(MIY_>8>>PT>#I17+IP'5;HM,3;DE[,4J.I"%LRF
M@8"%HOC KS84^NI;*/31R%LC;&R(/6,?T.,E8NQ(H )55XTJ7HS<0ZCU3.M2
M\J7UO6:*CJGD+,!^67/,)@70=DF)JY%S2) E7WEF!0@)/KM8;&.M^X+P@0#D
M!K2U?,:YIR_*W)]DH?QM'=% D<Y;JI"AHX"A=B9SW "#L;!3#?\/B_V3X@Z/
MO4N':^]2N=Q&'YV-.DW'6@Q-3L5(:>LZA[Z-&M4C'[RL!+'W5CZH-B+962 Y
M@X.NO MJJ5KNH!&)4(?"U#095MNTR2\:VTN[<:YJ=WLVHW[TATRM2(OD%CLT
MBBY)]UBD-> G#MU40R]$P:WN5 BQ:B)4GI25Q:P:K&/6X,:#B3!9M;%O*Y5:
M#VDGFQ90[8,1NU)3SW\K^\OL2<_Z.[<FA1)[X9Z3N*8J\!&\PL0!:?G4A]D0
M(N#QPZ74V1AL/GH_ 7)4L%>I,Y)I&OI D3=[:C2M-E>1S.O%60$#ANT4$EZ8
M:!S\TED.B,KIO_!8N"<.F%+X/.U0#27K8+ID7@?^J6=4EA>76C!0+BYD&]:F
M([Y<M3+MD$#QV_2.Z4U$%$FYQP4<TQQH/".%7U;/T^Z@<\VNKH.X5S+S(?R#
M3#V.>BL;2![VAC6CP2:#Y!L3IJ#Q"H=ACOS/.*2+H;O>@FI30+0AS0?18LNH
M0FS";3_/Y4P]W?U1C'?N+M]QP=GS4(Y!V;"^H^X9!-ZGRYI)^PC)=<O<!2RW
M3LA;;;-SNNBI5OB/9<S%6L!XE$H#4S:E(#V[),"?TPIDN+3K!P$2Y. T;\5K
MUGZSP'+*12[L<J"N-E;NSSF"OJ1^%&0?AMQJK/;I<! X66N94IC>J)1R)"_O
MU;BY/SD$_-B;>[3VYEYA0L$D7^?NA95/XEB2B_Z+:WM+"W-AI</E6Z) ,:F-
M)^6L#1#?O).:P@"U)$Z/!F$.AXHR=OT=248E0@HS;$)KR5<]EXY5S7\L\I'D
MK8.]0\@47WP&I:A0:SG7DK3PS*6$.9L'[AJ:4^7 L #5A%%2W<0!&KV9-/>W
M(@VC1RO";B,N)RE60Q3^0[BP9"[-*:O5[5SLX_JP\/0^80!@M9/OCU-5KPW<
M"HH&(RI4RC9NLYR/)9HJP3]*J%MFKOY[,.[M^00D^>ZSP>N$VIYY6S"0HD4
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M%<"2E72>HI[#-!,"Q[ :2>#"Q$$V2A", 0]RMG#>9.J$NSNM1$*$^XO(J8(
MOI29$>IL3R./.FPUN4']FY7+8/8?3BW-TO):M.KH]89=KK2SY>N#0BPQ8T>Y
M97WD HA'2=$.(A<0X,NJZ)GH>+M?/B.>3/[W,_WW<_.9Y\REB93*\"-^K&7Z
MM:PJ1V1;AA,H!\7C)(ZAM:],"U^;?S]]+LU"#@14/DY(^=C]B #F$?Y(VRUL
M;YUD=E(LRFCG.:?JEFE25DT@\H^$56/0],K^]--I:!N]!OWM?1'M' 0-HWP=
MH8]K,&DKK%O3<& VWDVZ #UY(#P2Q9R*%=PU;2B>6$O:N-_Z=>JQVXI)3K2%
M7D:1554P'XK0/G0IU#?C3R",IQUW+C*_0 )4R0]3\K>*4DLTD96AR%44&(ZE
MN*,1NE=,7_A[MB?;6[X&IQL5+]C8XI[(1.@OR!.A!)KT.W-8N^ER)I9B5F^A
MRIVATTDN+;YG9H7Y30D2+(:YT7WLKD!(B4<<Q3 @PO@78.<V>COWI)CHH.3N
M7)91]ZJL/VI[BYYEIQ9'^0Z_S3BO&ELX^7PQSO1=-B80(\8CKFE2%/M%I]3*
MA\6J.Z08/X#S_'FKL#ZTP1)/=ICP*+ UQJ5,2LF],US,E6T#%*[A2=5NC.JV
M.9!_X0U%T-^8$ N K,8%9DHD&A2D,0N?0:C$#8$S'5>P<=?9+!L(0#M)HD=#
ME15\K$8%J&T@$T*-?)OC*\Q$:ZDBN\C;$2-&8F1Y2")-NG[(,PYODFW5_2B@
ML:&6I>,??-4"36XEI2N(Z97?B<X-"'LY@VNFW!Q1B1@3^([9Y.TP3NA",5:U
M++#>3?6(!PS#@G%SGLV!%1(@.S>4TQ_!-R8ZF3_ZTH553<\4Y#,3SI!&^V/3
M^I*(Y<8$S$170!5A;Y-E49+=-1JYT6-FN) R!X"0UTF>_5L+=1[0V<CT%211
M36='4BD&AK7O,,>P&IW^93 X7\OY[AX[-H^] =2];!52&9B -0(LJN[P1#(A
M]\"R*+,*[=D9?!HV!UOFL;3(&>C)5$')]V[4TIQE+E7YJ/-MVUL]7^>:G]:6
M )T$: ")3@:CJ -D=&N5.WX8@C?Y:-GJ=[15R^ZL(0TT4W);.C-JGM(RLJ8[
M+')=@9X7C8Y'[R2/H68$A:6@))GHEE(X%[5,@P!A02F?\-W6.$W<T$V,+K6<
MQ)/H]F99 <$B+65>\;/BCBO%Z*%01#$2#D;:*CK<IFH-@-O^)X2]WAMX*'EA
M[@(3BNEU8VD>1@^"S49 VK'G@6C@D'==9Z]WNQD,D+N:YY]I^H539E1#"8JT
M4;!N1LJ7#(%B;L:/6%QU8W:72'YF9*%!")YE($%(,DWG1(29<_D@U0E@86_Q
M1RK["TR\F9RYX'<ZCW7.16GNDEX@E5)2YD2+"64ST<3=1K[< "R$2@XWO5#]
M2.(\IR7"^&&H)*9-GL1&M0AZTL5X3/?_+-Q9<05WH*$3'AR^B\X'%U>_1^^.
M+HZNSO!_?OX].KZX./KU['#P\\GOT6^#XU^/+J/!Z>_N_X%<YB2Z@$SFY?;6
M\57T?N"^._CU*')??G/T'CYQ]6YP11\_O#H^.XV_VECKB_UOL=9'DTN<7YP=
M'AT!)#4ZNX@.SSY 0P]/!L?OH\'%\27^_L-5=/86_GQ\B@OF-[>8+HY.!E='
M;V ]7;T[=NONEXNCH_>NF_"YJW='] &WKB[?'9]?PO?AE["(C]TJY67\LUN/
M%\?N*6XM_\^'B]_WZ%FXE"^BH_]W=73ZYA)>T5S5?B$[?QB>,CB1IVC#WUZ<
MO<>O7IY]N#@\<LT_//D 78VCGUV?3L^NHI/C]\?4C1@;>.@:?'5\]0%:+HW^
M<(H?N;QR';Z$[N$CX2?X\\71L=L[AV?OW[MOG Q^DP\,SL]/C@^9-6O@GG@$
M?[DX^N4#CTO;OAX<_M_3L]].CM[\XMZ$&]3M73<B\%O7[A,<A>VM7\].W#RY
M;O*^A\X>NS'!H;%;W [+!J,?!SUKV0;D'TA$IQ:R[TUBZ,'M=!7XISK+XK8@
MF0,X;)\>_+#_-$KV9GOBT(V1!4^<H68E/O/8&X$AN%7'MJ:D)58;T@5CZ14$
M(KKD>U.H?R;Z((Q8A+&N6ND)=\6YJFY$;D#(5-1/M((T&?^QJ.8F0,Y^XKGH
M"IR7 ) -JMQ03EWJU6KE]QN]47M629T6T7&. E.!K,]QGE0SU+2I6C+GC"W@
MVGY#,54):X>S\XM;][TY9@B\(C58M_\">1%F^<#%A@$HC9:2O<=X!7"_H?*0
M&HA9Z^0.D1'DCY#L=2RUS37Z['&9W.?>? 5U-5_PC<K$K=@ \**1]]1]?S+7
M@%T0X?\R:% />E;0G+#F_17*@Y/>.'%(NUU59G5!)S*=E9*A*_^'CBP8MCF0
M$)ATW3QDC>8\C CZD@=DZB=;Z:*U:,<P1..4$S\TDXCA<I1X$C;%!BL-XQ!4
M;/N4>T?EGGS(!@:&.DQ+I62Y!;8F4XK'06%/?^%=("^R(ZY>J+TC& W;7&:0
M+5/1PXB\K+MM4)9J(*PA*F+R7WY0IYM=K#WA/3 TP&<M$_3=0-A9#7I#Z2NP
M0-G,N9]76(D?*DH8$_/H]M8*[M'3(G_R1BMW#0.IY:B$PU*KH,>DG8W#/EA<
MN[N#&07BZ&#_X"!6"B.#;[<34U^'"UA(Z1A6 +(/I'<983LI-,YKWL<4*\T2
ME*D1UH%0BR\D=S[O&*,0+%R=_ID1_X(T#O;4K)#8 B]!63/_7WO7MMLT$$3?
M*_4?+'@!R>J%@E2HA)3>"**)J\8JZJ/3!&0*MF2W@OX].Y>=G5T[5@J%)E'Z
M4M5.MK9W?69V+N?P83"4>1&0Z'(M2QFBKN:18!2H_9<#"0))KTV19O?JSFM"
M4U!6(*4"W6^2)_7;V240;=YG8X2T*%Q>7)?&K:G$%<J5I I'!<)R*-\C\893
ME&!D5/*"2*><%B *1F&M-]Y*,_CO'K<9D %4^+_:\H<JLM01M 9PPIG!IUY3
MP0 ]IW!0+UH52XC9/DYHYIU6XPP-\:W2YVE[F%BT81?Q1):'"I-A;SL32G9)
MTPM!R\1ZDC 6*>':A'5K;[*Y<^1HUG0O,(=^@W/&:0Q4>Z/G][,4(GWT@J<5
M#((1%_""G/)94%+'N?P,[HWE5AL?EM1+(RD V1!(+UC;@&W>K@[@2=%ZSA*[
MB[R^0=6/LE9>1$OJ94;?>KL2:D6C;FX Z3W6E"#AO2BHZ'@G?:,OH79Y_O;_
MF16)8HZ* 9HF)F^7]-5OJ4ST&#@DU:;%R3*?R!8C15'#0@4L793>_]23SNR<
M]6$)/K]C*M2 -U:K9;M?6YR]_"1HZ#'7[!^@]>%Z X_01O!3/J?626U<5JAR
M=" +^P9'JXE[-S93=EGXX!9[@K,\JC4=6$2RK(&\W74@[X\#>2'9!2;5'5<C
M<CV#=U,W5AAAAF-$@16GG?Q[W#A*^W^@BXV[T*R=4]: DW><RB@X<2&>/VD2
MJ,P.*W7>Z!<OR%(S@[(]T]?YR,;UOXMF]*?%?.)4<@K!B2.7?PG.)))Y"$X,
M.,^4V!Z'8K(-5T5GAW=5K;Z$0J*@*&J+^2[/83]9@$>#VJ)U[GPDU;0LHPLD
MD5<B/<YQ=#']"G"R9Z_4CC+KQO10X/&!>X"EA03U*CR5%Y!:<I2HM$VTX)?_
M@$Q;AMK!8^03)5X=N_^VD'DNWU(E(/>JO"/&U<$%-C$EU<SR XT9:C.X)LU5
M* <ECPVQ\5MI?-0(BC_,K@",XQW$4:10@_^^+IUBLX"HU3[-=264DEC#"_P@
M"YI7U_(6J;]YM<;;QW-"/@[-':3#D]$H^@SA_.04O A_/\2UQEA<A*'=1M"&
MH[O.A=_<@'9($' 33[SF;#20Y+>QRF>$)Z42>?^25_5ME(W-XK4 WL@'_ 7G
M"<X(3QF&;)X]G ;E]<X_I$'IY#W9F9?W9'<&[\G;)^,]\?MW#XE9)!D,(&<%
M6:7>6=J/1E>C]&0PBB$!MH4>[JIURA[>S]$H_YAMLMC&.48]9G?H%X0ZS T]
MW\&?!T+(=KT=I=/*&-;^5M2?%A.@]5Q!7@.4D5K^Z?(Y9;IFZO^\_:%Q?Q'N
M3/</7K:U"Y/A7YN!E3(#P^2R-TP9_]>XO]!  KA_E%7?HQ[D7\HUYB_N5'70
MW"PD^ N==C?V+^/6=:][ZVK0+CF^,@?[Z>#L_6]02P,$%     @ X(-<5@$O
M*BR?!@  DA<  !$   !D-#0Y,#DW9&5X.3DQ+FAT;>U8:W/:.!3]GIG\ASOL
M;F<[ P3(.R',$' "6QX9<-/-1V$+K,:6O):!LK]^CV2<D*1M9K=I9CO3+V#+
M5]*YCW.N['K'[?<:]8[3;#>VM^INU^TY#>?/TO%QN5K?R6XQOK,VH/KYL'U#
MYY>M86\X.BM\Z'1=I]"@[2T8M;A,>=*HM[O7-'9O>LY982G\-#@Y*N\+62 6
MBID\*X1\FA;L6E>Y6<22F9"E5,4GE3@]I?7]1*6IBK*AJ9)I28N_^4GU_G[*
M(A&N3EP1<4T#OJ21BAAV:O:ZEX.S0B)F ;:JGS><3X&8B)2,6U3?.6_4=ZX:
M&P V5J]A]4=XGL I--[(B8Y/S2IP_$M^?&:>"11F=/N7-!ZUS@JSO;WCRO'A
MK%*K'54K>[7*[E&M6OX8SXP3[EFA-[P<9L%Z"'AC)XOXI4+FV1S:F+6&_?[[
M0=>](22_YW9H?#-VG?Z8FH/!\/V@Y8RI[5QT8=&]=JAY.7*<OC-P[\+[E<!\
M![3ND,9.KT?NAR$-AB/ ;35'PUYWT*3.<'S5=9N],;GFV743(-<N/8/U14+;
MN!@U!^^ I$@NE[),OU_P23)GR8IJ1T6J56J[;^G-+]7]RBFU5!3-I4A7U.$L
M3 ,:KW3*(UVDKO0P<W S=DZH==-Y2TQ*-9<>]RE5/EM1&K"4]'RBA2]8(@!!
M33'(S9HQDRL*V(*3!@4QA6UO^7PJL)/ ()LEG$>()9;*"EOS,*3ZQ1"1RID<
MB)27=,P\?B+5,F%QH5&M[98FW*_O&,,&]=@MIX%*X#2-^$PHR4+J<U]X^,_$
MH0C8Q+QYRLEC":= Z5BD>"PD]95*N%Z(,.1%&K2,J4]MMA#Z2ZN96>.4I0]F
M :@7$";AH7$_3I3'M8G&]E::,*GALY)"SFB:J(@8S;CD"=;\'*Q4&<!"QBP5
M)CX3CB@*9<R#+$&Y:3$+G,&,745"3&OE"8#SS25/D4.L]CA! [5@6'>=[:E*
M $ 'Y"G@] '+8#5V+(8?GT2$]<(5_;I;JV3[H>)"F)3INU>QBUC:^#'/@D*$
M^:>8>ZFM0/)"I3F%S*0E#?!PQ1G2#7\_PL9:S#5V-F6?\-D<E@J7UJ\%"[7-
MMEG$9 ;N^S9-^I4<R[-HJL8+YSY\LN4#/S9]-K7!(@6$IK*8GX%$,<0J17D(
M7/D@E$Y%.D<MXT;#:XW5E-SD(MB^=W"J@6N>(.U_00Q,W$P(,M)M;WV%=B:R
M)2[O> <%J1'&3%%KU$\8EK_6+HY>(FA0W.9$S=.L"I^1K6=4]N E #T# 8E4
MDN>2*"VO\BR$V!HY6S/:"H!G\P2.ELE]FC8VG8K04%O;B@@Y\TW5FDHVI+7$
MOE]L>TOS9"$@0D7R^8*'*C;6)MDJMA3'W<;>/@]10^"&SCPPE;BW;VH)EJ 2
M(G4+.8%>)0JZ5CT@;36P3*W.^)' +"$>B0$(;AX>WP/W-RI^*1"MA_I2W2U6
M*A6HG:\W<'**H-"FT4BJ6@-H:29C!GAQS1VXL[T5!RLM('\243'DL=[/$6>(
M719AJ^ 8G*+WP %I0X@N9&R\%:(0@Q2F*<%&>=X\9FNN1:8'""33"]' /#P&
M[)F5C7Q-CZ$Q)OF]=8%%DUQSM,&!__7C,HT#9MB*.#]3108X],"_)[2IP!N5
MW*(/*>]V>\OYY"$\,TYSZ5LE1,M=11,5F@Z_=WB*UETV5T>GZ'=83<BI:9B9
MNAA"/6C9\ -),#(A[8X":5_RB0D[H=LOE\NR%^BRY.D3QG_#B9;,BT#SO.=0
M"R>J\56SU1U<GA4J!7M_U6RW\_L/W;;;.2M4*Y7?"G0^'+6=D1U?8\A&2GA7
MZ#6O<'#)+[Y*Y<>\?W+8,P=H"W'46%^T[X#L_P9IVG';]T^NU[,S5^\AYX8/
M%SBJY>/X&6ULE;L4LQDO31+.;DO"MN@3ME#"IW_G4N,1.*2ET.A*TSE UQ:,
MP1E]L@GPD1_K=.5)>VIGEWS'%RCJ/\K481':EK[W[-6\^F8?KD!-(()N&!JW
M L&G="$D&&[:[1"*!JJ_KF,/\7^+A[G=LT?M9PT.JONEO8/]TB%T>7TPN/O[
M\9*N7CFC+X-Z'."U:47OT%&\P)S[S#M)J]_\(7WA$N\YU!8)CN\J,0UP+4\C
M'MI^]<IJ\G\F7>UPM_:3=/\)M7FC9WG+^_:.-^(3[GF,FBN<OJY$FO[H17J-
M]D9W/1!RHI)8V</X^JSJ_23C8S+N?[$#FD_9]FC[FM]22\Z@7<J_8^RTN]?
MLOY6GATO=\Q'=0S:;_'_ %!+ 0(4 Q0    ( ."#7%;=X1Q".@,  #D+   0
M              "  0    !C>6@M,C R,S R,C@N>'-D4$L! A0#%     @
MX(-<5L+/*A9?!@  O4,  !0              ( !: ,  &-Y:"TR,#(S,#(R
M.%]L86(N>&UL4$L! A0#%     @ X(-<5B!,,>RR!   <"H  !0
M     ( !^0D  &-Y:"TR,#(S,#(R.%]P<F4N>&UL4$L! A0#%     @ X(-<
M5G9M;77/%@  &X,   X              ( !W0X  &0T-#DP.3=D.&LN:'1M
M4$L! A0#%     @ X(-<5D7\"Q%E]   ;.D& !               ( !V"4
M &0T-#DP.3=D97@R,2YH=&U02P$"% ,4    " #@@UQ6 2\J+)\&  "2%P
M$0              @ %K&@$ 9#0T.3 Y-V1E>#DY,2YH=&U02P4&      8
,!@![ 0  .2$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
